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Abstract 
 
The important human pathogen Pseudomonas aeruginosa causes a broad-spectrum of 
diseases including life threatening infections. A cell density-dependent regulatory network 
termed quorum sensing (QS) is pivotal in the control of P. aeruginosa pathogenicity, and 
the signal molecules employed are N-acyl-L-homoserine lactones (AHLs) and the 
Pseudomonas quinolone signal (PQS). Production of these QS signal molecules (QSSMs) 
requires precursors including fatty acids, S-adenosyl-L-methionine (SAM) and aromatic 
amino acids. SAM is derived from the activated methyl cycle (AMC) which is an 
important pathway dedicated to the degradation of the toxic metabolite S-adenosyl-L-
homocysteine (SAH). Through removing the genes encoding the AHL synthases, RhlI 
and LasI from the complex hierarchical system of P. aeruginosa by expressing them in the 
heterologous host, Escherichia coli, this study has measured the influence of AHL 
production upon bacterial metabolism. AHL profiles were broader than previously 
reported, correlated with a reduction in the intracellular concentrations of several 
metabolites, and were more pronounced in the E. coli strain producing the LasI synthase 
than the RhlI enzyme. Production of foreign QSSM synthases had a knock-on effect on 
the native E. coli QSSM, autoinducer-2 (AI-2). We hypothesize that AI-2 production was 
significantly reduced since it also requires AMC metabolites for its synthesis. The 
influence that these metabolic perturbations had on cell fitness was manifest through 
reduced growth in minimal media. Complementation of growth by exogenously added 
metabolites confirmed our hypothesis that QSSM synthesis creates a drain on metabolite 
levels with consequences for cell fitness. Site-directed mutagenesis of key catalytic 
residues in the QSSM synthases was performed to directly prove that the effects 
observed were due to the function of the synthases, and not the production of a 
heterologous protein. Moreover, complete profiling of P. aeruginosa PA01 AHL synthase 
mutants is unravelling the interrelationship between metabolism and cell-to-cell 
communication in P. aeruginosa. 
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HPLC   high-performance liquid chromatography 
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i-BuOH  iso-butanol 
IPTG   isopropylthio-E-D-galacto-pyranoside 
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kDa   kilodalton 
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LB   Luria Bertani 
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xx 
 
MeOH  methanol 
MET   methionine 
min   minute 
mg    milligram 
ml   millilitre 
mm   millimetre 
mM    millimolar concentration 
MMM   MOPS minimal media 
MOPS   4-morpholinepropanesulfonic acid 
MS/MS  tandem mass spectrometry 
MTA   ·-methylthioadenosine 
MTR   ·-methylthioribose 
Ƭ)   microfaraday 
ƬJ   microgram 
ƬO   microlitre 
ƬP   micrometre 
PM   micromolar concentration 
NADPH  nicotinamide adenine dinucleotide phosphate 
NCC   negative control condition 
NHQ   2-nonyl-4-quinolone 
nm    nanometre 
OC6-HSL  N-(3-oxohexanoyl)-L-homoserine lactone 
OC8-HSL  N-(3-oxooctanoyl)-L-homoserine lactone 
OC10-HSL  N-(3-oxodecanoyl)-L-homoserine lactone 
OC12-HSL  N-(3-oxododecanoyl)-L-homoserine lactone 
OC14-HSL  N-(3-oxotetradecanoyl)-L-homoserine lactone 
xxi 
 
OD   optical density 
O/N   overnight 
ORF   open reading frame 
pBS   pBluescript vector 
PBS    phosphate buffered saline 
PCR   polymerase chain reaction 
PDB   protein data bank 
psi   pounds per square inch pressure 
PQS   Pseudomonas quinolone signal; 
   2-heptyl-3-hydroxy-4-quinolone 
QS   quorum sensing 
QSSM   quorum sensing signal molecule 
R   resistance 
RE   restriction enzyme 
RNA   ribonucleic acid 
rpm   revolutions per minute 
RT   room temperature 
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1.1 Quorum sensing 
For many years, bacteria were considered as autonomous unicellular organisms deprived 
of the cognitive and co-operative capacities that characterise collective behaviour. A 
VWDWHPHQW E\ )UDQFRLV -DFRE  VXPV XS WKDW ORQJ WKRXJKW YLHZ ´,W LV SHUIHFWO\
possible to imagine a rather boring Universe without sex, without hormones and without 
nervous systems peopled only by individual cells reproducing ad infinitum. This Universe 
LQIDFWH[LVWV,WLVWKHRQHIRUPHGE\DFXOWXUHRIEDFWHULDµ&XUUHQWNQRZOHGJHRSSRVHV
those dated opinions; in fact, the strength of co-operative social community offers far 
greater benefit as can be demonstrated by a plethora of examples outside the microbial 
world. The discovery of the co-operative regulation of bioluminescence in two marine 
bacterial species, Vibrio fisheri and Vibrio harveyi marked this historical transition. These 
bacteria demonstrated a co-ordinated behavioural phenotype which was governed by the 
expression and secretion of specific signalling molecules in a cell-density-dependent 
manner. Accumulation of these small, diffusible, low-molecular weight autoinducer (AI) 
or quorum sensing signal molecules (QSSMs) to a critical threshold concentration in the 
immediate environment triggers alterations in the expression of target genes (Figure 1.1). 
The communicative phenomenon highlights the importance of a sufficient number or 
¶TXRUXP·RIEDFWHULDWREHSUHVHQWLQWKHSRSXODWLRQKHQFHWKHWHUP´TXRUXPVHQVLQJµ 
(QS) was born (Fuqua, Winans & Greenberg 1994). Table 1.1 lists a selection of bacteria 
which have been shown to utilise QS, the AI molecules exploited and some of the 
regulated phenotypes. However, it is important to note that quorum sensing does not 
function in isolation; such a sophisticated mechanism is considered to act in conjunction 
with several other parameters which a bacterial cell must integrate in order to adapt and 
survive within a given ecological niche. 
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Figure 1.1: Quorum sensing (QS): Cell to cell communication in a bacterial population. Though bacterial cells secrete chemical (purple triangles), the low 
concentration of signal molecules in the environment does not alter gene expression. Once a specific cell density has been attained and a threshold signal 
concentration has been exceeded, this triggers signal concentration dependent gene expression. 
  
Figure 1.2: QS in Gram-negative bacteria. [A] At low population densities, the concentration of the AI is low and is unable to bind to the corresponding 
transcriptional regulator protein due to unfavourable binding kinetics. [B] At higher population densities, the concentration of the AI exceeds a threshold level 
and induces a conformational change in the transcriptional regulator protein, allowing it to bind. The transcriptional regulator-signal complex activates further 
production of the signal and the expression of various QS dependent phenotypes. 
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Bacterial Species 
 
QS System AI Identity Phenotype 
Agrobacterium 
tumefaciens 
TraI/TraR OC8-HSL Ti plasmid conjugal 
transfer (tra, trb) 
Bacillus subtilis ComP/ComA ComX; CSF 
(competence and 
sporulation factor) 
Competence; 
sporulation 
Chromobacterium 
violaceum 
CviI/CviR OC6-HSL Violacein, HCN, 
antibiotics; 
exopreseases 
Escherichia coli ?/SdiA ? Cell division 
(ftsQAZ; 
chromosome 
replication 
Erwinia carotovora (a) ExpI/ExpR;  
(b) CarI/CarR 
OC6-HSL (a) Exoenzymes;  
(b) carbapenam 
antibiotics 
Pseudomonas 
aeruginosa 
(a) LasI/LasR; 
 
 
 
(b) RhlI/RhlR 
(a) OC12-HSL;  
 
 
 
(b) C4-HSL 
(a) Exoprotease 
virulence factors 
(lasA, lasB, toxR); 
biofilm formation 
(b) protease (lasB); 
rhamnolipids 
(rhlAB); stationary 
phase 
Rhizobium 
leguminosarum 
(a) RhiI/RhiR;  
 
 
(b) CinI/CinR 
(a) C6-HSL;  
 
 
(b) HC14:1-HSL 
(a) Rhizosphere 
genes (rhiABC); 
stationary phase; 
(b) QS regulatory 
cascade 
Salmonella 
typhimurium 
LuxS AI-2 Lsr ABC 
transporter 
Serratia liquefaciens SwrI/? C4-HSL Swarming motility; 
exoprotease 
Staphylococcus aureus AgrC/AgrA AIP (autoinducing 
peptide) 
Exoenzymes; 
exotoxins 
Steptococcus 
pneumoniae 
ComD/ComE CSP (competence 
stimulating peptide) 
Competence 
- 5 - 
 
Vibrio cholera LuxS AI-2 Biofilm formation, 
cholera toxin, toxin 
co-regulated pilus, 
haemagglutinin 
Protease 
Vibrio fisheri LuxI/LuxR OC6-HSL; C8-HSL Bioluminescence 
(luxICDABE) 
Vibrio harveyi LuxS AI-2 Bioluminescence, 
type III secretion, 
metalloprotease, 
siderophore, colony 
morphology 
Yersinia 
pseudotuberculosis 
(a) YpsI/YpsR;  
(b) YtbI/YtbR 
(a) OC6-HSL;  
(b) C8-HSL 
Aggregation, 
motility 
Table 1.1: Examples of QS mediated gene regulation in bacteria. Pertinent 
examples are given of phenotypes as for some, including P. aeruginosa, but not all are 
listed. 
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1.1.1 Interspecies communication 
The QSSM made by the greatest number of bacterial species, a collection that includes 
both Gram-positives and Gram-negatives, is autoinducer-2 (AI-2). For this reason, it has 
been proposed that AI-2 may mediate communication between different species. AI-2 
was first discovered as a cell-to-cell signal molecule in the marine pathogen V. harveyi, 
where it regulates bioluminescence through a complex independent phosphorelay 
cascade. The ease in detection of extracellular AI-2 using the V. harveyi bioluminescence 
induction biosensor led to the discovery of functionally equivalent signalling molecules 
produced by many bacterial species. The LuxS synthase (Surette, Miller & Bassler 1999), 
responsible for producing the AI-2 precursor, has also been identified in many species 
and recent figures indicate its presence in approximately half of all sequenced Gram-
positive and Gram-negative bacterial genomes (National Centre for Biotechnology 
Information, NCBI). Despite the identification of the LuxS synthase and confirmation of 
AI-2 activity as a global regulator of gene expression, the precise chemical nature of the 
AI-2 molecule secreted with respect to individual species may vary. This may be a 
consequence of the spontaneous chemical interchange that occurs between the different 
molecules that constitute the cocktail of AI-2. 
The AI-2 precursor molecule, 4,5-dihydroxy-2,3-pentanedione (DPD), is a highly reactive 
product that can rearrange and undergo further reactions forming various structural 
derivatizations with similar stereochemistries (Miller et al. 2004). In V. harveyi, the 
cyclization pathway leading to AI-2 formation involves hydration of (2S, 4S)-2,4-
dihydroxy-2-methyldihydrofuran-3-one (S-DHMF), one of two epimeric furanoses, 
followed by borate addition, forming (2S, 4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran-borate (S-THMF-borate) (Chen et al. 2002). The structural 
identification of boron in a QSSM under these circumstances appears to be unusual, but 
provides a feasible explanation for the biological dependency for the element (Chen et al. 
2002, Winans 2002). In contrast, Salmonella typhimurium recognizes another derivative, 
proposed to be (2R, 4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R-THMF), 
formed simply by hydration of the other epimeric furanose (R-DHMF) (Miller et al. 
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2004)7KHUHIRUHWKH´$,-µDEEUHYLDWLRQLVDFROOHFWLYHWHUPXVHGWRGHVFULEHWKHJURXS
of furanone derivatives which form spontaneously from the common DPD precursor. 
The primary role of AI-2 as a signal molecule in QS is extremely controversial. The DPD 
precursor synthesised by the LuxS enzyme is a by-product of the main conversion of 
substrate S-ribosyl-L-homocysteine (SRH) to homocysteine (HYC), which is an essential 
step in a fundamental recycling pathway referred to as the activated methyl cycle (AMC). 
Therefore, one potential explanation for the lack of evidence for a role of AI-2 in QS in 
some species may be due to AI-2 by-production occurring solely as a result of the AMC, 
rather than for exploitation for QS. Under these circumstances, the activity of LuxS is 
maintained because the metabolic role of the AMC is important to the cell. Further to 
this, attempts to restore phenotypes of mutants defective in AI-2 production to those of 
the parent by the addition of exogenous signal have not all resulted in complementation 
(DeLisa et al. 2001, Sperandio et al. 2001; Hardie et al. 2003), suggesting a primarily 
metabolic role for LuxS. In addition, there is a significant lack of evidence for the 
presence of important functional components including sensors, receptors and response 
regulators necessary for the corresponding signalling cascade (Sun et al. 2004, Rezzonico 
& Duffy, 2007, Bjarnsholt & Givskov 2008). 
1.1.2 Intraspecies communication 
Unlike AI-2, most QSSMs are species specific and enable intraspecies communication. In 
doing so, a species can use the QSSM to monitor its own population density without 
noise from co-habitants, enabling it to control gene expression accordingly. 
1.1.2.1 QS in Gram-positive bacteria 
Gram-positive bacteria use peptide-based QS signals and membrane bound sensor 
histidine kinases in a two-component signal transduction system (TCS); this mechanism 
allows the modulation of gene expression through a DNA binding protein termed the 
response regulator (Waters & Bassler 2005). The peptide-based signals are different from 
other types in that their secretion requires dedicated signal export channels. In the 
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majority of circumstances, these channels often transport the signal concomitantly with 
processing and modification such as the addition of thioactone rings (e.g. the 
autoinducing peptide of Staphylococcus aureus), lanthinines (lantibiotics such as nisin 
produced by Lactococcus lactis) and isoprenyl groups (the comX pheromone of Bacillus 
subtilis) (Waters & Bassler 2005). 
1.1.2.2 QS in Gram-negative bacteria 
Gram-negative bacteria exploit a variety of small AI molecules for cell-to-cell 
communication. The best studied signalling systems use a family of molecules referred to 
as N-acyl-L-homoserine lactones (AHLs), which have been found to be produced in at 
least 70 different bacterial species. AHL-dependent QS circuits are regulated by two 
component sensory systems LQZKLFKDVSHFLILFV\QWKDVH¶,·SURWHLQJHQHUDWHVWKHVLJQDO
molecules. After diffusing into the environment, these signals can enter other bacterial 
cells and bind to the N-terminal AHL binding domain of a cognate transcriptional 
regulator ¶5·SURWHLQZKLFKDFWVDVWKHVHQVRUWRWKHV\VWHP$WORZSRSXODWLRQGHQVLWLHV
both proteins are produced at basal levels. When a sufficient concentration of the AI has 
been attained, itVELQGLQJWRWKH¶5·SURWHLQHOLFLWVDFRQIRUPDWLRQDOFKDQJHLQWKHprotein 
to allow it to bind via a C-terminal DNA-binding domain and alter the expression of a 
subset of QS controlled genes. The signal-¶5· SURWHLQ FRPSOH[ FDQ IXUWKHU DFWLYDWH
expression of those genes responsible for the production of the signal synthase protein, 
thus creating a positive feedback loop with increasing concentration of the specific AI 
(Figure 1.2). 
This phenomenon was first reported as a QS system in the regulation of bioluminescence 
in the marine bacterium V. fisheri, a property which allows the organism to live in 
symbiotic association with a number of eukaryotic hosts. In these circumstances, the 
regulatory proteins, LuxI and LuxR, regulate production of the luciferase enzyme, 
luxCDABE, which exists as part of a luxICDABE operon. LuxI synthesises the signal, N-
(3-oxohexanoyl)-L-homoserine lactone (OC6-HSL), whilst LuxR binds this signal, 
unmasks the LuxR DNA binding domain, allowing it to bind to the luxICDABE 
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promoter and activate its transcription. A positive feedback circuit means that an 
exponential increase in growth accompanies similar increases in production of OC6-HSL 
and thus light emission.  Many LuxI/LuxR homologous systems have been now been 
uncovered in other Gram-negative bacteria, some of which have been listed in Table 1.1; 
these have diverse biological roles that enable adaptation of a particular bacterial species 
to its specialized niche. 
1.2 The genus Pseudomonas 
The Pseudomonads are a class of gamma Proteobacteria belonging to the family 
Pseudomonadaceae. They are aerobic, non-spore forming, oxidase-positive Gram-
negative bacilli. These bacteria are extremely versatile, having incredible nutritional 
versatility which allows adaptability to multiple natural environmental niches, including 
soil, marches and water reservoirs, as well as vegetation and animal tissues. The most 
extensively studied member of this genus is Pseudomonas aeruginosa, a clinically relevant 
RSSRUWXQLVWLFSDWKRJHQRIWKHKXPDQKRVWZKLFKKDVEHHQODEHOOHGDVD´VXSHUEXJµE\
the media by virtue of its prevalence in nosocomial environments and resistance to 
multiple antibiotics. Other members of this genus include the plant pathogen Pseudomonas 
syringae, bioremediation agents Pseudomonas putida and Pseudomonas fluorescens and several 
species known for their ability to cause food spoilage, Pseudomonas fragi, Pseudomonas 
mudicolens and Pseudomonas lundensis. Until 2000, the genus comprised over 100 species; 
however, the advancement in genotyping methods, primarily use of 16S rRNA 
sequencing has led to phylogenetic reclassification of many bacterial species to other 
taxonomic locations including Burkholderia spp., Ralstonia spp., Brevundimonas spp. and 
Stenotrophomonas spp (Anzai et al. 2000). 
1.2.1 Pseudomonas aeruginosa 
P. aeruginosa was first described as a unique bacterial species at the end of the 19th century, 
after the development of sterile culture media by Pasteur. In 1882, the first scientific 
study on the bacterium was published by a pharmacist named Carle Gessard. P. aeruginosa 
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is a rod-shaped bacterium, with a size of approximately 0.5-1.0 Pm in breadth and 1-5 
Pm in length. The bacterium is monoflagellated and demonstrates unipolar motility. 
Growth and division of the organism is characterised by the appearance of 
microscopically-defined clusters of pearlescent spherical colonies. Of particular 
significance, P. aeruginosa secretes aminoacetophenone, giving a distinctive grapelike 
odour and pyocyanin, a derivative of phenazine which produces a characteristic blue-
green pigmentation; these are often valuable in providing viable measures in the definitive 
identification of the bacterium. The latter characteristic has also been illustrated in old 
names for the organism: Bacillus pyocyaneus, Bakterium aeruginosa, Pseudomonas polycolor, and 
Pseudomonas pyocyaneus. In terms of its metabolic activity, the bacterium is adaptable to a 
variety of environmental conditions. P. aeruginosa is an obligate aerobe, but due to its 
capability to synthesize arginine, P. aeruginosa can also proliferate in anaerobic conditions. 
It is able to grow within a reasonably large temperature range, optimally at 37 qC, but 
notably up to 43 qC (Lyczak et al. 2000). Consequently, as well as being found amongst 
soil, water, humans, animals, plants, sewage, and hospitals, P. aeruginosa has the ability to 
survive in some fairly unusual conditions which include concentrated nitrogenous 
environments, high mercury concentrations and amongst fuels such as diesel where it 
utilises the hydrocarbon components. Complete genome sequencing of P. aeruginosa PA01 
revealed it constitutes 6.3 Mbp and 5,570 predicted open reading frames (ORFs) (Stover 
et al. 2000). This represents one of the largest bacterial genomes to be sequenced to date, 
having the genetic complexity of a smaller eukaryotic organism, such as Saccharomyces 
cerevisiae. 
1.2.1.1 Clinical significance of P. aeruginosa 
As mentioned, P. aeruginosa is an extremely versatile organism, ubiquitous to numerous 
ecological niches. More significantly, however, P. aeruginosa is known for its ability to 
persist as a dangerous and medically significant human pathogen capable of causing a 
broad-spectrum of mild to potentially life threatening conditions. The latter is invariably 
GHSHQGHQWRQWKHRUJDQLVP·VSUHGRPLQDQWRSSRUWXQLVWLFEHKDYLRXU0RUHVSHFLILFally, P. 
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aeruginosa is associated with a wide variety of community-acquired infections including 
ulcerative keratitis, otitis externa and skin and soft tissue infections with contact lens 
solutions, swimming pools and hydrotherapy pools offering possible sources of 
contamination. Individuals with burns and wounds are also susceptible to infection; upon 
destruction of the natural skin barrier, P. aeruginosa is able to colonise the lower layers of 
the skin and can release degradative enzymes to cause further destruction whilst 
simultaneously imposing immune modulatory effects in the host. P. aeruginosa infections 
are often established in patients with primary immunodeficiencies such as those with 
cancer or AIDS. In addition, the existence of hospital-acquired nosocomial infections 
such as pneumonia, urinary tract infections (UTIs), and bacteraemia account for an 
estimated 10,000 cases each year in UK hospitals (Lister, Wolter & Hanson 2009; Mayor 
2000; Spencer 1996); often, these are associated with medical interceptive measures such 
as lumbar punctures, intravenous infusions and intravascular catheters, where P. aeruginosa 
IRUPVFRPSOH[ ¶ELRILOP·EDFWHULDOFRPPXQLWLHVWKDWDGKHUHWRWKHVXUIDFHRIELRPHGLFDO
devices. The persistent colonisation of the sinopulmonary tract in cystic fibrosis (CF) 
SDWLHQWVKLJKOLJKWVWKHEDFWHULD·s best known role, with an estimated 80% of adults with 
CF carrying P. aeruginosa in their lungs; chronic and recurrent respiratory infections in 
these individuals ensures a progressively worsening morbid state, eventually leading to 
mortality (George, Jones & Middleton 2009; Doring et al. 2000). Furthermore, the 
treatment of conditions caused by P. aeruginosa is significantly more problematic due to 
the continual acquisition of intrinsic antibiotic resistance leading to multi-drug resistant 
(MDR) strains, which typically exhibit several resistance mechanisms simultaneously (El 
Solh & Alhajhusain 2009; Lister, Wolter & Hanson 2009; Driscoll, Brody & Kollef 2007). 
This further highlights the LPSRUWDQFHRIWKHRUJDQLVP·VLQWULQVLFYLUXOHQFHDQGWKHQHHG
to explore its pathogenic nature. 
1.2.1.2 Virulence determinants of P. aeruginosa 
P. aeruginosa virulence is generally thought to be multifactorial and attributable to several 
aspects of the orgDQLVP·VYDULDEOHSURWHLQ H[SUHVVLRQSURILOH7DEOH VXPPDULVHV WKH
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function of a selection of virulence determinants displayed by P. aeruginosa. These include 
a wide range of mechanisms encoded chromosomally and/or on plasmids.  
Cell surface components include the production of a single flagellum, multiple pili, and 
the biosurfactant rhamnolipid, all of which confer motility and adherence to host 
surfaces. P. aeruginosa as a pathogen is an interesting organism in that it relies heavily on 
the secretion of virulence determinants including several exoenzymes; these disrupt host 
immune defences and mediate damage to target cells whilst simultaneously allowing the 
provision of nutrients to the bacteria. Specific examples of virulence determinants 
secreted by P. aeruginosa include enzymes (elastase, LasA protease, alkaline protease), 
toxins, pigments (pyocyanin, pyoverdin and pyorubin) and other metabolites. 
Biofilm formation is another important characteristic of P. aeruginosa; distinct from 
planktonic growth are the bacteria that adhere to a living or non-living surface and/or 
each other thereby forming a complex community of cells. Development of biofilms is 
facilitated by an H[WUDFHOOXODU SRO\PHULF PDWUL[ RU ´VOLPHµ RI VHFUHWHG SRO\VDFFKDULGHV
proteins and nucleic acids and water channels that distribute nutrients, oxygen and 
signalling molecules and remove metabolic waste products (Costerton 1995). Bacterial 
accumulation through biofilms increases the possibility for horizontal gene transfer and 
metabolic interactions, conferring resistance to antibiotics and the host immune system, 
thus the biofilm lifestyle supports survival in hostile environments (Mah et al. 2003; 
Burmolle et al. 2006). The development of a biofilm is thought to occur in five distinct 
stages: (i) initial attachment, (ii) irreversible attachment, (iii) maturation-I, (iv) maturation-
II and (v) dispersal (Sauer et al. 2002). Most notably the stages involved in biofilm 
formation highlight the important role of communication within the microbial 
community. Indeed, communication via QS by P. aeruginosa is essential for the collective 
regulation of gene transcription having subsequent and simultaneous effects on 
metabolism, protein synthesis and virulence. 
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Virulence 
determinant 
 
Biological function Reference 
Alkaline protease Inactivation of protease inhibitors 
and complement proteins; 
hydrolysis of fibrinogen and fibrin. 
Howe & Iglewski 1984; 
Hong & Ghebrehiwet 1992; 
Gambello, Kaye & Iglewski 
1993; Latifi et al. 1995 
Alginate Viscous exopolysaccharide; 
increases adherence to respiratory 
epithelia; inhibits phagocytosis; 
increases resistance to antibiotics 
and disinfectants 
Doig et al. 1987; Leid et al. 
2005 
Elastase Degrades elastin leading to 
breakdown of host tissue. 
Blackwood et al. 1983; 
Elsheikh et al. 1987; Toder et 
al. 1994 
Exoenzyme S GTPase activating protein; ADP-
ribosylation of GTP-binding 
proteins; inhibits phagocytosis. 
Iglewski et al. 1978; Nicas et 
al. 1985a; Nicas et al. 1985b; 
Knight et al. 1995 
Exoenzyme T GTPase activating protein; inhibits 
host-cell division and 
phagocytosis; induces epithelial 
cell apoptosis 
Krall et al. 2000; Shafikhani 
& Engel 2006; Shafikhani, 
Morales & Engel 2008 
Exoenzyme U Phospholipase; induces acute 
cytotoxicity and epithelial injury 
Finck-Barbancon et al. 2007; 
Sato et al. 2003 
Exotoxin A Catalyses ADP-ribosylation 
causing inactivation of elongation 
factor 2; inhibits protein synthesis; 
induces tissue damage and host 
immunosuppression. 
Iglewski, Liu, & Kabat 1977; 
Blackwood et al. 1983; Wick, 
Hamood, & Iglewski 1990; 
Gambello, Kaye & Iglewski 
1993; Armstrong, Yates & 
Merrill 2002 
Flagella Swimming and swarming motility; 
adherence to cell surfaces. 
Arora et al. 1998; 
Hydrogen 
cyanide (HCN) 
Inhibits aerobic respiration in host 
cells; accumulates in CF lungs. 
Pessi & Haas 2000; 
Gallagher & Manoil 2001; 
Ryall et al. 2008 
LasA protease 
(staphylolysin) 
Serine protease; nicks elastin 
increasing sensitivity to LasB 
elastase, alkaline protease, and 
Kessler et al. 1993 
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neutrophil elastase degradation. 
LasB protease Zinc metalloprotease; degrades 
elastin. 
 
Lectins 
(LecA/LecB) 
Mediate adhesion to host epithelial 
surfaces; cytotoxins; inhibit human 
ciliary beating 
Glick & Garber 1983; 
Bajolet-Laudinat et al. 1994; 
Winzer et al. 2000 
Lipase Cleaves lipids; degrades platelets, 
granulocytes and monocytes. 
Konig et al. 1996 
LPS Outermembrane glycolipid; 
stimulates host inflammatory 
responses; impedes diffusion of 
antibiotics. 
Pier 2007; Nakamura et al. 
2008 
Neuraminidase Cleaves sialic acid residues on host 
cell surfaces; enhances pilin-
mediated adhesion; contributes to 
biofilm formation. 
Cacalano et al. 1992; Soong et 
al. 2006 
Pili Swimming and swarming motility; 
adherence to cell surfaces. 
Hazlett et al. 1991; Comolli et 
al. 1999 
Phospholipase C Heamolysin; induces vascular 
permeability; mediates tissue 
invasion. 
Meyers & Berk 1990 
Pyochelin & 
Pyoverdine 
Siderophores; allow iron 
acquisition from the host; 
catalyses the formation of free 
radicals to cause damage to tissue. 
Meyer et al. 1996; Britigan et 
al. 1997 
Pyocyanin Redox-active phenazine pigment; 
interferes with ion transport; 
stimulates inflammatory response. 
Brint & Ohman 1995; Latifi 
et al. 1995; Parsek & 
Greenberg 2000; Mavrodi et 
al. 2001 
Rhamnolipids Heamolysin; glycolipid 
biosurfactant; solubilisation of 
lung surfactant phospholipids to 
assist phospholipase C; inhibits 
mucociliary transport and ciliary 
function of host respiratory 
epithelium. 
Ochsner et al. 1994; Ochsner 
& Reiser 1995; Lang & 
Wullbrandt 1999; Pearson, 
Pesci & Iglewski 1997 
Table 1.2: Selected virulence factors of P. aeruginosa and their biological effects. 
- 15 - 
 
1.3 QS in P. aeruginosa 
P. aeruginosa is a species in which cell-to-cell communication systems have been intensely 
investigated. Microarray studies have suggested that 6% of the P. aeruginosa genome is 
regulated by QS (Schuster et al. 2003; Wagner et al. 2003). Figure 1.3 summarises the QS 
system of P. aeruginosa, including regulators. Like many Gram-negative bacteria, P. 
aeruginosa possesses two AHL-dependent QS circuits; these LuxRI homologues are 
recognised as the las and rhl systems. The las system was the first cell-to-cell signalling 
system to be described in P. aeruginosa as a regulator of the expression of the LasB 
elastase, hence the origin of its name. This system includes the transcriptional activator 
LasR (Gambello & Iglewski 1991), and the AHL synthase, LasI (Passador et al. 1993), 
which regulates the production of primary N-(3-oxododecanoyl)-L-homoserine lactone 
(OC12-HSL) (Figure 1.4) (Pearson et al. 1994). Together, the activated complex of LasR 
and OC12-HSL are effective regulators of a variety of virulence genes including aprA: 
alkaline protease (Gambello, Kaye & Iglewski 1993; Latifi et al. 1995) lasA/lasB: elastase 
A/B (Toder et al. 1994), toxA: exotoxin (Gambello, Kaye & Iglewski 1993) and also lasI 
itself, therefore creating a positive feedback loop (Seed, Passador & Iglewski 1995). The 
rhl system is secondary and was termed according to its ability to control the production 
of rhamnolipid; it consists of the transcriptional regulator RhlR, and the AHL synthase, 
RhlI, which is responsible for the synthesis of N-butanoyl-L-homoserine lactone (C4-
HSL) (Figure 1.4) and small amounts of N-hexanoyl-L-homoserine lactone (C6-HSL). 
Inducing the synthesis of this AHL is known to activate RhlR (Brint & Ohman 1995; 
Latifi et al. 1995), and in turn induce the expression of numerous pathogenicity 
determinants including lasB: elastase A (Pearson, Pesci & Iglewski 1997), rhlAB: 
rhamnolipid surfactant (Ochsner & Reiser 1995; Pearson, Pesci & Iglewski 1997), rpoS: 
stationary phase (Latifi et al. 1996), pyocyanin (Brint & Ohman 1995; Latifi et al. 1995), 
hcnABC: HCN (Pessi & Haas 2000), lecA: cytotoxic lectins (Winzer et al. 2000) and rhlI.  
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Figure 1.3: AHL and AQ-dependent QS in P. aeruginosa. The AHL-based QS 
cascade is initiated when bacterial cells exceed a critical population density, with the 
activation of the LasR protein by OC12-HSL. Together, the activated complex of LasR 
and OC12-HSL in turn activates the rhl system. The AHL-dependent system is intimately 
linked to the AQ system via LasR²OC12-HSL being necessary for pqsH expression, pqsR 
being positively regulated by LasR²OC12-HSL and RhlR²C4-HSL repressing pqsA and 
pqsR. The AHL and AQ-dependent systems are responsible for the regulation of 
numerous, sometime overlapping, phenotypes. The entire system is itself regulated at 
various points by numerous regulators. 
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Figure 1.4: The structure of the main QSSMs produced by P. aeruginosa. N-acyl-L-
homoserine lactones (AHLs): N-(3-oxododecanoyl)-L-homoserine lactone (OC12-HSL) 
and N-butanoyl-L-homoserine lactone (C4-HSL),  and alkyl-4(1H)-quinolones (AQs): 2-
heptyl-3-hydroxy-4-quinolone (PQS), 2-heptyl-4-quinolone (HHQ), 2-nonyl-4-quinolone 
(NHQ) and 2-heptyl-4-quinolone N-oxide (HHQNO). 
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Expression of some phenotypes such as alkaline protease, elastase and HCN are under 
the control of both the las and rhl systems.  As well as existing as mutually exclusive 
circuits, with their respective AIs unable to activate the transcriptional regulator protein 
of the other system, the two systems interact creating a hierarchical organisation between 
them. The las system exerts positive control over the rhl system; in P. aeruginosa and 
Escherichia coli, LasR and OC12-HSL have been shown to positively regulate the 
transcription of rhlI and rhlR, and in E. coli OC12-HSL posttranslationally controls RhlR 
by blocking the interaction of C4-HSL with RhlR (Latifi et al. 1996; Pesci et al. 1997). 
In 1999, further investigations by Pesci et al. showed that spent culture supernatant of P. 
aeruginosa wildtype (WT) strain PA01 was able to induce lasB expression in an AHL-
negative PA01 lasR mutant. Spent culture media extracted from a double AI lasI/rhlI 
mutant had a similar effect on the lasR mutant. This provided strong evidence for the 
discovery of a novel non-AHL-dependent QS system in P. aeruginosa. The chemically 
distinct molecule was characterised as 2-heptyl-3-hydroxy-4-quinolone, being designated 
as the Pseudomonas quinolone signal (PQS) (Figure 1.4). PQS is a derivative molecule 
belonging to a family of compounds known as 2-alkyl-4(1H)-quinolones (AQs), which 
were originally identified by their antibacterial properties, more specifically the 
preventative development of anthrax in rabbits. PQS represents one of many AQs 
produced by the species; other major AQs produced by P. aeruginosa include 2-heptyl-4-
quinolone (HHQ), 2-nonyl-4-quinolone (NHQ) and 2-heptyl-4-quinolone N-oxide 
(HHQNO) (Figure 1.4).  
The study by Pesci et al. (1999) additionally demonstrated that the signal in culture 
extracts of WT PA01 and PA01 lasI/rhlI mutant failed to induce lasB expression in a 
PA01 lasR/rhlR mutant, suggesting that the rhl system was required for the bioactivity of 
PQS. Subsequently, using lacZ reporter fusions it was confirmed that PQS regulates rhlI at 
a transcriptional level (McKnight, Iglewski & Pesci 2000), thus illustrating that PQS was 
significant to the hierarchical QS circuitry, providing another fundamental regulatory link 
between the las and rhl systems. In addition to this, Gallagher et al. (2002) illustrated that 
LasR controls PQS production via the transcription of pqsH which is required for the 
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final conversion of HHQ to PQS, Furthermore, the relevance of PQS to P. aeruginosa 
virulence has been demonstrated through the abundance of the molecule in the lungs of 
P. aeruginosa-infected CF patients (Collier et al. 2002). 
1.4 Global QS regulators in P. aeruginosa 
As well as the las, rhl and AQ systems, other global regulators, operating at both the 
transcriptional and translational level have been identified. These influence the expression 
of the various QS components and the associated virulence determinants under their 
control. Table 1.3 lists some of the important global regulators together with the 
regulated aspects of QS and associated virulence determinants. It also includes the two 
additional LuxR homologues, QscR and VqsR.  
1.5 Biosynthesis of AHLs in P. aeruginosa 
More than 40 AHL synthases homologous to LuxI have now been characterised (Fuqua, 
Winans & Greenberg 1994), which collectively generate a considerable repertoire of 
AHLs, with all conforming to a general structure of a homoserine lactone (HSL) ring 
linked to an acyl chain. Specificity is attained by variable acyl chain lengths from C4 to C18, 
oxidation at the C3 position and different degrees of unsaturation. In consideration of the 
above, the nature of the AHL molecule(s) synthesised is determined by the specific LuxI 
hoPRORJXH SUHVHQW LQ DQ RUJDQLVP·V JHQRPH -LDQJ et al. 1998). More specifically, this 
variability is a function of the synthase acyl chain specificity. In fact, the introduction of 
RhlI into E. coli has demonstrated production of both C4-HSL and C6-HSL to levels 
similar to that observed in P. aeruginosa, confirming both the former and the availability of 
all the necessary substrates in E. coli. More specifically, Jiang et al. (1998) showed that RhlI 
catalyses the in vitro enzymatic synthesis of C4-HSL and C6-HSL from either S-adenosyl-
L-methionine (SAM) (also referred to as AdoMet) or HSL and the butanoyl- or hexanoyl-
charged coenzyme A (CoA) derivative in an NADPH-dependent manner.  
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Regulator 
 
Type Phenotypes Regulated & References 
 
GacA/GacS Two component 
regulator system: 
comprising a 
membrane bound 
histidine kinase sensor 
that relays information 
on environmental 
stimuli to a 
phosphorylated 
response regulator 
(Rodrigue et al. 2000) 
² Positively activate las and rhl systems: 
enhances C4-HSL and associated 
virulence factor production (Reimmann 
et al. 1997) including biofilm 
development (Parkins, Ceri & Storey 
2001) 
MvaT DNA binding protein 
of H-NS family 
² Global regulator of virulence 
determinants: suggested QS repressor 
since mvaT mutants demonstrate 
reduced swarming behavior and LasA 
and LasB protease production, and 
enhanced lecA expression, pyocyanin 
production and C4-HSL and C12-HSL 
levels (Diggle et al. 2002) 
² Also microarray analysis has shown 
approximately 150 genes are 
differentially expressed in mvaT mutant 
(Vallet et al. 2004) 
QscR (quorum-
sensing-control 
repressor) 
Suggested function: 
transcriptional 
antagonist which 
sequesters LasR and 
RhlR monomers 
forming inactive 
heteromultimers thus 
SUHYHQWLQJ´IDOVHµ
activation of QS 
controlled genes 
(Fuqua 2006); LuxR 
homologue exhibiting 
significant homology to 
² Repression of lasI since a qscR mutant 
has premature C12-HSL production 
which leads to premature expression of 
a number of QS regulated genes 
including those responsible for the 
AHL synthesis, HCN, pyocyanin and 
elastase (Chugani et al. 2001; Ledgham et 
al. 2003) 
 ² Transcription profiles of more than 
400 genes also differentially expression 
in a qscR mutant (Lequette et al. 2006) 
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LasR and RhlR 
RsaL Transcriptional 
regulator 
² Represses las system at low 
population densities by binding to the 
lasI SURPRWHUWKHUHE\SUHYHQWLQJLW·V
expression and preventing LasR²OC12-
HSL dependent transcription 
² Regulated itself: las (LasR²OC12-HSL) 
regulated rsaL transcription (de Kievit et 
al. 1999; Rampioni et al. 2006) 
RsmA Post-transcriptional 
regulator which acts via 
mRNA binding, 
promoting 
decomposition or 
extending stability of 
the corresponding 
transcript (Heeb et al. 
2006): E. coli CsrA 
homologue (Romeo et 
al. 1993) 
² RsmA positively regulates 
rhamnolipid biosynthesis, swarming 
motility and lipase production (Heurlier 
et al. 2004) 
² Represses pyocyanin, PA-IL lectin, 
C4-HSL and C12-HSL production (Pessi 
et al. 2001) 
 [RsmA regulation antagonised by the 
high-affinity binding of small non-
coding regulatory RNAs RsmY and 
RsmZ that prevent it from binding to 
mRNA (Babitzke & Romeo 2007)] 
Vfr E. coli cyclic adenosine 
monophosphate 
(cAMP) receptor 
protein (CRP) 
homologue; regulates 
many genes which are 
responsible for 
catabolite repression by 
glucose (Botsford & 
Harman 1992; Kolb et 
al. 1993) 
² Activates LasR by binding to CRP-
binding consensus sequence (CCS) in 
lux operon promoter region (Dunlap & 
Greenberg 1988; Shadel, Devine & 
Baldwin 1990; Stevens, Dolan & 
Greenberg 1994) 
² Important to las dependent exotoxin 
A and protease production (West et al. 
1994) 
² Additionally modulates rhlI, twitching 
motility, flagella production and various 
effector proteins involved in type III 
secretion 
VqsR (virulence 
and quorum 
sensing 
regulator) 
LuxR homologue ² VqsR lies at the same level as RhlR 
and QscR in the QS hierarchy with 
direct regulatory control exerted from 
the las system (Li, Malone & Iglewski 
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2007) 
² Both activates the expression of genes 
known to be promoted by QS 
(including phenazine and rhamnolipid 
biosynthesis, HCN synthesis, protease 
secretion and PQS production) and 
negatively regulates the expression of 
genes known to be repressed by QS 
(nitrogen metabolism) (Juhas et al. 2004) 
Table 1.3: Global QS regulators in P. aeruginosa 
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However, the activity of the RhlI preparations observed in this study were significantly 
lower than previously observed with preparations of other LuxI homologues; it has since 
been confirmed that the substrates are SAM and the appropriately charged acylated acyl 
carrier protein (acyl-ACP), providing the HSL moiety and acyl chain donor, respectively 
(Val & Cronan 1998).  
7KH V\QWKDVH HQ]\PHV DUH WKRXJKW WRSURGXFH$+/V LQ D´EL-WHUµ VHTXHQWLDOO\RUGHUHG
reaction. In the primary acylation reaction, the acyl chain is presented to the AHL 
synthase as a thioester of the ACP phosphopantetheine prosthetic group, and results in 
nucleophilic attack on the carbonyl position of C1 by the amino nitrogen of SAM, 
generating an amide linkage. The secondary lactonization reaction, subsequent to, or 
concomitant with, amide bond formation, occurs by nucleophilic attack on the J carbon 
of SAM by its own carboxylate oxygen and results in HSL ring formation; this is coupled 
to the release of by-products holo-acyl carrier protein (holo-ACP) anG ·-
methylthioadenosine (MTA) (Parsek et al. 1999). 
1.6 AQ-dependent QS in P. aeruginosa 
Synthesis of the PQS is dependent upon anthranilate availability and a functional 
biosynthetic pqsABCDE operon. To date, the enzymatic contribution of many of the 
individual pqs gene products to PQS biosynthesis remains unclear, although sequence 
comparisons have illustrated putative functions. PqsA demonstrates significant homology 
to a variety of benzoate coenzyme A ligases (Gallagher et al. 2002), and has been 
confirmed to be required for the activation of the anthranilate precursor; the ligase 
generates an activated anthraniloyl-CoA thioester which is necessary for priming 
anthranilate for PQS biosynthesis (Coleman et al. 2008). The pqsB, pqsC and pqsD genes 
are thought to encode for 3-oxo-acyl-(ACP) synthases and may be important in the 
synthesis of the corresponding fatty acid hydrocarbon chains. Recently, crystal structures 
of PqsD have revealed its involvement in a condensation reaction between anthraniloyl-
PqsD and malonyl-CoA or malonyl-ACP with 2,4-dihydroxyquinoline (DHQ) as the 
product (Zhang et al. 2008; Bera et al. 2009); however, though PqsD has relevance to PQS 
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biosynthesis, DHQ has not been shown to be a possible PQS precursor to date. The last 
gene in the polycistronic operon, pqsE, is either thought to facilitate the cellular response 
to PQS or be involved in the synthesis of a currently unidentified PQS-derivative 
signalling molecule. The crystal structure of PqsE indicates a metallo-E-lactamase fold 
with a Fe(II)Fe(III) centre in the active site and the presence of benzoate indicating the 
possible substrate may be a chorismate derivative (Yu et al. 2009).  Nevertheless, it has 
been determined that AQs are formed via the condensation of anthranilate and a E-keto-
fatty acid; the 2-heptyl-4-quinolone (HHQ) intermediate which is released into the 
extracellular environment is hypothesised to be converted into PQS by the addition of a 
hydroxyl group by a cytoplasmic FAD-dependent monooxygenase (pqsH) in a 
neighbouring cell. 
The anthranilate requirement for PQS synthesis draws on one of several aspects of 
aromatic amino acid (AA) metabolism (Figure 1.5). The P. aeruginosa genome encodes 
several distinct anthranilate synthase enzymes, notably TrpEG, and PhnAB, which is 
located downstream from the PQS biosynthetic operon (Essar et al. 1990a). Both 
synthase enzymes are thought to synthesize the anthranilate precursor of PQS from 
shikimate via chorismate (Essar et al. 1990a). In the former, the trpE and trpG genes have 
been shown to participate in the tryptophan synthetic pathway (Essar et al. 1990b), whilst 
the phnA and phnB genes are important for the biosynthesis of phenazine antibiotics, 
particularly in the production of the pyocyanin pigment (Mavrodi et al. 2001). In contrast, 
a recent paper by Farrow & Pesci (2007) suggests that the degradation of tryptophan 
through the kynurenine (kyn) pathway additionally represents a fundamental source of 
anthranilate for PQS production. This research has extended an earlier suggestion made 
by D'Argenio et al. (2002) in relation to the involvement of tryptophan 2,3-dioxygenase 
(kynA) in autolysis. Nevertheless, levels of tryptophan are consistent with PQS 
biosynthesis (Farrow & Pesci 2007).  
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Figure 1.5: Scheme for PQS biosynthesis and degradation. Production of anthranilic 
acid can occur through two alternative routes, either from shikimic acid via chorismic 
acid or through tryptophan degradation in the kynurenine pathway. Anthranilic acid 
condenses with E-ketodecanoic acid to produce the PQS precursor (HHQ) upon 
decarboxylative cyclisation and this undergoes oxidative hydroxylation at the 3-position 
thus giving PQS. Anthranilate catabolism produces several aromatic intermediates, 
notably catechol, cis,cis muconate and muconolactone. 
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Through the development of a synthetic medium that nutritionally mimics CF sputum, 
Palmer, Aye & Whiteley (2007) have additionally demonstrated the high incidence of 
aromatic AAs, notably phenylalanine and tyrosine, in CF sputum samples. This occurs in 
association with elevated production of PQS, and several PQS-regulated factors including 
pyocyanin. Other aromatic AAs linked to anthranilate metabolism include catechol, the 
initial product of anthranilate catabolism via the anthranilate dioxygenase (antABC), cis,cis 
muconate, the product of catechol degradation by catechol dioxygenase (catA), and 
muconolactone, the result of processing by muconate lactonizing enzyme (catB); the latter 
are involved in the E-ketoadipate pathway in P. aeruginosa (Kukor, Olsen & Ballou 1988). 
1.7 The activated methyl cycle (AMC) 
As well as the significance of SAM to the production of AHLs, it is an extremely versatile 
molecule with several additional functions, one of which is fundamental to the recycling 
pathway linked to methionine metabolism. The AMC is a pathway dedicated to the 
metabolism of SAM, the major methyl donor in eubacterial, archaebacterial and 
eukaryotic cells (Figure 1.6). However, the metabolic link between the AMC to AHL 
synthesis via SAM is rarely taken into consideration; it may actually be of greater 
importance to determine the metabolic consequences of AHL synthesis upon the 
RUJDQLVP·VFHOOSK\VLRORJ\JLYHQ WKDWDOWHUDWLRQV WR LQWUDFHOOXODU6$0OHYHOVDUH OLNHO\ WR
subsequently impact upon essential methylation reactions within the cell.  
Living organisms exploit methionine for the production of SAM. SAM is an essential 
nucleoside that serves as an activated group donor in various metabolic and biosynthetic 
reactions, including methylation, propylamine group transfer in polyamine synthesis and 
SAM radical-mediated vitamin synthesis (Parveen & Cornell 2011). DNA methylation is 
critical in the regulation of gene expression and the bacterial cell cycle, allows nuclease 
recognition and performs protective roles against damage from other restriction 
endonucleases. Methylation additionally represents an important post-transcriptional 
modification for rRNA and proteins, carbohydrates, lipids and other molecules.  
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Figure 1.6: The activated methyl cycle (AMC). Methionine is converted to S-
adenosvl-L-methionine (SAM) in a reaction catalyzed by the SAM synthetase (Met K, 
methionine adenosyltransferase). Through the action of numerous methyltransferases, 
SAM is converted to the toxic metabolite S-adenosyl-L-homocysteine (SAH). It is 
acknowledged that two alternative routes exist for processing SAH, but only one of 
which produces the precursor of AI-2, 4,5-dihydroxy 2,3-pentanedione (DPD). In 
bacteria generating AI-2, SAH is immediately detoxified to S-ribosyl-L-homocysteine 
65+ DQG DGHQLQH E\ WKH 3IV HQ]\PH ·-methylthioadenosine/S-adenosyl-L-
homocysteine nucleosidase). During the conversion of SRH to homocysteine (HCY), 
LuxS, originally identified as the SRH cleavage enzyme, then produces DPD and this 
forms AI-2 via spontaneous cyclization. Eukaryotes, archaebacteria and certain eubacteria 
replace this two step process with a single enzyme, SAH hydrolase. In these 
circumstances, the removal of SAH generates adenosine and homocysteine with no 
production of AI-2. In either case, the cycle is completed via the regeneration of 
methionine from homocysteine by a homocysteine methyltransferase (MetE, 5-
methyltetrahydropteroyltriglutamate²homocysteine methyltransferase or MetH, 5-
methyltetrahydrofolate²homocysteine methyltransferase). 
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For example, in P. aeruginosa, PhzM is necessary for production of the pyocyanin pigment 
(Parsons et al. 2007). In SAM-dependent methyltransferase reactions, SAM is converted 
to S-adenosyl-L-homocysteine (SAH). 
Analysis of 138 bacterial species by Sun et al. (2004) demonstrated 51 possess SAH 
nucleosidase, 60 possess SAH hydrolase, 20% possess neither, whilst a couple, 
Bifidobacterium longum and Escherichia blattae had both; the AMC therefore functions as an 
important SAH-degradation pathway that reduces feedback inhibition of SAM-dependent 
methylation (Figure 1.4). The importance of SAM has been illustrated by growth and cell 
division defects which arise following alterations to normal levels of the metabolite. SAM 
mediated-activities such as DNA modifications and spermidine biosynthesis from 
putrescine were shown to be impaired with high levels of expression of T3 SAM 
hydrolase (T3SH) (Hughes, Brown & Ferro 1987). In a similar manner, Posnick and 
Samson (1999) have demonstrated an increase in hemimethylated or unmethylated 
GATC sites of both chromosomal and plasmid DNA with a reduction in SAM pool size. 
In E. coli, reduced SAM synthase activity in metK mutants has been associated with a 
partial cell division defect characterised by the formation of long filaments and even 
nucleoid distribution intracellularly (Newman et al. 1998). In certain circumstances, the 
altered phenotypes are due to the accumulation of SAH and other thionucleosides 
including MTA which have been shown to inhibit mammalian and bacterial 
methyltransferase and polyamine synthesis activities. 
In providing the available metabolic pool of SAM, the AMC represents an important 
pathway, which will be affected by changes in the production of various AHLs since their 
synthesis consumes SAM, and vice versa. Experimentally, this has been demonstrated in 
vivo by Val and Cronan (1998); one of their major findings indicated that comparatively 
small reductions in levels of intracellular SAM, achieved by expression of bacteriophage 
T3SH resulted in a significantly marked reduction in AHL production driven via 
recombinant TraI in E.coli. Furthermore, this consequential effect is not confined just to 
AHL QSSMs; Winzer et al. (2002a) showed that expression of bacteriophage T3SH and 
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rat liver SAM synthetase lead to a significant reduction and moderate increase in AI-2 
levels respectively. 
1.8 Fatty acid biosynthesis 
The fatty acid precursor to AHL synthesis is an important one as it defines each 
individual AHL molecule with differing specificities; the fatty acyl side may vary in length, 
backbone saturation and in the nature of the substitutions present (Waters & Bassler 
2005). The confusion surrounding the origin of the acyl chains of AHLs has now been 
resolved; contradictory to the previous notion that they are acquired as CoA 
LQWHUPHGLDWHVRIWKHIDWW\DFLGƢ-oxidation pathway, it has now been confirmed that the 
precursors are acyl-ACPs, which are derived from intermediates in the fatty acid 
biosynthesis pathway (Figure 1.7). 
As with SAM and the AMC, the fact that AHL synthesis draws on the activity of the fatty 
acid biosynthesis pathway means that it is probable that an interlinked relationship can be 
observed. Several studies have reinforced the relationship between various proteins 
involved in fatty acid biosynthesis and the subsequent consequences on AHL production. 
Through the construction of a temperature-sensitive fabG mutant, Hoang et al. (2002) 
have demonstrated that the reduction of E-ketoacyl ACP reductase activity correlated 
with an altered AHL profile, most notably an elevated incidence of short chain 3-oxo-
substituted AHLs. In another study of reductases, it was shown that reduction of the 
enoyl-ACP reductase (FabI) activity, correlated with a 50% decrease in the production of 
C4-HSL and 3-oxo-C12-HSL (Hoang & Schweizer 1999). Other components of the Fab 
system, including FabB (E-ketoacyl-ACP synthase I) and FabZ (E-hydroxyacyl-ACP 
dehydratase), have additionally been shown to be essential for AHL formation (Hoang et 
al. 2002). 
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Figure 1.7: Fatty acid biosynthesis pathway. FabD is responsible for transferring 
malonyl-CoA to ACP, whilst FabH is responsible for performing continuous cyclization 
reactions resulting in the elongation of fatty acids. The next step of the elongation cycle is 
carried out by E-ketoacyl-ACP reductase (FabG). The E-hydroxyacyl-ACP intermediate 
then undergoes dehydration to form trans-2-enoyl-ACP (FabA or FabZ) and the final 
steps of elongation are catalysed by enoyl-ACP reductase (FabI, FabK or FabL) 
producing acyl ACPs. Subsequent elongation is initiated via the elongation condensing 
enzymes (FabB and FabF). The acyl ACP end products of fatty acid synthesis provide the 
precursor for production of AHLs. 
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1.8 Aims and objectives 
In order to further define the specific associations which interlink the QS and metabolic 
circuits, the main aim of this project is to determine the influence that AHL synthesis has 
upon the levels of metabolites linked to the AMC and vice versa. This can more 
specifically be assessed by the objectives described below: 
i. It is hypothesised that QS directed by the production of signal molecules will 
draw on resources from metabolic pathways which are common to other cellular 
processes. The precise nature of this was investigated. The potential of the 
hierarchical organisation of the P. aeruginosa QS system to complicate such studies 
was avoided by using a heterologous host. Here, the AHL synthase genes, lasI and 
rhlI, were cloned downstream of an inducible promoter and transformed into 
Escherichia coli, which lacks the equivalent QS system but possesses the 
appropriate metabolic pathways for sourcing of AHL substrates. The 
consequences of these expression studies was analysed using established mass 
spectroscopic methods to determine AMC metabolite profiles. Fitness tests were 
also performed in both rich and chemically defined media to determine whether 
the associated metabolic disruptions caused cellular growth defects. 
ii. To take this further, and determine the importance of specific AA residues of 
LasI and RhlI, site-directed mutagenesis was combined with metabolic analyses in 
the heterologous host system described above. It was unknown whether the 
residues chosen and substitutions made would produce functional synthases with 
signal producing activity; however, it was hypothesised that the metabolic status 
and signal production phenotypes of the mutant proteins would determine 
whether the synthases needed to fully active to influence metabolism. 
iii. With the hypothesis that disrupting the levels of AMC metabolites would impact 
upon AHL synthesis, mutants of the heterologous host predicted to alter AMC 
metabolite levels were analysed for their capacity to support AHL synthesis. 
iv. Lastly, the reciprocal of these studies was conducted via analysis of P. aeruginosa 
AHL synthase mutants. It was hypothesised that this would increase the 
- 33 - 
 
intracellular availability of metabolites. However, the complexity of the regulatory 
QS cascade would predict that this approach would generate new avenues of 
investigation by revealing novel links between cellular metabolism and QS. 
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Chapter 2 
Materials and methods 
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2.1 Chemical reagents 
2.1.1 General chemicals 
All general chemicals were obtained from Sigma (UK) unless otherwise stated. High-
performance liquid chromatography (HPLC)-grade solvents including acetonitrile (ACN), 
ethanol (EtOH), ethyl acetate (EtAc), methanol (MeOH) and dichloromethane (DCM) 
were obtained from Fisher Scientific (Loughborough, UK). 
2.1.2 Synthesis of QSSMs 
Synthetic AHLs and AQs were made by A. Truman/ S.R. Chhabra at the School of 
Molecular Medical Sciences, Centre for Biomolecular Sciences, The University of 
Nottingham as described in Diggle et al. (2006). The compounds were stored as stocks of 
the appropriate concentration in ACN (AHLs), MeOH or DMSO (AQs) and stored at  
-20 °C. 
2.2 Growth media and additives  
All media were obtained from Oxoid Ltd (UK) and prepared according to the 
PDQXIDFWXUHUV·LQVWUXFWLRQVXVLQJGLVWLOOHG+2O (dH2O) and autoclaved at 121 °C for 20 
min at 15 psi unless otherwise stated (Sambrook et al. 1989). 
2.2.1 Luria Bertani media 
Luria Bertani (LB) broth was prepared as described by Sambrook et al. (1989) and 
consisted of 10 g tryptone, 5 g yeast extract and 10 g NaCl in 1 L of dH2O. LB agar was 
prepared by addition of 0.8 % (w/v) Technical Agar No. 3 (Oxoid) to LB broth. 
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2.2.2 Chemically defined media (CDM) 
Chemically defined media (CDM) was prepared as described by Ombaka et al. (1983). 
Chemical Final Concentration / 
mM 
D-C6H12O6 20 
KCl 3 
NaCl 3 
(NH4)2SO4 12 
MgSO4.7H20 3.2 
K2HPO4 0.02 
MOPS (pH 7.8) 1.2 
Table 2.1: Composition of chemically defined media (CDM).  
2.2.3 MOPS minimal media (MMM) 
MOPS (4-morpholinepropanesulfonic acid) minimal media (MMM) (Table 9.1) was 
prepared as described by Neidhardt et al. (1974). 
2.2.4 Antibiotics/ X-Gal/ IPTG 
Antibiotic supplements to the media and their working concentrations were: carbenicillin 
&EƬJPOE. coliFKORUDPSKHQLFRO&PƬJPOE. coli); gentamicin (Gm) 10 
Pg/ml (P. aeruginosaWHWUDF\FOLQH7FƬJPOE. coliDQGƬJPOP. aeruginosa). To 
perform screening for positive transformants using blue/white colour selection of 
recombinants on LB plates, 5-bromo-4-chloro-3-indolyl-E-D-galacto-pyranoside (X-Gal) 
ZDVDGGHGWRPROWHQDJDUWRDILQDOFRQFHQWUDWLRQRIƬJPO7RLQGXFHH[SUHVVLRQRI
genes under the control of a Ptac promoter in pME6032, isopropylthio-E-D-galactoside 
(IPTG) was added at a final concentration of 1 mM. All stock solutions were prepared 
according to Sambrook et al. ILOWHUVWHULOLVHGEHIRUHXVHƬP- Sartorius 
MLQLVDUWDQGVWRUHGDFFRUGLQJWRWKHPDQXIDFWXUHUV·UHFRPPHQGDWLRQV 
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2.3 Growth conditions 
V. harveyi was grown at 30 qC unless otherwise stated. E. coli and P. aeruginosa were 
routinely grown at 37 qC. Liquid cultures were grown in LB with agitation at 200 rpm in a 
shaking incubator. Growth of bacterial cultures was monitored by absorbance readings at 
a wavelength of 600 nm (optical density, OD600) using a Biomate 3 spectrophotometer 
(Thermo Scientific), or a TECAN Infinite F200 multifunctional, automated luminometer-
spectrometer. When performing growth curves, strains were grown in identical 500 ml-
Erlenmeyer flasks containing 125 ml LB, CDM or MMM. 
2.4 Bacterial strains 
The bacterial strains used in this study are listed in Table 2.2. 
Strain 
 
Description Reference/Source 
Escherichia coli   
 DH5D )·endA1, hsdR17(R- M+), 
supE44, thi-1, recA1, gyrA, relA1, 
'(lacZYA-argF)U169, deoR[)80d 
lac'(lacZ)M15] 
Sambrook et al. 
(1989) 
 JM109 [F
 traD36, proAB, lacIq, 
lacZ'M15] recA1, endA1, gyrA96, 
thi, hsdR17, supE44, relA1 '(lac-
proAB) mcrA 
Yanisch-Perron et al. 
(1985) 
 
 MG1655 F-  O- ilvG- rfb-50 rph-1 Jensen et al. (1993) 
 MG1655::pfs- pfs::Kmr derivative of MG1655 Tavender et al. 
(2008) 
 MG1655::luxS- luxS::Cmr derivative of MG1655 Tavender et al. 
(2008) 
 MG1655::sdiA- sdiA::Kmr derivative of MG1655 Van Houdt et al. 
(2006) 
Pseudomonas aeruginosa   
 PA01 Wildtype, Nottingham strain Klockgether et al. 
(2010); Stover et al. 
(2000) 
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 PA01'lasI PAO1 derivative with a Gm 
cassette insertion into a unique 
EcoRI site within the lasIPa gene, 
Gmr 
Beatson et al. (2002) 
 PA01'rhlI PAO1 derivative with a Tc 
cassette insertion into a unique 
KpnI site within the rhlIPa gene, 
Tcr 
Beatson et al. (2002) 
 PA01'lasI'rhlI PA01 derivative with 
chromosomal deletion of lasIPa 
and rhlIPa genes 
Pustelny (personal 
communication) 
Vibrio harveyi   
 BB170 Biosensor AI-1-, biosensor AI-
2+ 
Bassler et al. (1993) 
Table 2.2 Bacterial strains used in this study. 
2.5 Plasmids 
All plasmids used in this study are listed in Table 2.3. 
Plasmids 
 
Description Reference/ 
Source 
pGEM-T Easy Cloning vector, Cbr, Ampr, lacZ, allowing 
selection via blue-white screening 
Promega 
 
pGEM-lasIPa pGEM-T Easy derivative carrying the lasIPa 
gene, Cbr 
This study 
pGEM-lasIPa 23:  
R > W 
pGEM-lasIPa derivative carrying a 
substitution of Arg for Try at codon 23 of 
the lasIPa ORF, Cb
r 
This study 
pGEM-lasIPa 27:  
F > L 
pGEM-lasIPa derivative carrying a 
substitution of Phe for Leu at codon 27 of 
the lasIPa ORF, Cb
r 
This study 
pGEM-lasIPa 27:  
F > Y 
pGEM-lasIPa derivative carrying a 
substitution of Phe for Tyr at codon 27 of 
the lasIPa ORF, Cb
r 
This study 
pGEM-lasIPa 33:  
W > G 
pGEM-lasIPa derivative carrying a 
substitution of Try for Gly at codon 33 of 
the lasIPa ORF, Cb
r 
This study 
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pGEM-lasIPa 103: 
S > A 
pGEM-lasIPa derivative carrying a 
substitution of Ser for Ala at codon 103 of 
the lasIPa ORF, Cb
r 
This study 
pGEM-lasIPa 103: 
S > E 
pGEM-lasIPa derivative carrying a 
substitution of Ser for Glu at codon 103 of 
the lasIPa ORF, Cb
r 
This study 
pGEM-lasIPa 103: 
S > V 
pGEM-lasIPa derivative carrying a 
substitution of Ser for Val at codon 103 of 
the lasPa ORF, Cb
r 
This study 
pGEM-rhlIPa pGEM-T Easy derivative carrying the rhlIPa 
gene, Cbr 
This study 
pGEM-rhlIPa 28:  
F > L 
pGEM-rhIIPa derivative carrying a 
substitution of Phe for Leu at codon 28 of 
the rhlIPa ORF, Cb
r 
This study 
pGEM-rhlIPa 28:  
F > Y 
pGEM-rhIIPa derivative carrying a 
substitution of Phe for Tyr at codon 28 of 
the rhlIPa ORF, Cb
r 
This study 
pGEM-rhlIPa 34:  
W > G 
pGEM-rhIIPa derivative carrying a 
substitution of Try for Gly at codon 34 of 
the rhlIPa ORF, Cb
r 
This study 
pGEM-rhlIPa 103:  
S > A 
pGEM-rhIIPa derivative carrying a 
substitution of Ser for Ala at codon 103 of 
the rhlIPa ORF, Cb
r 
This study 
pGEM-rhlIPa 103:  
S > E 
pGEM-rhIIPa derivative carrying a 
substitution of Ser for Glu at codon 103 of 
the rhlIPa ORF, Cb
r 
This study 
pGEM-rhlIPa 103:  
S > V 
pGEM-rhIIPa derivative carrying a 
substitution of Ser for Val at codon 103 of 
the rhlIPa ORF, Cb
r 
This study 
pME6032 lacIQ Ptac expression vector, Tcr Heeb et al. 2002 
pME-lasIPa pME6032 derivative carrying the lasIPa gene 
under Ptac control, Tcr 
This study 
pME-lasIPa 23:  
R > W 
pME-lasIPa derivative carrying a substitution 
of Arg for Try at codon 23 of the lasIPa 
ORF, Tcr 
This study 
pME-lasIPa 27:  
F > L 
pME-lasIPa derivative carrying a substitution 
of Phe for Leu at codon 27 of the lasIPa 
ORF, Tcr 
This study 
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pME-lasIPa 27:  
F > Y 
pME-lasIPa derivative carrying a substitution 
of Phe for Tyr at codon 27 of the lasIPa 
ORF, Tcr 
This study 
pME-lasIPa 33:  
W > G 
pME-lasIPa derivative carrying a substitution 
of Try for Gly at codon 33 of the lasIPa 
ORF, Tcr 
This study 
pME-lasIPa 103: S 
> A 
pME-lasIPa derivative carrying a substitution 
of Ser for Ala at codon 103 of the lasIPa 
ORF, Tcr 
This study 
pME-lasIPa 103: S 
> E 
pME-lasIPa derivative carrying a substitution 
of Ser for Glu at codon 103 of the lasIPa 
ORF, Tcr 
This study 
pME-lasIPa 103: S 
> V 
pME-lasIPa derivative carrying a substitution 
of Ser for Val at codon 103 of the lasPa 
ORF, Tcr 
This study 
pME-rhlIPa pME6032 derivative carrying the rhlIPa gene 
under Ptac control, Tcr 
This study 
pME-rhlIPa 28:  
F > L 
pME-rhIIPa derivative carrying a substitution 
of Phe for Leu at codon 28 of the rhlIPa 
ORF, Tcr 
This study 
pME-rhlIPa 28:  
F > Y 
pME-rhIIPa derivative carrying a substitution 
of Phe for Tyr at codon 28 of the rhlIPa 
ORF, Tcr 
This study 
pME-rhlIPa 34:  
W > G 
pME-rhIIPa derivative carrying a substitution 
of Try for Gly at codon 34 of the rhlIPa 
ORF, Tcr 
This study 
pME-rhlIPa 103:  
S > A 
pME-rhIIPa derivative carrying a substitution 
of Ser for Ala at codon 103 of the rhlIPa 
ORF, Tcr 
This study 
pME-rhlIPa 103:  
S > E 
pME-rhIIPa derivative carrying a substitution 
of Ser for Glu at codon 103 of the rhlIPa 
ORF, Tcr 
This study 
pME-rhlIPa 103:  
S > V 
pME-rhIIPa derivative carrying a substitution 
of Ser for Val at codon 103 of the rhlIPa 
ORF, Tcr 
This study 
pSB1142 lux-based acyl-HSL bioreporter, Tcr Winson et al. 1998 
pSB436 lux-based acyl-HSL bioreporter, Ampr Winson et al. 1998 
Table 2.3 Plasmids used in this study. 
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2.6 DNA preparation and manipulation 
2.6.1 Preparation of plasmid DNA 
Small scale plasmid DNA isolation was performed using the Qiagen Miniprep Kit 
(QIAGEN, Ltd) according to the manufacturer·s instructions. Briefly, cells pelleted from 
1-10 ml of an overnight (O/N) bacterial culture was subjected to alkaline lysis, then 
neutralised and centrifuged at 13,000 rpm for 10 min to remove denatured and 
precipitated cellular debris. Crude lysates were then loaded onto a silica-gel column, 
washed and plasmid DNA was eluted into 30-50 Pl HPLC grade H2O (Fisher Scientific, 
UK). 
Preparation of microgram quantities of low copy number plasmids was performed using 
the Qiagen Midiprep Kit (QIAGEN, Ltd) DFFRUGLQJ WR WKH PDQXIDFWXUHU·V protocol. 
Briefly, cells pelleted from 100 ml of an O/N bacterial culture was subjected to alkaline 
lysis, then neutralised and centrifuged at 10,000 rpm in a Beckman Avanti 30 centrifuge 
for 30 min to remove denatured and precipitated cellular debris and then centrifuged for 
another 15 min. Crude lysates were then loaded onto a pre-equilibrated anion-exchange 
resin column, washed and plasmid DNA was eluted with 4 ml high-salt buffer. Finally, 
the DNA was precipitated with isopropanol, desalted by washing with 70% (v/v) EtOH 
and resuspended in 50-100 Pl HPLC grade H2O (Fisher Scientific, UK). 
2.6.2 Purification of chromosomal DNA 
To amplify specific genes or DNA sequences from E. coli or P. aeruginosa, genomic DNA 
was used as a template. Genomic DNA was isolated as per the manufactureU·s 
instructions using the Wizard® Genomic DNA Purification Kit (Promega, UK). 
Bacterial cells pelleted from 1 ml of an O/N culture were lysed by incubDWLRQZLWKƬO
Nuclei Lysis Solution at 80 °C for 5 min. After cooling to rRRP WHPSHUDWXUH  ƬO RI
RNAse Solution was added and the sample incubated at 37 °C for 15-60 min. Proteins 
were precipitated E\DGGLQJƬORI3URWHLQ3UHFLSLWDWLRQ6ROXWLRQfollowed by 5 min 
RQLFHDQGFHQWULIXJDWLRQDWUSPIRUPLQ7KHVXSHUQDWDQWZDVDGGHGWRƬO
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of isopropanol and centrifuged for 10 min at 13,000 rpm. After removal of the 
VXSHUQDWDQWƬORIYY(W2+ZDVDGGHGDQGWKHUHVXOWLQJPL[FHntrifuged at 
13,000 rpm for 5 min. The ethanol was aspirated off and the DNA pellet air-dried for 10-
PLQ7KHSHOOHWZDVUHK\GUDWHGLQƬO5HK\GUDWLRQ6ROXWLRQIRUKDW°C. 
2.6.3 Precipitation of DNA 
DNA precipitation was routinely performed by adding 2.5 volumes of 100% EtOH to 
the samples and 0.1 volumes of 3 M NaOAc, pH 5.2. This was left at -20 qC for at least 
20 min or O/N before centrifugation at 13,000 rpm for 20 min at 4 qC. The pellet was 
washed with 70% (v/v) EtOH followed by centrifugation at 13,000 rpm for 10 min at 4 
qC. The ethanol was carefully removed and the pellet allowed to dry. The DNA was 
resuspended in an appropriate volume of HPLC grade H2O. 
2.6.4 Quantifying DNA concentrations 
The NanoDrap® ND-1000 (Nanodrop Technologies) was used to measure DNA 
concentrations. 1-2 Pl of sample was used to determine characteristic absorbance and 
concentrations. Whole spectra of samples could also be measured to assess purity. 
2.6.5 Restriction enzymes 
Restriction enzymes (REs) were purchased from Promega (UK) and New England 
Biolabs (UK) and were used according to the manufacturers· recommendations. 
Reactions generally contained 0.05-1 Pg DNA, 0.5-1 Pl restriction endonuclease(s) and 
1x appropriate restriction buffer made to a final volume of 20 Pl with sterile dH20 and 
incubated at the appropriate temperature for a minimum of 1 h or until the digestion was 
complete.  
 
 
- 43 - 
 
2.6.6 Analysis and purification of DNA by agarose gel 
electrophoresis 
DNA loading buffer (Table 2.4) was added to DNA samples and analysed on 0.7-1% 
(w/v) agarose gels using horizontal gel apparatus (Biorad, UK). The gels were prepared 
using the method described by Sambrook et al. (1989), using analytical grade agarose 
(Promega, UK) in 1x tris-acetate-ethylenediaminetetraacetic acid (TAE) buffer with the 
addition of ethidium bromide (EtBr) to a final concentration of 10 Pg/ml. The gels were 
run in 1× TAE buffer and electrophoresis was performed at 70-120 V. DNA fragments 
were visualised on a UV transluminator with Vision Works software (UVP, USA). DNA 
fragments were extracted from agarose gel slices using the Qiagen Qiaquick Gel 
Extraction Kit (QIAGEN, Ltd) in accordance with the manufacturer·s instructions. Final 
elution of the purified product was carried out using 30-50 Pl HPLC grade H2O (Fisher 
Scientific, UK). 
6x DNA loading buffer  
Sucrose 10% (w/v) 
Orange G (in 1x TAE) 0.4% (w/v) 
1x TAE  
Tris-acetate-EDTA base 40 mM 
EDTA pH 8.0 50 mM 
Glacial acetic acid 0.1142% (v/v) 
Table 2.4: Standard recipes for agarose gel electrophoresis. 
DNA loading buffer and 1x TAE were stored at RT. 
2.6.7 Molecular weight markers 
To establish the size of DNA fragments, 1 Pg of 1 kb Plus Ladder (Invitrogen, UK) in 
DNA loading buffer were loaded on agarose gels. 
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2.6.8 DNA ligation 
DNA ligations were routinely performed using 1:1, 1:3 or 1:10 ratios of vector to insert. 
Reactions were carried out at 4 qC O/N using 1 Pl T4 DNA ligase (Promega, UK) and 2 
Pl T4 ligation buffer in a final volume of 20 Pl. Control ligations containing no insert 
were also conducted where appropriate. 
2.7 Polymerase chain reaction (PCR) amplification 
2.7.1 Synthesis of oligonucleotide primers 
Oligonucleotide primers were synthesised by Sigma-Genosys Ltd (UK). All primers 
contained a minimum of 18 bases to ensure accurate hybridization. Where necessary, 
restriction sites were incorporated into the ·HQGRIWKHSULPHUWRDLGFORQLQJRIWKH3&5
product. Primer sequences are listed in Table 2.5. 
Oligonucleotides 
 
6HTXHQFH·o · Function 
lasIF TATCAATTGATGA
TCGTACAAATTGG
TCGG 
Forward primer used to amplify the lasIPa 
ORF region with an underlined MfeI 
restriction site directly upstream of the 
start codon (bold) 
 
lasI R23W F [Phos]TTGTGGGCT
CAAGTGTTC 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Arg for Trp 
lasI F27L F [Phos]TGCTGAAG
GAGCGCAAAG 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Phe for Leu 
lasI F27Y F [Phos]TGTACAAGG
AGCGCAAAG 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Phe for Tyr 
lasI W33G F [Phos]AGGCGGCG
ACGTTAGTGT 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Tyr for Gly 
lasI S103A F [Phos]TCGCCCGTT
TCGCCATCA 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Ser for Ala 
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lasI S103E F [Phos]TGGAACTCG
AGCGTTTC 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Ser for Glu 
lasI S103V F [Phos]TCGTGCGTT
TCGCCATCA 
Forward primer used to amplify the lasIPa 
ORF region with bold italicized codon for 
substitution of Ser for Val 
lasIR ATAAGGCCTTCAT
GAAACCGCCAGTC
GCT 
Reverse primer used to amplify the lasIPa 
ORF region with an underlined StuI 
restriction site directly downstream of the 
stop codon (bold) 
 
lasI R23W R [Phos]CTTGTGCAT
CTCGCCCAG 
Reverse primer used to amplify the lasIPa 
ORF region for substitution of Arg for 
Trp 
lasI F27L R [Phos]CTTGAGCAC
GCAACTTGT 
Reverse primer used to amplify the lasIPa 
ORF region for substitution of Phe for 
Leu 
lasI F27Y R [Phos]CTTGAGCAC
GCAACTTGT 
Reverse primer used to amplify the lasIPa 
ORF region for substitution of Phe for 
Tyr 
lasI W33G R [Phos]TTGCGCTCC
TTGAACACT 
Reverse primer used to amplify the lasIPa 
ORF region for substitution of Tyr for 
Gly 
lasI S103A/V R [Phos]GTTCCCAGA
TGTGCGGCG 
Reverse primer used to amplify the lasIPa 
ORF region for substitution of Ser for Ala 
or Val 
lasI S103E R [Phos]GATGTGCG
GCGAGCAAGG 
Reverse primer used to amplify the lasIPa 
ORF region for substitution of Ser for 
Glu 
Ptac CGGCTCGTATAAT
GTGTGGA 
Primer to sequence multiple cloning site 
in pME6032 
 
P6032 
 
CCCTCACTGATCC
GCTAGTC 
Primer to sequence multiple cloning site 
in pME6032 
rhlI F TATCAATTGATGA
TCGAATTGCTCTC
TGAAT 
Forward primer used to amplify the rhlI 
ORF region with an underlined MfeI 
restriction site directly upstream of the 
start codon (bold) 
rhlI F28L F [Phos]TCCTGATCG
AGAAGCTGG 
Forward primer used to amplify the rhlIPa 
ORF region with bold italicized codon for 
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substitution of Phe for Leu 
rhlI F28Y F [Phos]TCTACATCG
AGAAGCTGG 
Forward primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Phe for Tyr 
rhlI W34G F [Phos]TGGGCGGC
GACGTGGTCT 
Forward primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Tyr for Gly 
rhlI S103A F [Phos]TTGCCCGCT
ACGCCGCCA 
Forward primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Ser for Ala 
rhlI S103E F [Phos]TGGGAGCTT
GAGCGCTAC 
Forward primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Ser for Glu 
rhlI S103V F [Phos]TTGTGCGCT
ACGCCGCCA 
Forward primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Ser for Val 
rhlI R ATAAGGCCTTCAC
ACCGCCATCGACA
GC 
Reverse primer used to amplify the rhlIPa 
ORF region with an underlined StuI 
restriction site directly downstream of the 
stop codon (bold) 
 
rhlI F28L R [Phos]CCTGATGCC
GGTAGCGTC 
Reverse primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Phe for Leu 
rhlI F28Y R [Phos]CCTGATGCC
GGTAGCGTC 
Reverse primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Phe for Tyr 
rhlI W34G R [Phos]GCTTCTCGA
TGAAGACCT 
Reverse primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Tyr for Gly 
rhlI S103A/V R [Phos]GCTCCCAGA
CCGACGGAT 
Reverse primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Ser for Ala or Val 
rhlI S103E R [Phos]GACCGACG
GATCGCTCGG 
Reverse primer used to amplify the rhlIPa 
ORF region with italicized codon for 
substitution of Ser for Glu 
Table 2.5 Oligonucleotide primers used in this study. 
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2.7.2 PCR amplification 
PCR amplification was performed according to methods described by Sakai et al. (1988) 
in a final volume of 50 Pl. 
PCR mix  
Template DNA 50-100 ng 
Forward primer 1 PM 
Reverse primer 1 PM 
dNTPs 1-2 mM 
High Fidelity Polymerse (Roche) 1-2.5 U 
PCR buffer including MgCl2 1x buffer 
dH20 make up to 50 Pl 
Table 2.6: Components of a standard PCR. 
Reactions were carried out in a Progene PCR Thermocycler (Techne) for a total of 35 
cycles. Briefly, the DNA template was denatured at 96 °C for 5-10 min, followed by 30-35 
cycles of extension at 72 °C for 1-3 min depending on the DNA polymerase and length 
of the DNA to be amplified (1 min per kb), denaturation at 96 °C for 20 s and then 
annealing at 55-65 °C for 30 s. The last cycle finished with a final extension stage at 72 °C 
for 10 min to ensure completion of all strands. The annealing temperature was varied 
depending on the nature of the primers used and the stringency levels required. Reaction 
mixes were then incubated at 4 °C indefinitely to allow PCR reactions to be carried out 
O/N. 
2.8 DNA sequencing 
2.8.1 Obtaining DNA sequence data 
Routine DNA sequencing was conducted by the DNA Sequencing Laboratory, Queens 
Medical Centre, University of Nottingham, using the Applied Biosystems BigDye® 
Terminator v3.1 Cycle Sequencing Kit and 3130x1 Genetic Analyzer. 
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2.8.2 DNA sequence analysis 
All pre-determined DNA and protein sequences were obtained from the NCBI 
(http://www.ncbi.nlm.nih.gov/ ¶*HQH· DQG ¶3URWHLQ· GDWDEDVHV UHVSHFWLYHO\ 7KH
Pseudomonas Genome Sequence Database (http://www.pseudomonas.com) was 
additionally used to analyse P. aeruginosa sequences. Analysis of DNA sequences was 
performed using the Lasergene DNAStar software package. Comparison of DNA and 
SURWHLQVHTXHQFHVWRLGHQWLI\KRPRORJ\ZDVFDUULHGRXWXVLQJWKH1&%,¶%/$67·VHUYHU 
2.9 Transformation 
2.9.1 Preparation of electro-competent E. coli cells 
To prepare competent E. coli cells, a 1% (v/v) inoculum from an O/N E. coli culture was 
added to 100 ml of sterile LB broth in a 500 ml-Erlenmeyer flask and grown at 37 ʃC with 
shaking at 200 rpm to an OD600 of 0.4-0.8 (reached approximately 6 h after inoculation). 
Cells were harvested by centrifugation at 6000 rpm (JA-14, Beckman) for 10 min at 4 ʃC 
and washed twice in sterile ice-cold 10% (v/v) glycerol containing 1 mM MOPS before 
being resuspended in 1 ml of the same buffer. Cells were aliquoted into 50Pl samples in 
microcentrifuge tubes, flash frozen in liquid nitrogen and stored at -80 qC until needed. 
2.9.2 Electroporation of electro-competent E. coli cells 
For electroporation of DNA into E. coli cells, salts were firstly removed from the DNA 
solution by filter dialysis on 0.025 PM Millipore filters (Millipore Corporation, UK) for at 
least 20 min. Electroporation was then performed in 0.2 cm electrode gap Gene Pulser 
cuvettes (BioRad, UK) containing 50Pl of competent cells and 2-3 Pl dialysed DNA. An 
electroporation pulse of 2.5 kV (25PF, 200 :) was delivered using the BioRad Gene 
Pulser connected to a BioRad pulse controller (BioRad, UK). A 0.95 ml volume of pre-
warmed (37 qC) LB broth was added to the cells which were then incubated at 37 qC for 1 
h in the absence of antibiotics. Aliquots of cells were subsequently plated onto LB agar 
plates containing appropriate antibiotics to select for transformants and grown O/N at 
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37 qC. Negative controls of electroporated cells with no plasmid were also similarly 
prepared. 
2.9.3 Preparation of electro-competent P. aeruginosa cells 
Competent P. aeruginosa cells for electroporation were prepared from 1.5 ml of culture, 
grown O/N in LB at 37 qC, by centrifugation at 13,000 rpm for 5 min. The cells were 
washed with 1 ml ice-cold 10% (v/v) glycerol with 1 mM MOPS prior to a second 
centrifugation step. The pellet was then resuspended in 50 Pl ice-cold 10% (v/v) glycerol 
with 1 mM MOPS and the resulting electro-competent cells were immediately used for 
electroporation. If necessary, the cells were flash frozen in liquid nitrogen and stored at -
80 qC. 
2.9.4 Electroporation of electro-competent P. aeruginosa cells 
Transformation of P. aeruginosa cells was performed as for E. coli using electro-competent 
cells prepared as described in Section 2.8.2. 
2.10 Recombinant protein production, purification and 
analysis 
2.10.1 Whole cell protein preparation 
Strains to be investigated were grown in an appropriate volume of LB broth as previously 
described. At specific time points, the OD600 of the culture was determined and 1 ml 
aliquots removed. The aliquots were pelleted by centrifugation for 2 min at 13,000 rpm 
and prepared in the following way. Pelleted cells were then resuspended in 50 µl gold lysis 
buffer (Table 2.7) to which phenylmethanesulphonylfluoride (PMSF) protease inhibitor 
was then added. Resuspended cell pellets were then incubated on ice for 30 min and 
sonicated for approximately 30 s. 50 µl sample loading buffer was then added and the 
samples were boiled for 5 min prior to loading on an SDS-PAGE gel. When necessary, 
samples were stored at -20 °C. 
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Gold lysis buffer  
Tris-HCl pH 8.0 20 mM 
NaCl 137 mM 
EDTA 5 mM 
Triton X-100 1% (v/v) 
Glycerol 15% (v/v) 
Table 2.7: Gold lysis buffer. 
Stored at RT. 
2.10.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) analysis 
For the analysis of proteins, SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel 
electrophoresis) was performed as described by Laemmli (1970). A 12% resolving gel was 
used in gels shown in this thesis, which allowed separation of proteins which had first 
been electrophoresed through a 5% stacking gel. Samples were boiled for 5 min prior to 
ORDGLQJDQGƬODOLTXRWVRISUHSDUHGVDPSOHVZHUHORDGHGRQWRWKHVWDFNLQJJHOZLWKD
disposable gel loading tip (Bio-Rad). 10 Pl of the Bio-Rad Precision Plus Dual Colour 
Protein Standard was also loaded and provided the molecular weight marker. 
Electrophoresis was performed in electrophoresis running buffer (Table 9.2) using a Bio-
Rad mini-protean II gel pouring and electrophoresis rig and separated using a Bio-Rad 
power pack at 16 mA per gel until the protein entered the resolving gel. Subsequently, 40 
mA per gel was used to allow samples to resolve, until the dye had migrated to the 
bottom of the gel. The gel was stained and destained to visualize the proteins.  
2.10.3 Western blotting 
To detect proteins of interest, they were transferred from SDS-PAGE gels onto 
nitrocellulose membranes using a Mini Trans-Blot cell (Biorad, UK). Blotting was 
performed in blotting buffer at 80 V for 1 h at RT. Once the polyacrylamide gel had been 
transferred to a nitrocellulose membrane, the membrane was submerged into 5-10 ml 
Ponceau S (Table 2.8) for 1-2 min or until the bands had become visible. The membrane 
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was then rinsed with copious dH2O until the protein bands were no longer visible. The 
membrane was then blocked shaking for 1 h at RT or O/N at 4 qC in blocking solution 
(Table 2.8). The blocking solution was discarded and the membrane incubated shaking 
with the appropriate dilution of the primary antibody in fresh blocking solution for 1 h. 
The membrane was washed (3 x 20 min) before addition of the secondary antibody at 
1:1000 dilution in blocking buffer and incubated at RT shaking for 1 h. The membrane 
was again thoroughly washed as before. The blot was developed using the ECL Plus 
Western Blotting Detection System (Amersham Biosciences, UK) for approximately 1 
min. Blots were exposed to HyperfilmTM Chemiluminescence Film (Amersham 
Biosciences, UK) for 2-60 min. The film was developed and allowed to dry. 
Blotting buffer  
Tris base 20 mM 
Glycine 150 mM 
MeOH 20% (v/v) 
Blocking solution  
PBS with: - 
Tween-20 0.05% (v/v) 
Dried skimmed milk power 5% (w/v) 
Ponceau S  
Ponceau S 0.5% (w/v) 
Acetic acid 10% (v/v) 
Washing solution  
PBS with: - 
Tween-20 0.05% (v/v) 
Table 2.8: Standard recipes for western blotting solutions.  
Blotting buffer was stored at 4 qC, ponceau S at RT and blocking and washing solutions 
freshly prepared for each experiment. 
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2.11 Extraction, detection and quantification of QSSMs 
2.11.1 Extraction of QSSMs 
For extraction of AHLs, E. coli and P. aeruginosa strains were grown in 125 ml LB 
supplemented with 1 mM IPTG (in 500 ml Erlenmeyer flasks) at 37 qC. Cells were 
removed by centrifugation and 1 ml supernatant samples were spiked with 5 µl of 10 µM 
deuterated N-pentanoyl-L-homoserine lactone (d9 C5-HSL; 1 µM in ACN) as the internal 
standard (IS). Supernatants were combined with 1 ml acidified ethyl acetate with 0.01% 
acetic acid, the mixture vortexed for 30 s and the organic phase removed following brief 
centrifugation at 10,000 rpm. The extraction procedure was performed three times and 
the combined extracts were evaporated to dryness with a rotary evaporator. The dried 
extracts were stored at -80 q&XQWLOUHFRQVWLWXWHGLQƬORI$&1 
A ten point calibration line was established by spiking sterile LB medium with a mixture 
of analytes with a concentration range from 2 to 500 µM of N-butanoyl-L-homoserine 
lactone (C4-HSL) and N-(3-oxo-dodecanoyl)-L-homoserine lactone (OC12-HSL); a 
concentration range from 0.2 to 50 µM  of N-hexanoyl-L-homoserine lactone (C6-HSL) 
and N-(3-oxodecanoyl)-L-homoserine lactone (OC10-HSL); and a concentration range 
from 0.08 to 20 µM  of N-acyl-L-homoserine lactone (C8-, C10-, C12- and C14-HSLs), N-(3-
oxo-acyl)-L-homoserine lactone (OC4-, OC6-, OC8- and OC14-HSLs) and N-(3-hydroxy-
acyl)-L-homoserine lactone (HC4-, HC6-, HC8-, HC10-, HC12- and HC14-HSLs). Stock 
solutions of 1 mg/ml were prepared in ACN and stored at -20 qC before use.  
2.11.2 Analysis of AHLs by TLC-biosensor overlay plates 
 ƬO VDPSOHV RI H[WUDFWHG FXOWXUH RU FHOO-IUHH VXSHUQDWDQW IUDFWLRQV DQG ƬO RI  P0
synthetic AHL standard were spotted individually onto a RP-18 F254s reversed phase silica 
(Merck). Spots were dried with a hairdryer. Extracts were separated using a MeOH:H20 
(60:40 v/v) mobile phase until the solvent front was approximately 1 inch from the top 
of the plate. After chromatography, TLC plates were dried and then overlaid with 0.3% 
(w/v) LB agar seeded with 0.5% (v/v) of an O/N culture of either E. coli JM109[pSB536] 
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for C4-HSL or JM109[pSB1142] for C12-HSL. Plates were incubated at 37 
qC and 
bioluminescence examined after 4-6 h using a Luminograph LB980 (Berthold, 
Pforzheim, Germany) photon video camera. 
2.11.3 AHL detection by biosensor strain overlay plates 
Rapid confirmation of AHL production was performed using a similar method to that 
described above in section 2.11  ƬO VDPSOHV RI H[WUDFWHG FXOWXUH RU FHOO-free 
supernatant fractions and ƬORIP0V\QWKHWLF$+/VWDQGDUGZHUHDSSOLHG WRZHOOV
made in LB agar plates (petri dishes) overlaid with 0.3 % (w/v) LB agar seeded with 0.5% 
(v/v) of an O/N culture of either E. coli JM109[pSB536] for C4-HSL or JM109[pSB1142] 
for C12-HSL. Once plates had been prepared, they were placed in a sealed container to 
prevent evaporation and incubated at 37 qC. Bioluminescence was examined after 2-4h 
using a Luminograph LB980 (Berthold, Pforzheim, Germany) photon video camera. 
2.11.4 LC-MS/MS analysis of QSSMs 
LC-MS/MS analysis of QSSMs in extracted supernatants was performed as described by 
Ortori et al. (2011). Briefly, a 5 µl volume of the crude extracts resuspended in ACN was 
separated at a flow rate of 0.45 ml/min by HPLC equipped with binary pumps, a vacuum 
degasser, a SIL-HTc autosampler and column oven (Shimadzu, Columbia, MD, USA) 
using a Phenomenex Gemini Column C18, 150 x 2 mm (5 µm particle size) heated at 50 
qC. The HPLC system used a mobile phase A constituted by 0.1 % formic acid and 200 
µM EDTA in water and a mobile phase B constituted by 0.1 % formic acid in ACN. The 
mobile phase A was sonicated for 30 min and all mobile phases were filtered through 
0.45 µm nylon Whatman disk filters (Maidstone, UK) prior to use. The HPLC gradient 
profile was as follows: isocratic for 1 min, a linear gradient from 10% to 50% B over 0.5 
min, then a further gradient from 50% to 99% B over 4 min followed by 99% B for 1.5 
min, at a flow rate of 0.45 ml/min. The column was re-equilibrated for a total of 2.9 min. 
All mass spectrometry (MS) experiments were conducted on a 4000 QTRAP hybrid 
triple-quadruple linear ion trap mass spectrometer (Applied Biosystems, Foster City, CA, 
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USA) equipped with a TurboIon source used in positive ion electrospray mode. A 
Windows XP (Microsoft, Redmond, WA, USA) workstation running Analyst (version 
1.4.1) was used for data acquisition and processing.  MRM parameters (precursor and 
product ion pairs, declustering potential, collision cell exit potential and collision energy) 
were optimized by software automation whilst infusing at 50 µl/min with the MS peak 
widths set to 0.7 Th. Source parameters were optimized during infusion experiments at 
the working flow rate and were as followed: curtain, Gas 1 and 2 were 20, 30 and 10 
respectively. The ion source potential was 5000 V and the source was held at 450 qC. 
Quantification was performed using Analyst 1.4.1. 
2.12 Extraction, detection and quantification of AMC 
metabolites 
2.12.1 Sample collection and storage 
E. coli and P. aeruginosa strains were grown up in 125 ml LB media in 500 ml Erlenmeyer 
flasks at 37 qC shaking as previously described. At appropriate ODs, samples were 
harvested by the rapid addition and mixing of 5 ml of the bacterial culture into 15 ml of 
ice-cold PBS. A volume of the quenched culture, equivalent to 2.5 ml of a culture with 
OD600 = 1.0, was pelleted by centrifugation at -5 
qC and 5,000 rpm for 5 min to produce 
a standard-sized cell pellet. Once the supernatant was discarded, cell pellets were washed 
by resuspending in a 10 ml aliquot of the ice-cold PBS and pelleted again by 
centrifugation at -5 qC and 5,000 rpm for 5 min. After discarding the supernatant, the cell 
pellets were stored at -80 qC until metabolite extraction was carried out. 
2.12.2 Extraction of AMC metabolites 
Extraction of AMC metabolites in bacterial pellets was facilitated by solvent extraction as 
described by Halliday et al. (2010). Briefly, cell pellets were resuspended in 0.5 ml of 80% 
(v/v) MeOH spiked with 10 Pl of the IS mix ([13CD3]MET and SAC were used as ISs at a 
concentration of 1.0 Pg/ml in dH2O). Cell lysis was ensured by repeated cycles of freeze²
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thaw (cooling to -80 qC), with rapid vortex mixing between cycles. Cellular debris was 
pelleted by centrifugation (13,000 rpm, 0 qC, 10 min), and the methanolic extract was 
transferred to a clean sample vial. Cell pellets were extracted twice more with 0.5 ml 
portions of 80% (v/v) MeOH, combining extracts to give a total volume of 
approximately 1.5 ml of methanolic extract per sample. Extracts were concentrated to 
approximately 20% of the initial volume under vacuum and then dried by lyophilisation 
O/N.  
2.12.3 Chemical derivatization of AMC metabolites 
Following solvent extraction, compounds underwent chemical derivatization as this 
improves the extraction, ionization, and chromatographic properties of all the AMC 
metabolites (Halliday et al., 2010). For this, the dried extracted metabolite samples were 
first redissolved in 80 Pl dH20. 10 Pl of 0.05M tris-(hydroxyl-propyl)phosphine (THP; 
Novagen, Merck Chemicals, Nottingham, UK) solution was added and the samples were 
allowed to stand for approximately 30 min at RT. Then 40 Pl of iso-butanol (i-
BuOH)/pyridine mix (3:1, v/v) was added, followed by 10 Pl of iso-butylchloroformate 
(i-BuCF). The samples were then vortex-mixed for approximately 30 s, and 200 Pl of 
DCM/tert-butylmethyl ether (1:2, v/v) was added. After a further period of vortex 
mixing, the layers were separated and 150 Pl of the upper organic phase containing the 
derivatized metabolites was removed to an autosampler vial. The aqueous layer was then 
extracted with a second 200 Pl portion of the organic solvent mix and combined with the 
initial organic extract. The organic solvent was removed under vacuum, and the residue 
of derivatized metabolites was dissolved in 100 Pl of the initial LC mobile phase (55% 
MeOH in 10 mM aqueous ammonium formate). 
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2.12.4 LC-MS/MS analysis of AMC metabolites 
LC²ESI²MS/MS was performed as described by Halliday et al. (2010) using a triple 
quadruple Quattro Ultima mass spectrometer (Waters Micromass, Manchester, UK) in 
conjunction with an Agilent 1100 LC system (Agilent Technologies, Waldbron, 
Germany) with a cooled autosampler. The LC column was a Luna ODS C18(2) (5 Pm, 
150 _ 2.0 mm, Phenomenex, Macclesfield, UK) with an appropriate guard column, 
maintained at 30 qC with a mobile phase flow rate set at 200 Pl/min. Gradient elution 
mobile phases consisted of A (aqueous 10 mM ammonium formate) and B (10 mM 
ammonium formate in MeOH). The gradient began initially at 55% B, increasing linearly 
to 100% B over 15 min, maintained at this percentage for a further 5 min and returned to 
55% B for reequilibration. The total run time was 30 min for each sample. Sample 
temperature was maintained at 4 qC in the autosampler prior to analysis with injections of 
20 Pl per sample. Quantitation of analytes was undertaken using tandem electrospray 
mass spectrometry in positive mode (+ESI). Cone and desolvation gas flows of 155 and 
765 L/h with source and desolvation temperatures of 150 and 350 qC, respectively, were 
used. The dominant product ion for each derivatized metabolite was selected to monitor 
in multiple reaction monitoring (MRM) mode (Table 2.11). Dwell time was set to 0.1 s. 
Peaks were integrated, and the software package MassLynx (version 4, Waters) was used 
to quantify levels of the AMC metabolites. 
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Analyte Retention 
time (min) 
Precursor 
ion (m/z) 
Product ion 
(m/z) 
Collision 
energy (eV) 
IS used 
HCY 18.6 392.2 292.4 14 [13CD3]MET 
MET 15.8 306.2 104.2 19 [13CD3]MET 
SAH 12.1 541.2 136.1 25 SAC 
SAM 12.2 655.1 202.3 24 SAC 
SRH 11.5 424.2 202.2 20 [13CD3]MET 
[13CD3]MET
a 15.7 310.2 108.3 19 - 
SACa 11.2 527.2 136.2 23 - 
(HCY)2
b 19.3 581.2 290.4 17 - 
Table 2.9: AMC metabolites - Selected precursor product ion m/z values, 
retention times, and collision energies used to identify and quantify analytes 
using MRM. 
a Internal standards. b The presence of these oxidized metabolites was monitored for but 
not quantified. 
2.13 Extraction, detection and quantification of MTA 
2.13.1 Extraction of MTA 
Extraction of MTA in bacterial pellets was facilitated by solvent extraction. Briefly, cell 
pellets were resuspended in 0.5 ml MeOH spiked with 10 Pl 2-chloroadenosine (2-
C.ADE) as the IS. Cell lysis was ensured by repeated cycles of freeze²thaw (cooling to -
80 qC), with rapid vortex mixing between cycles. Cellular debris was pelleted by 
centrifugation (10 min, 13,000 rpm, 0 qC), and the methanolic extract was transferred to a 
clean sample vial. Cell pellets were extracted twice more with 0.5 ml portions of MeOH, 
combining extracts to give a total volume of approximately 1.5 ml of methanolic extract 
per sample. Extracts were then evaporated to dryness and reconstituted in 100 Pl dH2O.  
2.13.2 LC-MS/MS analysis of MTA 
LC²ESI²MS/MS was performed using a triple quadruple Quattro Ultima mass 
spectrometer (Waters Micromass, Manchester, UK) in conjunction with an Agilent 1100 
LC system (Agilent Technologies, Waldbron, Germany) with a cooled autosampler, with 
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conditions as described by Stevens et al. (2008). The LC column was a Synergi 4u Hydro-
RP (4 Pm, 150 _ 2.0 mm, Phenomenex, Macclesfield, UK) with an appropriate guard 
column. The column oven was kept at 25 qC with a mobile phase flow rate set at 125 
Pl/min.  LC separation was carried out using a mobile phase consisting of 0.1% acetic 
acid in H20 (A) and 0.1% acetic acid in ACN (B). The gradient employed was as follows: 
0²10 min linear increase from 0 to 100% solvent B, hold at 100% solvent B for 5 min. 
The total run time was 25 min for each sample. Sample temperature was maintained at 4 
qC in the autosampler prior to analysis with injections of 20 Pl per sample. Quantitation 
of analytes was undertaken using tandem electrospray mass spectrometry in positive 
mode (+ESI). Cone and desolvation gas flows of 155 and 765 L/h with source and 
desolvation temperatures of 150 and 350 qC, respectively, were used. Peaks were 
integrated, and the software package MassLynx (version 4, Waters) was used to quantify 
levels of MTA. 
Analyte Retention 
time (min) 
Precursor 
ion (m/z) 
Product ion 
(m/z) 
Collision 
energy (eV) 
IS used 
MTA 4.6 298.2 136.2 15 2-C.ADE 
2-C.ADEa 4.5 302.2 170.3 16 - 
Table 2.10: MTA - Selected precursor product ion m/z values, retention times, 
and collision energies used to identify and quantify analytes using MRM. 
a Internal standard. 
2.14 Detection of AI-2 using Vibrio harveyi bioassay 
Measurement of AI-2 activity within samples using V. harveyi BB170 was based upon 
methods described by Bassler et al. (1997). O/N cultures of V. harveyi BB170 were diluted 
50-fold in fresh LB medium and grown for 7-8 h. The culture was then diluted 5000-fold 
in assay for bioluminescence (AB) medium (Table 2.11). 20 Pl volumes of each test 
sample for AI-2 analysis were added to 180 Pl aliquots of the V. harveyi dilution in AB 
medium. Changes in bioluminescence were monitored at 30 qC every 30 min using a 
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multifunctional, automated luminometer-spectrometer (TECAN Infinite F200). This was 
performed in 96 well clear bottomed, black polystyrene plates (Matrix). 
For a single experiment, the V. harveyi bioassay was performed in triplicate for each 
sample. An appropriate negative control sample was also included for each set of test 
samples.  The light emission in response to this control was charted, the time during the 
assay at which light output in response to this control sample had reached a minimum 
level was identified. Consequently, all values of bioluminescence determined during this 
study are depicted in terms of fold-induction of bioluminescence relative to a negative 
control sample. 
AB media  
NaCl 0.3 mM 
MgSO4 0.05 M 
Vitamin-free casamino acids 0.2% (w/v) mM 
K2HPO4 10 mM 
HEPES (pH 7.8 using KOH) 25 mM 
L-arginine 1 mM 
Glycerol 0.5% (v/v) 
Table 2.11: Recipe for AB media. 
Stored at RT. 
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Chapter 3 
Analysis of the metabolic 
implications of the  
P. aeruginosa AHL synthase 
genes in E. coli 
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3.1 Introduction 
To enable P. aeruginosa to cause infection, the QSSMs it produces to control virulence 
factor production are synthesized from substrates that are derived from central 
metabolism. In P. aeruginosa, QS achieves co-ordinated cell-cell communication through 
the production of N-acyl-L-homoserine lactones (AHLs) and the Pseudomonas quinolone 
signal (PQS). Production of AHLs requires precursors including fatty acids and S-
adenosyl-L-methionine (SAM). SAM is derived from the activated methyl cycle (AMC) 
that functions as a metabolic pathway dedicated to the degradation of the toxic 
metabolite S-adenosyl-L-homocysteine (SAH). The AMC is therefore performing a highly 
important function and this is rarely taken into consideration in the context of QS. 
However, since metabolites integral to the AMC may be subverted for AHL synthesis, 
there are likely to be metabolic consequences of AHL synthesis which alter the bacterial 
FHOO·VSK\VLRORJ\DQGFRQVHTXHQWO\ILWQHVVDQGWKLVXOWLPDWHO\PD\LPSDFWXSRQYLUXOHQFH 
To study each QSSM synthase in isolation, each was subcloned into E. coli to avoid 
complicating interactions imposed by the P. aeruginosa hierarchical QS system. An IPTG-
inducible expression vector was exploited and the constructs transferred to a strain of E. 
coli, a heterologous bacterial host which has the appropriate metabolic systems yet does 
not itself produce any AHLs thus avoiding any interference issues. 
3.2 Cloning of lasIPa and rhlIPa 
Figure 3.1 shows the stratergy adopted for cloning the sequences of the P. aeruginosa AHL 
synthase genes. The ORFs of the lasIPa and rhlIPa genes were PCR-amplified using 
chromosomal DNA isolated from P. aeruginosa strain PA01 (Nottingham) using the 
primer pairs lasIF/lasIR and rhlIF/rhlIR respectively (Table 2.5). The resultant products 
were separated using agarose gel electrophoresis, which demonstrated the presence of the 
two expected 0.624 kb fragments (0.606 kb lasIPa/rhlIPa and 0.018 kb for additional 
restriction sites). The amplified sequences were excised from the gel and each sample 
purified via gel extraction. Directed ligation of the pGEM-T Easy cloning vector 
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(Promega) and inserts, produced pGEM-lasIPa and pGEM-rhlIPa, which were transformed 
into E. coli DH5D and plated out onto the appropriate selective medium comprising LB 
agar, Cb and X-gal, to allow selection via blue-white screening. As expected, subjecting 
the DH5D competent cells to transformation with water alone generated no 
transformants, whilst undigested pBS vector generated a lawn of transformants. 
The insertional inactivation of the lacZ gene with the lasIPa and rhlIPa genes to disrupt E-
galactosidase production resulted in a significant number of white colonies, some of 
which were chosen for further analysis. The plasmids extracted from all selected 
transformants generated the expected DNA fragments when digested with the REs MfeI 
and StuI confirming the presence of the AHL synthase encoding genes An absence of 
point mutations was confirmed by DNA sequencing. 
The lasIPa and rhlIPa inserts were released from their respective constructs in the pGEM-T 
Easy vector in a double digestion reaction with MfeI and StuI. The same REs were used 
to digest pME6032 and ligation of the two, produced pME-lasIPa and pME-rhlIPa, which 
were again transformed into E. coli DH5D. Colony PCR of potential Tc resistant clones 
confirmed the presence of either of the AHL synthase encoding genes. Sequencing was 
performed to verify that no point mutations had occurred. 
3.3 lasIPa and rhlIPa synthesize the cognate AHLs in 
MG1655 
Following successful cloning of lasIPa and rhlIPa into pME6032, and transformation into 
E. coli MG1655, AHL production was confirmed. This was performed using strain 
overlay plates in the first instance, and then thin-layer chromatography (TLC) analyses 
(Figure 3.2). Both methods confirmed that expression of lasIPa and rhlIPa in MG1655 leads 
to the production of OC12-HSL and C4-HSL, respectively. 
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Figure 3.1: Schematic representation of the strategy adopted for cloning the lasIPa 
and rhlIPa genes. The ORF sequence of each gene was PCR amplified to incorporate 
MfeI and StuI RE sites and then cloned into the pGEM-T Easy vector. Once successful, 
digestion of the recombinant T-clone construct with MfeI and StuI produces the insert 
and vector fragments upon electrophoresis. The insert sequences were then cloned into 
pME6032 digested with the same REs. 
- 64 - 
 
 
     
 
 
Figure 3.2: Cloned lasIPa and rhlIPa genes lead to the production of OC12-HSL and 
C4-HSL respectively in E. coli MG1655. Strain overlay plates [A, B] and thin layer 
chromatography [C, D] of methanol extracts of MG1655[pME6032] and -AHL synthase 
strains grown with and without IPTG induction in LB to late exponential phase. A and C 
have been overlaid with JM109[pSB1142], responding to long-chain AHLs, whilst B and 
D with JM109[pSB536], which luminescence in response to short-chain AHLs. AHL 
production occurs even without IPTG induction representing leaky vector. 
A                  B 
            
 
 
 
 
 
 
C 
 
 
 
 
 
D 
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The negative control, E. coli MG1655[pME6032], which lacked a cloned AHL synthase 
was completely devoid of detectable AHL production. However, both MG1655[pME-
lasIPa] and MG1655[pME-rhlIPa], directed production of their cognate AHL in the absence 
of the gene expression induced by IPTG, albeit at lower levels. 
3.4 LC-MS/MS profiling of AHLs reveals that LasI 
produces several other AHLs in MG1655 
As well as OC12-HSL and C4-HSL, P. aeruginosa produces other AHLs including C6-HSL, 
as well as an array of AQs. It was therefore interesting to investigate whether the AHL 
synthase genes would perform exactly the same function and replicate the AHL profile 
observed in the chosen heterologous organism. As expected, OC12-HSL and C4-HSL 
were the overriding signals, being detected above 600 PM and 800 PM, respectively, 
occupying averages of 71% and 95%, respectively of the total AHL profiles for 
recombinant lasIPa and rhlIPa expression (Figure 3.3 and 3.4). The distribution 
demonstrated by lasIPa was far more interesting, with the observance of 12 other AHLs, 
with half of them being present at concentrations above 5 PM (Figure 3.2). Amongst 
these, the OC-series seemed to dominate, with, as already mentioned, OC12-HSL, 
occupying the major percentage (71%) followed by, averages of 111.73 PM OC14-HSL 
(13%) and 50.07 PM OC10-HSL (6%). Subsequently, significant concentrations of the C-
series were observed, with averages corresponding to 41.87 PM C12-HSL and 18.8 PM 
C14-HSL. Other AHLs, in descending order of concentration, include OC8-HSL (5.45 
PM), OC6-HSL (3.54 PM), HC14-HSL (2.81 PM), C10-HSL (2.36 PM), C8-HSL (2.10 PM), 
HC10-HSL (0.45 PM) and C6-HSL (0.36 PM). In contrast, the AHL profile for rhlIPa was 
far narrower and differed from the lasIPa-dependent AHL profile since smaller acyl chains 
were linked to the lactone ring (Figure 3.4). In addition to C4-HSL, 3 other AHLs were 
observed with the average concentrations observed as follows: HC4-HSL (36.15 PM), C6-
HSL (6.06 PM) and C8-HSL (1.72 PM). 
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Figure 3.3: Relative molar proportions and quantitative profiling of AHLs 
produced by lasIPa expression in E. coli in LB growth media. Compounds were 
extracted from late exponential phase supernatants with acidified ethyl acetate and 
profiled by LC-MS/MS analysis. (A) The ratio between the different signalling molecules 
present in supernatants is represented by pie charts. (B) The actual concentration of 
AHLs.  
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Figure 3.4: Relative molar proportions and quantitative profiling of AHLs 
produced by rhlIPa expression in E. coli in LB growth media. Compounds were 
extracted from late exponential phase supernatants with acidified ethyl acetate and 
profiled by LC-MS/MS analysis. (A) The ratio between the different signalling molecules 
present in supernatants is represented by pie charts. (B) The actual concentration of 
AHLs. 
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3.5 LasI and RhlI proteins are detected in MG1655 
To confirm the production of the synthases themselves, protein profiles of the induced 
and uninduced E. coli expression strains were analysed. With the induced MG1655[pME-
lasIPa], it was possible to visualize the presence of an additional 26 kDa protein 
corresponding to the LasI synthase with Coomassie staining of an SDS-PAGE (Figure 
3.5A). The absence of this protein from profiles of extracts prepared from the uninduced 
strain and moreover MG1655 harbouring the empty vector, confirmed that its 
production was due to lasIPa. Furthermore, this protein was sequenced via MALDI 
fingerprint analysis to confirm its identity (Figure 3.5C). In contrast, with MG1655[pME-
rhlIPa], despite 3 independent rounds of sample collection, preparation and running of 
SDS-PAGE, detection of the RhlI synthase was not possible. However, the availability of 
a specific antibody meant that it was possible to visualise an additional protein 
corresponding to the RhlI synthase though a Western blot approach (Figure 3.5B). 
3.6 Production of AHL synthases in MG1655 alters the 
levels of metabolites of the AMC 
As LasI and RhlI synthesize AHLs from metabolite substrates, it was interesting to 
determine the metabolic repercussions of introducing these enzymes into E. coli. The 
AMC metabolic profile (SAM, SAH, SRH, HCY and MET) was determined in extracts 
prepared from late exponential phase cultures (125 ml LB in 500 ml-Erlenmeyer flasks at 
37qC shaking) of E. coli MG1655 with the empty vector or carrying an AHL synthase. 
The absence of calibration meant that the precise concentrations of each compound 
cannot be determined, but the presence of an internal standard allowed the comparison 
of metabolite composition from one extract to the other, the concentrations being 
expressed in arbitrary units. Introduction of AHL synthases reduced the level of each of 
the metabolites compared to the non-induced strain and the WT with the empty vector 
(Figure 3.6). 
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Figure 3.5: Protein production confirmed from cloned synthase genes in E. coli 
MG1655. E. coli MG1655 alone [pME6032] or containing pME-lasIPa (LasI) or pME-rhlIPa 
(RhlI) were grown in LB to OD600=0.5 and induced with (+) IPTG or not (²). After 
approximately 1 h, whole cell extracts were prepared and separated through 12% SDS-
PAGE gels which were subjected to Coomassie staining (A) or Western blotted using 
DRhlI (B). SDS-PAGE reveals the presence of the 26 kDa LasI protein (*) in lysates of 
the IPTG induced MG1655[pME-lasIPa] strain, whilst IPTG induction of MG1655[pME-
rhlIPa] leads to expression of the 26 kDa RhlI synthase (*) as shown by Western blotting. 
The top matches from the Mascot search of fragments generated from MALDI 
fingerprint analysis of the suspected LasI band confirm its identity (C). 
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Figure 3.6: Reduced levels of AMC-linked metabolic profile of E. coli MG1655-
AHL synthase strains. Intracellular accumulation of SAM, SAH, SRH, HCY and MET 
were determined by LC-MS analysis in three E. coli strains MG1655[pME6032] (1, 2), 
MG1655[pME-lasIPa] (3, 4) and MG1655[pME-rhlIPa] (5, 6) grown in LB with (2, 4, 6) and 
without (1, 3, 5) IPTG induction. Peak area corresponding to each compound was 
divided by the peak area of the appropriate internal standard for normalisation. 
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Addition of IPTG to the strain with the empty plasmid (negative control conditions; 
NCCs) did not alter AMC metabolite levels. Metabolic concentrations were most reduced 
when lasIPa was induced. Intracellular SAM concentrations average 42.19 r 3.06 in the 
NCCs and are significantly reduced to 1.39 r 0.02 with IPTG induction of 
MG1655[pME-lasIPa] and to 23.40 r 0.30 with induction of MG1655[pME-rhlIPa]. 
Similarly, SAH levels decrease to 28% with lasI and 57% with rhlI induction. HCY and 
SRH concentrations for MG1655[pME-lasIPa] are approximately 4-fold and almost 10-
fold lower than the corresponding NCC averages. In MG1655[pME-rhlIPa] +IPTG HCY 
and SRH levels fall, but less drastically. Changes in intracellular concentrations of MET 
are also less pronounced, but nevertheless do fall; average metabolite quantities are 
127.39 r 4.53 and 146.28 r 4.00 for MG1655[pME-lasIPa] and MG1655[pME-rhlIPa] 
respectively compared to the equivalent mean of the NCC (184.20 r 3.43). 
3.7 Production of AI-2 is reduced in the MG1655-AHL 
synthase strains 
As the E. coli AMC includes an enzymatic reaction catalysed by LuxS, it was interesting to 
look at the effect of lasIPa and rhlIPa on the synthesis of AI-2. As exploited by many 
others, the detection of extracellular AI-2 was undertaken using the Vibrio harveyi 
biosensor. Late exponential phase culture supernatants of the MG1655-AHL synthase 
strains were analysed using this bioassay and bioluminescence measured every 30 mins in 
an automated luminometer-spectrometer (TECAN Infinite F200). The stimulation of 
light production in the V. harveyi reporter over the initial 12-hr period is shown in Figure 
3.7. 
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Figure 3.7: Reduced AI-2 production in induced MG1655[pME-lasIPa] and 
MG1655[pME-rhlIPa] cell free-extract. (A) Stimulation of light production in V. harveyi 
BB170 over the first 12 hrs of growth. (B)  Average induction of bioluminescence at 
three hours for three E. coli strains: MG1655[pME6032] (1, 2), MG1655[pME-lasIPa] (3, 
4) and MG1655[pME-rhlIPa] (5, 6) grown in LB with (2, 4, 6) and without (1, 3, 5) IPTG 
induction.  AI-2 activities for a single experiment are shown, although the experiment has 
been repeated three times with similar results. 
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Maximal light production occurred at three hours and demonstrated that introduction of 
the synthases caused a reduction in the levels of AI-2 detected (Figure 3.7). The 
uninduced MG1655[pME-lasIPa] strain illustrated significantly lower levels of extracellular 
AI-2 compared to the other NCCs. Despite this reduction in AI-2 which likely indicates 
weak constitutive expression of lasIPa in the pME6032 vector. IPTG induction was 
associated with further reduction in production of AI-2, giving a massive 20-fold 
reduction in bioluminescence levels compared to the uninduced strain. Furthermore, if 
compared to the NCCs (MG1655[pME6032]) this corresponds to an approximate 55-
fold decrease. For MG1655[pME-rhlIPa], the reduction in AI levels is comparatively less. 
However, it still corresponds to a 95.33% reduction when considered against conditions 
of no IPTG induction and a similar 98.17% decrease in comparison with the empty 
vector strains (Figure 3.7). 
3.8 MTA levels increase upon expression of the PA01 AHL 
synthases 
As introduction of LasI and RhlI into the foreign MG1655 system led to the associated 
production of AHLs which is not normally a characteristic of the E. coli system, it was 
interesting to determine the changes to intracellular levels of MTA since this is a by 
product of AHL synthesis. The presence of MTA was determined from cell extracts 
prepared from late exponential phase cultures of MG1655 with the empty vector or 
carrying a synthase gene. As with profiling of the AMC metabolites, the presence of an 
internal standard meant that different extracts could be compared. With independent 
experiments, the levels of intracellular MTA observed were variable and this seemed 
unusual given that only two compounds were being selected for in one LC-MS/MS 
method; Figure 3.7A shows only one example. However, in E. coli, the Pfs enzyme which 
catalyses the detoxification of SAH to SRH, also acts as an MTA nucleosidase; this 
means that any MTA present in the cell will be susceptible to the activity of this enzyme 
making it difficult to access any alterations to levels of this metabolite caused by 
introduction of either of the synthase genes. In order to correct for this, the empty vector 
- 74 - 
 
and those carrying the AHL synthase genes were transferred to a 'pfs strain and the 
quantification repeated in exactly the same way (Figure 3.8B). Quantifying intracellular 
MTA using this strain gave rise to the much tighter standard deviation values as would 
have been expected. In fact, levels of this metabolite were generally higher in all 
conditions compared to the numerical scale for the analysis performed in the WT (Figure 
3.8A). Nevertheless, MTA levels are significantly higher with introduction of the synthase 
genes, with recombinant lasIPa expression causing a 32-fold increase and that of rhlIPa 
causing a 13-fold increase. 
3.9 Production of LasI and RhlI affect the growth of 
MG1655 
The growth of the three strains was initially compared in rich media (Figure 3.9A). In 
these conditions, the AHL synthase strains, MG1655[pME-lasIPa] and MG1655[pME-
rhlIPa], growth curves differ from that of the WT with the empty vector, 
MG1655[pME6032]. The difference only affects the initial growth period; expression of 
lasIPa in MG1655 results in a slight extension to the length of the lag phase when 
compared to that of the WT. In contrast, this initial growth period is slightly reduced 
with introduction of the rhlIPa synthase gene. However, in both situations, the remaining 
growth curve mimics that of the WT.  
Since the AHL synthases use SAM as a substrate (Moré et al. 1996, Jiang et al. 1998), it 
was predicted that AHL synthesis would draw upon the AMC. To test the hypothesis 
that cell fitness will be compromised when nutrient availability is limited in the 
environment and metabolites of the AMC are diverted, the E. coli strains were grown in 
MOPS minimal media (Figure 3.9B). 
Again, the lag phase of the MG1655[pME-lasIPa] is significantly extended. Indeed, there 
appears to be no distinction between ending this initial period and exponential phase 
growth; the rate of growth over the entire period monitored is extremely slow. In these 
circumstances, MG1655[pME-lasIPa] is not able to achieve the population size (OD600) 
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that is attainable by MG1655[pME6032] by stationary phase over the period monitored 
(Figure 3.9B).  
Whilst MG1655[pME-rhlIPa] did not grow as well as MG1655[pME6032], it grew better 
than MG1655[pME-lasIPa]. The length of the rhlIPa VWUDLQ·V ODJSKDVHZDVKRXUVOonger 
than that of the WT and approximately 5 hours greater than that observed in LB 
medium. However, once exponential growth is initiated, the growth profile mimicked 
MG1655[pME6032] (Fig. 3.9B). 
3.10 Exogenous methionine addition improves the growth 
of MG1655[pME-lasIPa] in MOPS minimal media 
As LasI and RhlI production impedes the growth of E. coli and alters intracellular AMC 
metabolic pools, the ability of an exogenous compound that is able to feed into the AMC 
to restore growth was investigated. Methionine was added at various concentrations to 
125 ml MOPS minimal media batch cultures grown up in 500 ml-Erlenmeyer flasks at 
37qC shaking. MG1655[pME6032] and MG1655[pME-lasIPa] were additionally grown up 
without further methionine supplementation and respectively provided the appropriate 
positive and negative controls for the experiment. The cell density (OD600) was 
monitored regularly for an initial 10-hour period during which none of the methionine 
concentrations tested significantly improved growth of MG1655[pME-lasIPa]. However, 
the following day, those cultures supplemented with 250 PM and 500 PM methionine 
had an optical density comparable to the WT. To enable continuous monitoring of cell 
densities, growth was subsequently monitored in an automated spectrometer (TECAN 
Infinite F200). Use of the automated spectrometer also meant that a wider concentration 
range of methionine supplementation could be tested. Despite the approximate 14-hour 
lag phase, exogenous methionine addition did allow MG1655[pME-lasIPa] to grow. From 
Figure 3.10A, the higher the concentration of methionine supplementation, the greater 
the rate of exponential growth measurable over 24-hours. 
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Figure 3.8: LC-MS/MS analysis of late exponential phase cultures revealed MTA 
levels increase with expression of the AHL synthases, which is emphasised by 
removal of the Pfs enzyme which metabolises MTA in MG1655. (A) Intracellular 
accumulation of MTA as determined by LC-MS analysis in three E. coli strains 
MG1655[pME6032] (1, 2), MG1655[pME-lasIPa] (3, 4) and MG1655[pME-rhlIPa] (5, 6) 
grown in LB with (2, 4, 6) and without (1, 3, 5) IPTG induction. (B) Quantification of 
MTA levels in MG1655'pfs are indicated by asterisks alongside an identical numbering 
system.  Peak area corresponding to MTA was divided by the peak area of the 
appropriate internal standard for normalisation. 
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Figure 3.9: Introduction of the AHL synthase genes into MG1655 results in a 
growth defect that is more apparent in defined media. Three strains 
MG1655[pME6032], MG1655[pME-lasIPa], and MG1655[pME-rhlIPa] were inoculated 
into 125 ml LB (A) or MOPS minimal media (B), IPTG induced and grown shaking at 
37qC in 500 ml-Erlenmeyer flasks. 1 ml samples were taken at regular intervals and 
measured with a spectrophotometer. The cell density (OD600) is plotted against time. 
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Figure 3.10: Exogenous methionine addition improves growth of MG1655[pME-
lasIPa] and has no effect on MG1655[pME-rhlIPa] in MOPS minimal media. 
MG1655[pME6032], MG1655[pME-lasIPa] (A) and MG1655[pME-rhlIPa] (B) were 
inoculated into MOPS minimal media and methionine was added to those cultures 
indicated at the point of set up of the experiment.  Strains were grown in an automated 
spectrometer (TECAN Infinite F200) and changes in cell density (OD600) were monitored 
at 30qC every 30 min. For each single experiment, the strain was grown in triplicate and 
the average shown. 
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3.11 Discussion 
The AMC plays a fundamental role in all living organisms. It functions as an important 
SAH-degradation pathway that reduces feedback inhibition of important SAM-dependent 
methylation reactions. In other words, it ensures the constant availability of SAM, thus 
allowing the continuation of normal metabolic processes. Simultaneously, this reaction 
also relieves any inhibitory effects caused by the accumulation of MTA. In Pseudomonas, 
SAM has another role; it additionally functions as a substrate for polyamine spermidine 
synthesis, providing valuable carbon and nitrogen sources and potential protection of 
DNA from oxidative stress. Furthermore, SAM radical enzymes have been shown to be 
important in production of vitamins, metabolites and antibiotics and the effective 
07$6$+ QXFOHRVLGDVH HQVXUHV UHPRYDO RI LQKLELWRU\ SURGXFW ·-deoxyadenosine 
·G$'2$VZHOO DV6$0RWKHUFRPSRQHQWVRI WKH$0&KDYHDOWHUQDWLYHPHWDEROLc 
functions; in particular, methionine is an AA which is needed for protein synthesis. It is 
inevitable therefore that the repercussions of any AMC-associated alterations will 
somewhat stimulate compensatory pathways to counterbalance the perturbations. To 
investigate this, the implications of disrupting the AMC have been studied by assessing 
the independent effects of the AHL synthase genes upon this cycle in the context of an 
E. coli background. 
Introduction of the P. aeruginosa PA01 AHL synthase genes into E. coli MG1655 led to 
the intended expression of the proteins and production of the corresponding signal 
molecules. Actual abundant concentrations of OC12-HSL and C4-HSL were confirmed 
upon LC-MS/MS based AHL profiling of the lasIPa and rhlIPa expression systems in E. 
coli, respectively. Furthermore, the identification of OC10-HSL and OC14-HSL in 
association with lasIPa was no surprise, given that these are additionally characteristic of 
the P. aeruginosa system. The remaining AHLs were novel to the E. coli background 
(Gould et al., 2006). Gould et al. (2006) reported remarkable differences between AHL 
production profiles between lasIPa expression in P. aeruginosa and E. coli. However, the 
methods chosen for mass spectrometric analysis were focused on the AHL OC-series 
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and did not identify the fuller spectrum of AHL production included in the analysis 
described here, which revealed production of C12-HSL and C14-HSL.  The overall 
differences, however, can be attributed to the allowance of the LasI active site to 
accommodate a larger repertoire of acyl-ACPs substrates; crystallisation of this enzyme 
has demonstrated that the shape of the acyl chain binding site is tunnelled, placing no 
limitation on the length of the acyl chain exploitable for the synthetic reaction. Hence, a 
variation in the proportion of acyl-ACP substrates and/or the availability of alternatively 
sized acyl-ACPs pools in the heterologous host allows for recombinant LasI to be able to 
produce a different AHL distribution. Ultimately, under these environmental 
circumstances, AHLs from the preferential acyl-ACPs will be produced initially, as they 
offer the most kinetically efficient choice, then others at sufficiently high concentrations 
will be utilised, given their favourability to the Km values for the enzyme; this is evident 
by signal distribution being skewed by AHLs of the OC-series. Obviously, this will vary 
in any particular cell throughout the duration of the growth cycle and be heavily 
dependent on the temporal metabolic status. For example, the importance of FabG, 
which is central to the fatty acid biosynthesis pathway, in facilitating acyl-ACP elongation, 
allows for a much larger substrate repertoire (Hoang et al., 2002). In contrast, the 
observance of a smaller spectrum of AHLs with recombinantly expressed rhlIPa indicates 
the more restrictive nature of the acyl-ACP binding pocket, giving the enzyme a much 
higher intrinsic specificity. 
AHL production was accompanied by a growth defect for MG1655 harbouring the lasIPa 
gene in rich and defined media. In contrast, rhlIPa had a less detrimental effect on fitness 
causing only a slight extension to the length of the lag phase in MOPS minimal media. 
One possible explanation for the compromised cell fitness could be the production and 
accumulation of a foreign protein that may be partly aggregating or imposing a drain on 
transcriptional and/or translational machineries. Alternatively, the defective growth 
patterns could be the result of an adverse response to the unusual signalling molecule 
types synthesised by the expressed synthases. Moreover, and in relation to the latter, the 
altered growth could be accounted for by the disruption to metabolism, specifically 
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demonstrated here by the reduction in intracellular concentrations of the metabolites of 
the AMC. The available pool of SAM is redistributed upon introduction of the AHL 
synthase genes to accommodate production of AHLs; this equates to a reduced 
availability for the continuation of normal cellular processes and homeostatic functions 
such as methylation reactions. Methylation directed by methyltransferases represents a 
fundamental epigenetic inheritance mechanism that plays an important role in cell 
survival through the regulation of transcriptional gene expression and the prevention of 
death (Hartwell et al., 2004); this primarily occurs following DNA replication and could 
explain the inability to maintain comparative growth rates. Methylation additionally 
affects RNA and proteins and could therefore affect the availability of methionine for 
synthesis of proteins. This seems like a feasible explanation given that supplementation 
with exogenous methionine helps to restore growth although not completely back to the 
phenotype of that of the WT. Full complementation may only be achievable in 
circumstances where balanced substitutions are provided for both SAM and the 
corresponding fatty acyl chains, thus compensating for the substrates directed towards 
AHL production. 
AI bioassays with Vibrio harveyi illustrated reduced levels of AI-2 in stationary phase 
culture supernatants of MG1655[pME-lasIPa] and MG1655[pME-rhlIPa]. This may again 
relate to the reductions in intracellular concentrations of metabolites across the AMC 
profile; lower levels of SAM, and in turn SAH translate to a reduced availability of the 
LuxS substrate, SRH, needed to provide 4,5-dihydroxy 2,3-pentanedione (DPD), the 
precursor to AI-2. Decreased AI-2 concentrations could additionally be the result of 
ORZHUPHWDEROLWH OHYHOV DQG UHIOHFW WKHRUJDQLVP·VFRQWUROOHGXSWDNH LQ DVVRFLation with 
processing and/or degradation of this 5 carbon compound for catabolism (Winzer et al., 
2002). Consistent with early and mid-exponential growth, a prolonged period during 
which the requirement for SAM is elevated and flux through the activated methyl cycle is 
maximal, it is necessary to remove the increasing amounts of AI-2 into the extracellular 
environment (Winzer et al., 2002). This is thought to prevent the build up of the toxic 
SAH metabolite intracellularly. SAH is structurally and biochemically similar to the MHF 
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and DMHF compounds, both of which have DNA-damaging and potentially mutagenic 
properties (Winzer et al., 2002). The toxicity of SAH provides an alternative explanation 
to signal molecule accumulation beyond a threshold level consistent with a mechanism of 
monitoring population density (Winzer, Hardie, & Williams 2002). However, during late 
exponential phase, the transition to stationary phase and stationary phase itself, AI-2 
concentrations decrease, reflecting controlled uptake in association with catabolism. The 
build up of AI-2 activity in stationary phase culture supernatants has been described by 
the term GRAIL (Glucose Retention of AI-2 Levels) (Surette & Bassler 1998; Surette & 
Bassler 1999; Hardie et al., 2003). In E. coli and Salmonella typhimurium, reductions in AI-2 
activity appear to be associated with the absence of a preferential carbon source; this 
effect has primarily been observed with glucose, but is also consistent with other 
carbohydrate monomers such as glycerol, maltose and galactose, suggestive of a 
´FDWDEROLWHUHSUHVVLRQµ-like effect (Hardie et al., 2003). Therefore, in these circumstances, 
lower levels of AI-2 could correlate with its degradation to maintain normal cellular 
processes and homeostatic functions. From a metabolic perspective, this can also be 
YLHZHGDVDQDGYDQWDJHRXVPHFKDQLVPLQWKDWWKHORVVRIDVLQJOH¶ULERVHHTXLYDOHQW·SHU
methylation reaction is expensive, and so is minimised effectively via degradation at an 
DOWHUQDWLYH PHWDEROLFDOO\ ¶OHVV VWUHVVIXO· WLPH (Winzer et al., 2002). Under the 
circumstances of AHL synthase gene expression, energy demands may be prioritised for 
signal production and the energy requirement for AI-2 catabolism becomes of secondary 
importance. It might be interesting to investigate whether there is a difference in ATP 
utilisation/availability throughout the growth of the three strains. Alternatively, reduced 
AI-2 activity may be due to the unexpected transcriptional and/or translational effects of 
the synthase upon the LuxS enzyme in a way which means it functions less effectively. 
Feasible aspects of posttranscriptional regulation which could be affected include indirect 
global regulator, CRP and/or the CRP-activated small non-coding regulatory RNA, 
CyaR, the latter of which has been shown to directly negatively regulate the translation of 
luxS and decrease AI-2 production (Wang et al., 2005; De Lay & Gottesman 2009). In 
addition, in Edwardsiella tarda, disruption of luxS expression by antisense RNA 
interference (constitutitive transcription of luxS antisense RNA: corresponding to the 
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region between positions 149 and ²65 relative to the translational start) lowered the level 
of AI-2 activity; this target therefore offers an alternative explanation for the altered AI-2 
levels observed with recombinant AHL synthase expression (Zhang, Sun & Sun 2008). 
The expression of lasI and rhlI may adversely affect the import and processing of AI-2 by 
its ABC transporter designated the Lsr transporter, the operon of which contains seven 
genes, lsrACDBFGE, and is itself luxS regulated (Taga, Semmelhack & Bassler 2001). In 
association with this lsrK and glpD, encoding the AI-2 kinase and the glycerol-3-
phosphate dehydrogenase have been shown to regulate AI-2 internalization by affecting 
transcription of the lsr operon (Xavier & Bassler 2005). To discount some of these 
possibilities, future investigations might involve performing a comparative microarray 
analysis of MG1655 comprising the empty vector, those comprising the synthase gene 
constructs and possibly even the constructs transferred to a luxS mutant, though this 
might introduce other complications. 
AHL synthesis is accompanied by the production of MTA and levels were determined. 
Independent experiments to monitor MTA levels produced variable results, often 
different patterns in the levels observed between strains or larger error bars causing 
insignificant results. MTA levels were therefore confirmed in a 'pfs strain in which MTA 
could accumulate. This lead to higher overall levels of MTA and this can be accounted 
IRU E\ PHWDEROLWH SURGXFWLRQ DV D UHVXOW RI QRUPDO LQWUDFHOOXODU SURFHVVHV DQG LW·V
accumulation due to an inability to convert it MTR; nonetheless, this increase affects all 
the conditions being tested equally. MG1655 containing recombinant AHL synthases 
increased intracellular MTA levels, with lasIPa causing a significantly higher increase 
compared to rhlIPa. This may relate to the larger distribution of AHLs associated with 
lasIPa. 
Overall, it is apparent and interesting that LasI affected AMC profiles, MTA levels and 
AI-2 production more severely than RhlI. This may be due to the larger repertoire of 
AHLs made by LasI. 
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4.1 Introduction 
The results presented in the previous chapter demonstrate that the P. aeruginosa AHL 
synthases cause significant AMC-related metabolic disturbances and in-turn these cause 
other aspects of metabolism and fitness to be compromised. To determine the 
relationship between the extent of metabolic modulation and the specific activity of the 
AHL synthases, site-directed mutagenesis was performed using existing knowledge of 
crystal structures and the role of specific residues of these considerably homologous 
enzymes. By altering the specificity of the active site with the aim of modulating substrate 
binding and thus creating differing AHL profiles, the consequential metabolic 
repercussions could be assessed. 
4.2 Identification of important residues of LasI and RhlI 
LasI and RhlI belong to a larger superfamily of AHL synthase proteins which are 
homologues of LuxI. To date, more than 40 AHL synthases have now been 
characterised. These enzymes share four blocks of signature sequence with an average of 
37% identity and eight absolutely conserved residues associated with each block. (Fuqua, 
Winans & Greenberg 1994, Watson et al. 2002). Overall, LasI and RhlI demonstrate 30% 
identity and this has been illustrated using the characterised crystal structure of LasI 
which was published in 2004 by Gould, Schweizer & Churchill (Figure 4.1). A crystal 
structure for RhlI remains undetermined.  
From the crystal structure of EsaI, an AHL synthase of Pantoea stewartii, it was predicted 
that several essential conserved residues including Arg23, Phe27 and Trp33 were highly 
mobile and stabilized via a conformational change caused by substrate binding (Watson et 
al. 2002). Through determination of the LasI structure, it has been shown that Phe27 and 
Trp33 are important for the N-terminal SAM binding pocket (Gould, Schweizer & 
Churchill 2004). 
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Figure 4.1: P. aeruginosa RhlI AA homology with the crystal structure of LasI. The 
conserved AA residues shared between LasI and RhlI have been highlighted in yellow in 
the LasI ribbon model. 
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In addition, Trp33 contributes structurally to the acyl-chain tunnel and may assist in 
correctly orientating the acyl-chain for catalysis. Arg23, on the other hand, participates in 
an N-terminal core electrostatic cluster of residues and is thought to be fundamental to 
the synthetic reaction (Gould, Schweizer & Churchill 2004). Furthermore, using random 
and site-directed mutagenesis, Parsek, Schaefer, & Greenberg (1997) demonstrated the 
importance of several residues in Rhll including those mentioned above. The serine at 
position 103 represents another well conserved residue and may be critical for substrate 
binding and amide bond formation (Parsek, Schaefer, & Greenberg 1997). Due to the 
conservation of AA residues between LasI and Rhll, these were chosen for the following 
mutagenesis studies. In a first round of mutagenesis, those RhlI site-directed mutants 
(SDMs) of interest from the study by Parsek, Schaefer, & Greenberg (1997) were 
replicated and the equivalent SDMs constructed in LasI. A second round of mutagenesis 
was then undertaken based on the findings from the initial batch. Their locations 
amongst the protein sequences and the nucleotides substituted in the lasIPa and rhlIPa 
genes have been summarised in Table 4.1. 
4.3 Predicting a model for the structure of RhlI 
The predictive modelling has been performed by Abigail Emtage and was determined as 
follows. The primary sequence of the RhlI protein was retrieved from the NCBI protein 
sequence database (RHLI_PSEAE; http://www.ncbi.nlm.nih.gov/protein/12230962) in 
FASTA format. Modeller version 9v7 was then used according to standard protocols (Sali 
& Blundell 1993, Sanchez & Sali 2000, Eswar et al. 2007) to search the protein data bank 
for homologues with known atomistic 3D structures. The results were used to produce a 
list of the best potential templates for constructing the RhlI model. The protein data files 
were downloaded for the top matches from the protein data bank (PDB); these were the 
P. aeruginosa LasI synthase (PDB ID: 1RO5) and P. stewartii EsaI synthase (PDB ID: 
1KZF), which have 30% and 22% identity with the RhlI protein sequence respectively. 
The 1RO5 and 1KZF template structures were aligned and the template RhlI sequence 
was aligned with the templates to visualise the resulting output alignment.  
- 88 - 
 
 
 
 
AA 
Position 
AA 
Encoded 
WT DNA 
Seq 
Mutant AA Mutant 
DNA Seq 
A lasIPa 
23 R CGT Wb TGG 
27 F TTC La CTG 
  TTC Yb TAC 
33 W TGG Ga GGC 
103 S AGC Ab GCC 
  AGC Ea GAA 
  AGC Vb TGC 
B rhlIPa 
28 F TTC La CTG 
  TTC Yb TAC 
34 W TGG Ga GGC 
103 S TCG Ab GCC 
  TTC Ea GAG 
  TTC Vb GTG 
Table 4.1: Nucleotide substitutions for AA chosen for mutagenesis within the P. 
aeruginosa AHL synthase genes. Nucleotides substitutions leading to mutagenesis in 
lasIPa (A) and rhlIPa (B) have been highlighted in red. 
a Based on structural knowledge and previous studies. 
b Refined choices following findings from a.
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Figure 4.2: Predictive modelling of P. 
aeruginosa RhlI structure. RhlI model (B, 
purple) was predicted using the Pantoea stewartii 
EsaI (A, green) and P. aeruginosa LasI (C, 
yellow) crystallographic structures which 
demonstrated most sequence homology to the 
RhlI amino acid sequence. D illustrates an 
overlap of the RhlI protein model with the 
crystal structures used for its determination. 
 
- 90 - 
 
 
 
 
 
 
            
Figure 4.3: The proposed structure of RhlI gained from predictive modelling. Ribbon (A) and hydrophobicity (B) models of one of 5 of the predicted 
models for RhlI. The location of the conserved residues selected for mutagenesis are indicated in various colours and are as follows: R23: green, F28: orange, W34: 
magenta and S103: yellow. 
 
 
 A                     B       
         
 
 
 
 
 
 
 
 
 
- 91 - 
 
This was used to create five output models, the average of which has been shown in 
Figure 4.2 alongside the AHL synthase crystal structures upon which the model has been 
based. Chimera was used for visualisation of the models, looking particularly at the 
location of the residues chosen for mutation within the suspected substrate binding 
pocket (Figure 4.3). 
4.4 Generation of SDMs in LasI and RhlI 
Having chosen some important residues involved in the catalysis of AHL synthesis by 
LasI and RhlI, a variation of a commercially available method of site directed 
mutagenesis developed by Finnzyme (Finland) was exploited. 
4.4.1 Design of mutagenic primers 
Mutagenic primers were designed to replace specific residues with alternative ones. To 
incorporate the desired AA substitutions, single, double or triple base mutations were 
incorporated into the mutagenic primers, creating mismatches which would create the 
alternative residue following transcription and translation. This primer was designed to 
allow at least 10 bp flanking the mutagenic site for the PCR amplification. The strategy 
employed additionally required an alternate primer which was non-mutagenic for each 
site. The non-mutagenic primer was designed to flank the mutagenic one on the opposite 
strand resulting in the correct sequence for the remaining template to be amplified. For 
each single AA VXEVWLWXWLRQERWKVHWVRISULPHUVZHUHSKRVSKRU\ODWHGDWWKH·HQGVWR
eliminate the need for a separate phosphorylation step following PCR amplification prior 
to the ligation process. 
4.4.2 PCR amplification of LasI and RhlI with single codon 
substitutions 
The reverse PCR reactions for site directed mutagenesis exploited previously prepared 
cloned constructs of the lasI and rhlI genes in the pGEM-T Easy vector (pGEM-lasIPa and 
pGEM-rhlIPa) to provide the template. For each mutation, a PCR product was purified 
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corresponding to a linear fragment comprising the mutant AHL synthase gene and the 
pGEM-T Easy cloning vector. 
4.4.3 Selection and confirmation of site directed mutagenesis of 
LasI and RhlI 
The linear PCR fragments generated from the reverse PCR were ligated to form a 
circularised vector product and immediately transformed into the transient host strain E. 
coli DH5D. Screening was initially performed via PCR, and subsequently DNA 
sequencing to confirm the presence of the desired base substitutions for each of the 
mutant lasI (pGEM-lasIPa: R23W; pGEM-lasIPa: F27L; pGEM-lasIPa: F27Y; pGEM-lasIPa: 
W33G; pGEM-lasIPa: S103A; pGEM-lasIPa: S103E and pGEM-lasIPa: S103V) and rhlI 
(pGEM-rhlIPa: F28L; pGEM-rhlIPa: F28Y; pGEM-rhlIPa: W34G; pGEM-rhlIPa: S103A; 
pGEM-rhlIPa: S103E and pGEM-rhlIPa: S103V) genes in pGEM-T Easy. 
4.4.4 Subcloning of mutant AHL synthase genes for 
overexpression 
As previously with the cloning of lasIPa and rhlIPa, the inserts were released from their 
respective constructs in the pGEM-T Easy vector in a double digestion reaction with 
MfeI and StuI, as was the multiple cloning site of pME6032. Directed ligation of the two, 
produced the corresponding constructs in pME6032 comprising the lasI (pME-lasIPa: 
R23W; pME-lasIPa: F27L; pME-lasIPa: F27Y; pME-lasIPa: W33G; pME-lasIPa: S103A; 
pME-lasIPa: S103E and pME-lasIPa: S103V) and rhlI (pME-rhlIPa: F28L; pME-rhlIPa: F28Y; 
pME-rhlIPa: W34G; pME-rhlIPa: S103A; pME-rhlIPa: S103E and pME-rhlIPa: S103V) 
mutant genes. PCR of potential Tc resistant clones confirmed the presence of either of 
the gene sequences and hence successful constructs. Sequencing was repeated for final 
confirmation. The successful cloned were subsequently used for transformation into 
electrocompetent E. coli MG1655. 
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4.5 Analysis of the synthase activity of each SDMs in 
MG1655 
As with the WT AHL synthase genes, AHL production was tested in the first instance 
using strain overlay plates to identify whether any of the SDMs of lasIPa and rhlIPa gave 
rise to functional proteins with enzymatic activity (Figure 4.4). Using the corresponding 
synthetic AHL standard and WT AHL synthase constructs as positive controls and the 
empty vector construct as the appropriate negative control, it was possible to identify 
those SDM still capable of producing AHLs and those null of any identifiable synthase 
activity. For SDM of lasIPa, the bioassay demonstrated MG1655 harbouring constructs 
pME-lasIPa: F27L; F27Y and S103A to be positive for AHL production whilst those 
carrying pME-lasIPa: R23W; W33G; S103A and S103V were devoid of detectable AHL 
production. In contrast, two SDMs of rhlIPa, pME-rhlIPa: S103A and S103V screened 
positive for production of short-chained AHLs whilst the others did not (pME-rhlIPa: 
F28L; F28Y; W34G and S103E). 
4.6 LC-MS/MS profiling of AHLs produced by SDMs of 
lasIPa and rhlIPa in MG1655 
A full spectrum AHL profiling was performed to identify whether the AHL repertoire 
and absolute levels produced by the SDMs were similar to those demonstrated by 
expression of lasIPa and rhlIPa in MG1655. LC-MS/MS confirmed the lack of AHL 
production with MG1655 strains harbouring the SDM lasIPa constructs: pME-lasIPa: 
R23W; W33G; S103A; S103V (Figure 4.5B) and rhlIPa constructs: pME-rhlIPa: F28L; 
F28Y; W34G and S103E (Figure 4.5D). Interestingly, the remaining AHL producing 
SDMs of lasIPa each demonstrated differing QSSM profiles. The overall QSSM profile 
resulting from the lasIPa: F27L was severely reduced compared to lasIPa; there was a 
significant 93% decrease in the cumulative AHL concentration (Figure 4.5B) and 
amongst the six AHLs profiled, OC12-HSL and OC14-HSL were observed as the 
dominant signals, accounting for 62% and 29% respectively (Figure 4.5A), hence 
- 94 - 
 
changing the proportions of the AHLs observed compared to lasIPa. In contrast, the lasIPa: 
F27Y mutation did not have much effect on the resulting AHL profile; the overall QSSM 
concentration and individual AHL proportions were similar to those demonstrated by the 
unaffected lasIPa gene. The lasIPa S103A mutation additionally illustrated an AHL profile 
similar to lasIPa and the lasIPa F27Y mutation with one significant difference. Under these 
circumstances, C4-HSL is heavily produced and represents the second dominant signal in 
the entire profile after OC12-HSL, accounting for 20% of the total profile. With the 
QSSM producing SDM of rhlIPa (pME-rhlIPa: S103A and S103V), the overall AHL profile 
is similar to rhlIPa (Figure 4.5C), with the S103V mutation causing a reduction in AHL 
production by approximately 200 PM. 
4.7 Variable stability of synthase proteins from site-directed 
mutagenesis of lasIPa and rhlIPa 
The production of a stable synthase protein was imperative to its functional activity 
especially in the heterologous host and the subsequent metabolic repercussions as shown 
in the previous chapter. It was therefore an important step to determine whether the 
substituting residues chosen for mutagenesis gave rise to stable protein products. As 
previously, detection of lasIPa SDM was performed via SDS-PAGE and rhlIPa SDM via 
Western blotting. In most cases, the detection method confirmed production of a protein 
approximately corresponding to 26 kDa (Figure 4.6). These were present only in lanes 
correlating to IPTG induced cultures. In the majority of these instances, the abundant 
protein of interest was accompanied by a less abundant protein migrating slightly above. 
In order to clarify the secondary protein was unrelated to the synthase, MALDI 
fingerprint analysis was exploited for sequencing of the two closely migrating proteins in 
one randomly chosen mutant: MG1655[pME-lasIPa: F27L]. The slower migrating protein 
gave rise to some overall non-confident matches of hypothetical proteins, whilst the 
VOLJKWO\ IDVWHU ORZHU EDQG ZDV FRQILUPHG WR PDWFK WKH ´DXWRLQGXFHU V\QWKHVLV SURWHLQ
LasI (P. aeruginosa 3$µ 
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Figure 4.4: SDMs of lasIPa and rhlIPa produce differing levels of OC12-HSL and C4-
HSL. Strain overlay plates of MeOH extracts of MG1655[pME6032], WT and SDM 
AHL synthase genes grown with IPTG induction in LB to late exponential phase. A, B 
and C have been overlaid with JM109[pSB1142], responding to long-chain AHLs, whilst 
D and E with JM109[pSB536], which luminescence in response to short-chain AHLs. 
AHL production occurs with lasI (pME-lasIPa 27: F > L; 27: F > Y and 103: S > A) and 
rhlI (pME-rhlIPa 103: S > A and 103: S > V) mutants. 
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Figure 4.5: Relative molar proportions and cumulative profiling of AHLs produced by SDMs of lasIPa and rhlIPa in E. coli. Compounds were extracted 
from late exponential phase supernatants with acidified ethyl acetate and profiled by LC-MS/MS analysis. (A) and (C) The ratio between the different signalling 
molecules present in supernatants is represented by pie charts for lasIPa (A) and rhlIPa (C) SDM producing AHLs. (B) and (D) The actual concentration of AHLs 
for lasIPa (B) and rhlIPa (D) SDMs. 
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Figure 4.6: The majority SDMs of lasIPa and rhlIPa lead to the production of a 
stable protein in E. coli MG1655. E. coli MG1655 alone [pME6032] or containing 
pME-lasIPa (LasI), pME-rhlIPa (RhlI) or pME6032 harboring a SDMs of either gene were 
grown in LB to OD600=0.5 and induced with (+) IPTG or not (²). After approximately 1 
h, whole cell extracts were prepared and separated through 12% SDS-PAGE gels which 
were subjected to Coomassie staining (A) or Western blotted using DRhlI (B). SDS-
PAGE reveals the presence of the 26 kDa protein (*) in lysates of the IPTG induced 
lasIPa WT and SDMs except for the substitution of W33G. Similarly, IPTG induction of 
rhlIPa SDMs leads to the expression of stable synthase proteins (26 kDa) (*) except for the 
W34G mutation. M indicates the lane of the size marker. 
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There was however, one exception. With both lasIPa and rhlIPa, it was not possible to 
visualise a recombinant protein associated with the mutation at residue 33/34: W > G. 
4.8 AMC metabolite profiles of lasIPa and rhlIPa SDMs 
In section 3.6, we confirmed that the AHL synthases cause significant disturbances to the 
homeostatic maintenance of metabolites of the AMC. It was therefore interesting to 
determine whether the production of AHLs from the mutant versions of the AHL 
synthase genes had any different effects on the metabolites through the AMC. Figure 4.7 
shows the metabolic change expressed as a percentage for each mutant relative to the 
WT E. coli strain possessing the empty vector. Two mutants of each of the AHL 
synthases demonstrate similar metabolic derivations to the unmutated genes: lasIPa: F27Y, 
lasIPa: S103A, rhlIPa: S103A and rhlIPa: S103V (For numerical figures on AMC metabolite 
levels of recombinantly expressed lasIPa and rhlIPa see Section 3.6). For each AMC 
metabolite detected, there appears to be no difference between levels demonstrated by 
the specific SDMs and the corresponding unmutated AHL synthase gene. The lasIPa: 
F27L mutant also has intracellular AMC metabolite levels which differ from that of lasIPa 
expressed alone but the reductions are much less than any of the SDMs mentioned above 
(SAM -22.0%, SAH -25.0%, SRH -15.2%, HCY -14.7% and MET -7.3%). The remaining 
SDMs (lasIPa: R23W, lasIPa: W33G, lasIPa: S103E, lasIPa: S103V, rhlIPa: F28L, rhlIPa 28: F > 
Y, rhlIPa: W34G and rhlIPa: S103E) did not trigger any severe metabolic disruptions. For 
these mutants, the lack of a significant percentage change as shown in Figure 4.7 
indicates that the metabolic status of the cell in terms of the AMC is similar to the 
MG1655 control harbouring the pME6032 construct. 
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Figure 4.7: AMC metabolite profiles of lasIPa and rhlIPa SDMs in E. coli. Metabolite 
levels were determined in E. coli AHL synthase SDMs grown in LB with IPTG induction. 
Intracellular accumulation of SAM, SAH, SRH, HCY and MET were determined by LC-
MS analysis. Peak area corresponding to each compound was divided by the peak area of 
the appropriate internal standard for normalisation. 
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4.9 Recombinant expression of P. aeruginosa AHL synthase 
SDMs in E. coli leads to variation in extracellular AI-2 
levels. 
Since the SDMs generated a range of altered AMC metabolite profiles, the impact of 
these changes was assessed upon the levels of the byproduct of the AMC, AI-2.  
Supernatants collected from late exponential phase cultures of all the SDMs were applied 
to the V. harveyi biosensor assay and comparisons made at 3 h which corresponded to 
maximal light production in the positive control, as described previously. As can be seen 
in Figure 4.8, the SDMs with lower AMC metabolite levels also made less AI-2. 
4.10 Intracellular MTA levels of lasIPa and rhlIPa SDMs are 
lower when less AHLs are made 
In Section 3.8, heterologous expression of the AHL synthase genes in MG1655 was 
associated with large increases in concentrations of intracellular MTA which correlated 
with the AHL production in this host. This was confirmed within an MG1655'pfs strain 
in which the conversion of MTA to MTR is not feasible. In order to detect MTA without 
any interference, the constructs for all SDMs within pME6032 were therefore also 
transferred to this Pfs inactive strain, the quantification was performed as previously 
described and it can be clearly seen in Figure 4.9 that higher levels of MTA were detected 
with SDMs that produced higher levels of AHLs. 
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Figure 4.8: V. harveyi biosensor-based AI-2 detection for P. aeruginosa AHL 
synthase SDMs expressed in E. coli. Average induction of bioluminescence at three 
hours for MG1655 strains expressing AHL synthase SDMs of lasIPa (A) and rhlIPa (B) 
alongside empty vector control, MG1655[pME6032], and the corresponding non 
mutated gene, MG1655[pME-lasIPa] or MG1655[pME-rhlIPa], respectively. AI-2 activities 
for a single experiment are shown, although the experiment has been repeated three 
times with similar results. 
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Figure 4.9: LC-MS/MS analysis of late exponential phase cultures revealed 
variable MTA levels of lasIPa and rhlIPa SDMs in E. coli MG1655'pfs. Intracellular 
accumulation of MTA as determined by LC-MS analysis in several E. coli strains including 
13 lasIPa (A) and rhlIPa (B) SDMs grown in LB with IPTG induction. Peak area 
corresponding to MTA was divided by the peak area of the appropriate internal standard 
for normalisation. 
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4.11 Fitness profiles of P. aeruginosa AHL synthase SDMs in 
E. coli. 
To establish whether the mutagenesis of lasIPa and rhlIPa had any additional pleiotropic 
effects on the heterologous host, the growth rates and profiles of the SDMs and the WT 
AHL synthase genes were initially compared when grown in rich media (Figure 4.10A 
and C). The growth profiles of the rhlIPa SDMs were indistinguishable from rhlIPa and the 
empty vector control (Figure 4.10C). This was additionally true for the majority of the 
SDMs of lasIPa, which demonstrated no significant growth differences from 
MG1655[pME6032] strain (Figure 4.10A). As mentioned in Section 3.9, the expression of 
lasIPa in MG1655 has minor effects on the growth profile causing slight extensions to the 
length of the initial lag phase. As expected from the AHL and metabolite level analysis, 
the F27Y and S103A SDMs of lasIPa grew in a similar manner, displaying an overall 
slower exponential growth rate and a marginally reduced optical density at stationary 
phase. 
The growth of the strains in CDM was then compared (Figure 4.10B and D). Again, all 
SDMs of rhlIPa grew at a similar rate to the rhlIPa construct in MG1655 (Figure 4.10D). In 
contrast, growth in minimal media highlighted that some of the SDMs of lasIPa were 
suffering from poorer overall fitness levels (Figure 4.10B). This appeared to influence the 
growth of the F27Y and S103A SDMs of lasIPa which demonstrate identical growth 
curves to the unmutated lasIPa in E. coli, achieving a maximal OD600 at stationary phase of 
just above 0.500 following 24 hr. The remaining SDMs of lasIPa grow at a similar rate to 
MG1655[pME6032] in CDM, reaching a population size which is approximately half of 
that achievable under nutrient rich conditions. 
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Figure 4.10: Fitness profiles of P. aeruginosa AHL synthase SDM in E. coli. E. coli 
SDM strains were inoculated into 125 ml LB media (A, C) or MMM (B, D) and grown 
shaking at 37qC in 500 ml-Erlenmeyer flasks. Aliqots (1ml) were taken at regular intervals 
and the mean OD600nm values of triplicate culture samples are shown. Error bars indicate 
standard deviations from the means. Fitness is compromised for lasIPa F27Y and S103A 
strains in MMM. 
 
0.010 
0.100 
1.000 
10.000 
0 2 4 6 8 10 12 
lo
g
 1
0
 (
A
ve
ra
g
e
 O
D
6
0
0
);
 N
=
3
 
Time (h) 
MG/pME6032 MG/rhlI MG/rhlI-F28L 
MG/rhlI-F28Y MG/rhlI-W34G MG/rhlI-S103A 
MG/rhlI-S103E MG/rhlI-S103V 
0.010 
0.100 
1.000 
10.000 
0 4 8 12 16 20 24 
lo
g
1
0
(A
ve
ra
g
e
 O
D
6
0
0
);
 N
=
3
 
Time / Hours 
C 
 
 
 
 
 
 
 
 
 
 
D 
- 107 - 
 
4.12 Discussion 
Following on from the recombinant expression of lasIPa and rhlPa in E. coli, the next 
strategic step involved using site-directed mutagenesis to target specific synthase residues.  
Combined with metabolic profiling, this was an interesting approach to unravel the 
biosynthetic activities of LasI and RhlI. 
Given that our initial batch of SDMs was based on a similar analysis performed with RhlI 
by Parsek et al. (1997), it was interesting to compare the findings observed here with what 
had been previously reported. Between the two studies, the common rhlIPa SDMs were 
F28L, W34G and S103E. Here, no significant differences in the AHL profiles, AMC 
metabolite profiles, intracellular MTA levels and AI-2 production between the three 
SDMs were observed; all mimicked a WT profile, as if no synthase gene had been 
expressed. In contrast, Parsek et al. (1997) reported differences in the C4-HSL producing 
activity of the SDMs as compared to the protein expressed from the unmutated rhlIPa 
gene. In order of F28L, W34G and S103E, a 500-, 1000- and 18-fold decrease in activity 
was observed. Though these figures vary considerably, they all indicate highly significant 
reductions in activity compared to the fully functional version of RhlI, therefore creating 
virtually inactive proteins or enzymes with very low levels of activity. However, the 
methods exploited to characterise such activities involved several rigorous steps which 
may have contributed to discrepancies between the two investigations. Nevertheless, the 
first batch of mutants were drastic ones and led to the construction of a second batch 
constituting milder substitutions and the potential for more variable metabolic alterations. 
The findings from all of the SDMs are discussed below. 
Targeted site directed mutagenesis of identical residues in the P. aeruginosa AHL synthases 
has highlighted key functional differences in the catalytic roles played in each case. Whilst 
substitution of serine for valine at position 103 in rhlIPa allows for the synthesis of a fully 
functional enzyme still capable of producing AHLs associated with severe metabolic 
consequences, this is not true for an identical substitution amongst lasIPa. With the latter, 
the active site structure of the protein appears to be somewhat altered, changing the 
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activity of the synthase such that no detectable AHLs are produced. This is perhaps due 
to hindering substrate access and/or catalysis of the enzymatic reaction.  
Abolition of AHL synthesis also occurred when phenylalanine substitutions were 
performed at positions 27/28 (lasIPa/rhlIPa). Whilst exchange for slightly more 
hydrophillic tyrosine does not appear to affect the activity of LasI, it created a null 
mutation in the resulting RhlI protein, illustrated in the drastic outcome of a relatively 
subtle mutation of this particular residue in this protein. The substitution of 
phenylalanine (F) for leucine (L) at the same position exchanges one hydrophobic side 
chain for another, allowing for the production of stable proteins in both instances. Whilst 
the resultant synthase exhibited a significantly reduced activity, there remained a residual 
activity in LasI, whilst a similar substitution in RhlI was again unable to produce any 
detectable AHLs. In RhlI, the phenylalanine residue at position 28 resides close to a salt 
bridge structure but more importantly appears to be close to the edge of a pocket, 
possibly altering active site structure when mutated. Where other substitutions have been 
performed mutating identical residues in lasIPa and rhlIPa, there is a similar outcome. The 
substitution of tryptophan at position 34 for glycine gives rise to unstable proteins that 
are not detectable for either LasI or RhlI by SDS PAGE. The predictive modelling for 
RhlI indicates that this tryptophan residue lies in a completely different position in the 
same binding pocket mentioned previously and the substitution of tryptophan (W) for 
glycine (G) constitutes loss of indole aromatic compound which creates a very different 
environment within the binding pocket; an ineffective protein is therefore expected.  
The serine residue at position 103 chosen for mutagenesis appears to occupy a deeper 
position within the same pocket. Its exchange for glutamic acid (E) results in the gain of a 
negatively charged side chain which causes significant disruption to the structure and is 
sufficient to inactivate the protein in AHL production. On the other hand, the 
substitution this serine for alanine (A) constitutes only the loss of a hydroxyl group and 
does not appear to affect the activity of the resulting mutant LasI and RhlI proteins and 
their associated metabolic profiles. The remaining mutation has substituted the arginine 
(R) residue at position 23 of LasI. Arginine is normally localised to the outside of 
- 109 - 
 
proteins where it can interact with the polar environment; however, in this case it appears 
WR UHVLGH ZLWKLQ WKH V\QWKDVH·V VWUXFWXUH SDUWLFLSDWLQJ LQ WKH IRUPDWLRQ RI D VDOW EULGJH
which is essential for holding the structure together. As a result, the tryptophan 
substitution is drastic and does not give rise to a stable protein; the destruction of the salt 
bridge correlates with a non-feasible structure incapable of performing the catalytic 
reaction. 
All mutagenesis resulting in detectable AHL produced profiles of a similar constitution, 
and the AHLs expressed were present at similar concentrations to each other and the 
recombinantly expressed AHL synthase genes from P. aeruginosa. However, the 
substitution of serine for alanine at position 103 in lasIPa gives rise to an AHL profile 
additionally constituting significant concentrations of C4-HSL, which accounts for 20% 
of the overall spectrum. In Section 3.4, recombinant expression of lasIPa in E. coli leads to 
the identification of specific AHLs which are not observed in the P. aeruginosa 
background. 
Overall, it is clear that the strategy of site-directed mutagenesis combined with metabolic 
profiling can reveal a breadth of information about the importance of specific residues 
within a protein. Unquestionably, this approach could be exploited further, and all 
findings collated to enable the development of new therapeutic approaches based on the 
HQ]\PHV·XQLTXHspecificity. 
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Chapter 5 
Analysis of the metabolic 
implications of lasIPa and 
rhlIPa in E. coli 
MG1655'luxS, 'pfs and 
'sdiA mutants 
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5.1 Introduction 
From the findings in Chapter 3, it has been indicated that lasIPa and rhlIPa rely heavily on 
the AMC. In order to determine the extent of this relationship and identify novel players, 
the AHL synthase constructs were transferred into several MG1655 mutants (luxS, pfs 
and sdiA) and the associated consequences determined.  
Pfs and LuxS are integral components of methionine metabolism since they contribute to 
the AMC directly. Together they recycle SAH by converting it to homocysteine in one 
version of the two alternative AMCs.  Pfs first catalyses the bioconversion of substrate 
SAH into SRH and adenine (Miller & Duerre 1968; Della Ragione et al. 1985), then LuxS 
(S-ribosylhomocysteinase) catalyses the cleavage of the thioether bond in SRH to 
produce HCY and DPD. DPD is the precursor of AI-2 (Schauder et al. 2001). Pfs has a 
dual function in that it additionally converts MTA to MTR, which is a preliminary step in 
the methionine salvage pathway for regeneration of SAM in certain bacterial species 
(Della Ragione et al. 1985; Sekowska et al. 2004).  
The suppressor of cell division, SdiA, is a homologue of the QS regulator LuxR. Since 
AHL production by E. coli has not been detected and a LuxI homologue has not been 
found, it is proposed that SdiA enables detection of exogenous AHL molecules and it 
appears to exert transcriptional control over a number of genes (Kanamaru et al. 2000; 
Rudd 2000). There remains considerable uncertainty over the precise role of sdiA in 
E.coli. However, in Salmonella enterica serovar Typhimurium, SdiA has been shown to 
detect AHLs produced by other bacterial genera (Michael et al. 2001; Smith & Ahmer 
2003). 
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5.2 Elevated SAH and SRH levels, and reduced HCY levels 
and AHL profiles characterise the expression of lasIPa and 
rhlIPa in the luxS mutant 
The inactivation of luxS in MG1655 led to significant differences in the QSSM profiles 
detected with recombinant expression of the AHL synthase genes (Figure 5.1). In 
contrast to the levels of QS signals observed with the WT, expression of AHL synthase 
genes in the luxS mutant led to much lower levels of total AHL production. For lasIPa, the 
overall QSSM profile was lowered by 22.6% compared to MG1655[pME-lasIPa]. Each of 
the 13 AHLs in the profile was affected, with the largest reductions influencing C10-HSL 
(-25.1%), C12-HSL (-28.6%), OC12-HSL (-25.0%), HC10-HSL (-44.1%) and HC14-HSL (-
31.9%) production. In addition, Figure 5.1D illustrates how the cumulative AHL profile 
in the luxS mutant decreases by approximately 30.4% compared to the equivalent 
expression of [pME-rhlIPa] in the WT strain. Again, the associated relative molecular 
proportions remain reasonably similar. (Figure 5.1C) More specifically, the individual 
percentage reductions indicate the extent to which each AHL in the profile was affected; 
the figures are reported as follows: C4-HSL (28.5%), C6-HSL (39.6%), C8-HSL (38.4%) 
and HC4-HSL (54.6%).  
Having already determined that the AHL synthases considerably draw from the AMC for 
acquisition of one of their common substrates, SAM (Section 3.6), it was an interesting 
next step to establish the effect of AHL synthesis upon AMC metabolites in a mutant of 
the AMC, here one with an inactivation of the luxS gene. The vector control and 
constructs harbouring lasIPa and rhlIPa were transferred into MG1655'luxS, grown, and 
extraction, derivatisation, and LC-MS/MS conditions used as described previously. As 
expected, profiling of the luxS mutant harbouring the pME6032 vector revealed several 
key differences in AMC metabolites in comparison to the equivalent WT strain (Figure 
3.2). The inactivation of luxS in MG1655 led to significant differences in the QSSM 
profiles detected with recombinant expression of the AHL synthase genes.  
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Figure 5.1: Relative molar proportions and cumulative profiling of AHLs produced by lasIPa and rhlIPa in E. coli MG1655, MG1655'luxS, MG1655'pfs 
and MG1655'sdiA. Compounds were extracted from late exponential phase supernatants with acidified ethyl acetate and profiled by LC-MS/MS analysis. The 
ratio between the different signalling molecules present in supernatants is represented by pie charts for recombinant lasIPa (A) and rhlIPa (C) constructs in the 
various MG1655 strains. The actual concentration of AHLs for recombinant lasIPa (B) and rhlIPa (D) constructs in the various MG1655 strains.
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Figure 5.2: Recombinant expression of lasIPa and rhlIPa in the MG1655 luxS 
mutant leads to the build up of intracellular SRH and SAH and fall of HCY. 
Intracellular accumulation of SAM, SAH, SRH, HCY and MET were determined by LC-
MS analysis in six E. coli strains MG1655[pME6032] (1,), MG1655[pME-lasIPa] (2), 
MG1655[pME-rhlIPa] (3), MG1655'luxS[pME6032] (4), MG1655'luxS[pME-lasIPa] (5) 
and MG1655'luxS[pME-rhlIPa] (6) grown in LB with IPTG induction. Peak area 
corresponding to each compound was divided by the peak area of the appropriate 
internal standard for normalisation. 
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In contrast to the levels of QS signals observed with the WT, expression of AHL 
synthase genes in the luxS mutant led to much lower levels of total AHL production. The 
largest metabolic fluctuations affect intracellular SRH and HCY levels. As expected, the 
luxS mutation alone causes SRH levels (its substrate) to increase by 68.5% and HCY (its 
product) to decrease by 63.1%. However, on expression of lasIPa and rhlIPa, SRH is further 
elevated by 59.4% and 18.2%, respectively, and HCY reduced even more so, by 31.6% 
and 23.5%, respectively. This is in contrast to the effect of these genes in a WT 
background, where as previously seen in Chapter 3, SRH levels fell when the AHL 
synthases were present. Additional quantification of SAM and SAH levels has 
demonstrated that they also undergo significant changes in the 'luxS cell with levels 
shown to increase by 21.2% and 50.5%, respectively. The presence of the synthases 
causes the levels of the two metabolites to encounter opposing patterns of change. SAH 
further accumulates whilst intracellular SAM levels decrease, the latter of which is similar 
to what was observed in the WT background (Section 3.9); the corresponding changes 
for SAH and SAM are 63.3% and 37.9%, respectively for lasIPa and 24.4% and 23.0% for 
rhlIPa (SAH increase and SAM decrease cf. MG1655'luxS[pME6032].  In contrast, levels 
of intracellular MET experienced more subtle alterations; with reference to 
MG1655[pME6032], the luxS mutation causes levels to decrease by 24.8%. With lasIPa 
and rhlIPa, this is lowered by another 12.4% and 6.3%. 
Figure 5.3A shows the fitness profiles for MG1655 and the luxS mutant independently 
expressing [pME6032], [pME-lasIPa] and [pME-rhlIPa]. However, there does not appear to 
be any noticeable differences between the growth curves of the two strains expressing 
each construct. 
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Figure 5.3: Expression of the AHL synthase genes in MG1655'pfs creates a 
growth defect, while there are no significant differences between MG1655, 
MG1655'luxS and MG1655'sdiA. MG1655, MG1655'luxS, MG1655'pfs and 
MG1655'sdiA, each expressing pME6032, pME-lasIPa and [pME-rhlIPa were inoculated 
into 125 ml LB, IPTG induced and grown shaking at 37qC in 500 ml-Erlenmeyer flasks. 
1 ml samples were taken at regular intervals and measured with a spectrophotometer. The 
cell density (OD600) is plotted against time. 
0.010 
0.100 
1.000 
10.000 
0.0 5.0 10.0 15.0 
lo
g
1
0
(A
ve
ra
g
e
 O
D
6
0
0
);
 N
=
3
 
Time (h) 
MG/pME6032 MG/lasI MG/rhlI 
MGdluxS/pME6032 MGdluxS/lasI MGdluxS/rhlI 
0.010 
0.100 
1.000 
10.000 
0 2 4 6 8 10 12 14 
lo
g
1
0
(A
ve
ra
g
e
 O
D
6
0
0
; 
N
=
3
) 
Time (h) 
MG/pME6032 MG/lasI MG/rhlI 
MGdpfs/pME6032 MGdpfs/lasI MGdpfs/rhlI 
0.010 
0.100 
1.000 
10.000 
0.0 5.0 10.0 15.0 
lo
g
1
0
(A
ve
ra
g
e
 0
D
6
0
0
; 
N
=
3
) 
Time (h) 
MG/pME6032 MG/lasI MG/rhlI 
MGdsdiA/pME6032 MGdsdiA/lasI MGdsdiA/rhlI 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
C 
- 118 - 
 
5.3 Expression of lasIPa and rhlIPa in the pfs mutant leads to 
growth defects, reduced AHL profiles and altered AMC 
metabolite levels 
Expression of the AHL synthase genes in MG1655'pfs led to the most significant 
differences in QSSM profiling compared to the WT and other mutants used for 
comparative analysis in this chapter . Recombinant expression of both lasIPa and rhlIPa in 
this strain caused a considerable reduction in the levels of each AHL present in each 
individual profile and therefore the overall cumulative total compared to that of MG1655 
(Figure 5.1B and D). These were considerably more significant than the alterations 
observed in the luxS mutant described above. With lasIPa, the majority of AHLs present 
below 5 PM in MG1655 were absent in MG1655'pfs (C8-HSL, C10-HSL and OC4-HSL), 
whilst those which were present at reasonable concentrations were reduced by at least 
90% (C12-HSL, C14-HSL, OC6-HSL, OC8-HSL and HC12-HSL) (Figure 5.1B). Production 
of predominant AHLs OC12-HSL and OC10-HSL were additionally reduced by 87.0% and 
87.9%, respectively. Furthermore, with rhlIPa, detection of C4-HSL, C6-HSL, C8-HSL and 
HC4-HSL were reduced by 53.7%, 68.0%, 78.4% and 77.1%, respectively, compared to 
levels observed with MG1655, resulting in an extensive 55.4% decrease in the overall 
QSSM profile (Figure 5.1D). 
Constructs were transformed into MG1655'pfs and treated in exactly the same way as for 
the luxS mutant for determination of metabolites of the AMC (Figure 5.4). The major 
metabolic disturbances in this background affected SAH, which accumulates in the 
mutant, a massive increase in intracellular levels of approximately 157.7%, and builds up 
even further with expression of lasIPa and rhlIPa, by an additional 93.3% and 69.8%, 
respectively. Furthermore, levels of the AHL substrate SAM are enhanced upon 
introduction of the pfs mutation (16.0%), but as with the MG1655 strain and luxS mutant, 
intracellular concentrations subside when hosting lasIPa and rhlIPa, a decrease of 21.6% and 
11.7% when values are calculated against MG1655'pfs[pME6032].  
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Figure 5.4: Recombinant expression of the P. aeruginosa AHL synthase genes in 
the MG1655 pfs mutant causes SAH accumulation and SRH and HCY levels to 
subside. Intracellular accumulation of SAM, SAH, SRH, HCY and MET were 
determined by LC-MS analysis in six E. coli strains MG1655[pME6032] (1,), 
MG1655[pME-lasIPa] (2), MG1655[pME-rhlIPa] (3), MG1655'pfs[pME6032] (4), 
MG1655'pfs[pME-lasIPa] (5) and MG1655'pfs[pME-rhlIPa] (6) grown in LB with IPTG 
induction. Peak area corresponding to each compound was divided by the peak area of 
the appropriate internal standard for normalisation. 
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Another distinguishing feature of the metabolic profiling in the pfs mutant is the 
significant differences in intracellular SRH levels. The mutation itself results in a 
considerable drop in background levels compared to the WT, which equates to a decrease 
of roughly 48.6%. The disruption to levels of this metabolite are further impaired with 
lasIPa (26.3%) and rhlIPa (15.4%). HCY are substantially reduced (24.0%) in MG1655'pfs 
compared to the WT. As with SRH, the intracellular quantities of this metabolite subside 
further with the presence of each AHL synthase, and approximately correspond to 
another 21.6% with lasIPa and 9.8% with rhlIPa when compared to MG1655[pME6032]. 
Similar to what has been observed previously with mutation of luxS, MET levels do not 
experience the major alterations encountered by the other AMC metabolites in the AMC. 
There is a small (17.8%) background reduction in MET, caused by mutation of the pfs 
gene, which is lowered slightly more when lasIPa (14.9%) and rhlIPa (8.5%) are expressed. 
Fitness profiles of the MG1655'pfs strain expressing lasIPa and rhlIPa determined in 
nutrient rich media illustrated a growth defect compared to the equivalent MG1655 
strains (Figure 5.5B). The growth profiles of MG1655'pfs[pME6032] and 
MG1655'pfs[pME-rhlIPa] were similar to that of MG1655[pME-lasIPa] with a slightly 
slower rate of exponential phase growth and incapability of achieving the maximal 
stationary phase cell density as possible by the WT[empty vector] strain. In comparison, 
the fitness of MG1655'pfs[pME-lasIPa] in the same media type was further compromised, 
with a significant decrease in growth exhibited throughout the growth curve 
demonstrated over 12 h. 
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5.4 lasIPa and rhlIPa create different AMC metabolite and 
AHL profiles in the sdiA mutant 
Given the suspected regulatory links of the sdiA gene to QS, the profiles of AHLs and 
AMC metabolites were characterised in the sdiA mutant of MG1655. 
Interestingly, the QSSM profiles created by lasIPa and rhlIPa in the sdiA mutant were 
different (Figure 5.1). Whilst lasIPa led to a decrease in the overall AHL profile in 
comparison to what has been observed in the WT, rhlIPa demonstrated a comparative 
increase. For lasIPa, the majority of AHLs detected within the C- and HC-series series 
were reduced by at least 36.1%, whilst those of the OC-series were reduced to a lesser 
extent (OC4-HSL: -4.1%, OC6-HSL: -11.1%, OC8-HSL: -6.6%, C10-HSL: -8.2%, C12-HSL: 
-12.9% and C14-HSL: -7.6%) (Figure 5.1B). In contrast, the expression of rhlIPa in the 
MG1655'sdiA led to a substantial increase in the levels detected of all its associated 
AHLs. Absolute concentrations of C4-HSL, C6-HSL, C8-HSL and HC4-HSL rose by 
17.4%, 13.2%, 27.3% and 36.3, respectively when compared to profiles obtained from 
MG1655. Overall, this corresponds to an increase of approximately 18.6% (Figure 5.1D). 
The impact of the AHL synthase genes on AMC metabolite profiles in this strain was co-
ordinately affected (Figure 5.5). With both synthases, and all metabolites profiled, a 
definitive decrease was apparent. The drain of all five metabolites upon lasIPa expression 
was significantly less than that observed in the WT. The percentage decrease in the WT 
followed by that in the sdiA mutant as compared to the corresponding empty vector 
control are as follows: SAM (-96.8%, -32.7%), SAH (-68.9%, -43.6%), SRH (-90.1%, -
13.0%), HCY (-76.8%, -21.9%) and MET (-34.8%, -20.0%). In contrast, the equivalent 
values for rhlIPa are: SAM (-44.9%, -83.1%), SAH (-58.3%, -74.9%), SRH (-24.3%, -
84.4%), HCY (-26.5%, -63.7%) and MET (-23.2%, -40.3%). 
The fitness profiles demonstrated by recombinant expression of lasIPa and rhlIPa in the 
sdiA mutant were similar to those observed with the WT, as described in Section 3.9 
(Figure 5.3C). 
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Figure 5.5: The expression of rhlIPa and lasIPa in the MG1655 sdiA mutant causes 
significant drains AMC metabolites, but the effect of rhlIPa is to a greater extent. 
Intracellular accumulation of SAM, SAH, SRH, HCY and MET were determined by LC-
MS analysis in six E. coli strains MG1655[pME6032] (1,), MG1655[pME-lasIPa] (2), 
MG1655[pME-rhlIPa] (3), MG1655'sdiA[pME6032] (4), MG1655'sdiA[pME-lasIPa] (5) 
and MG1655'sdiA[pME-rhlIPa] (6) grown in LB with IPTG induction. Peak area 
corresponding to each compound was divided by the peak area of the appropriate 
internal standard for normalisation. 
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5.5 Discussion 
Metabolic profiling of the consequences of the heterologous expression of the P. 
aeruginosa AHL synthase genes in MG1655 luxS, pfs and sdiA mutants has provided 
further information as to the greater metabolic complications caused when other aspects 
of metabolism are compromised..  
Both LuxS and Pfs are important components of the AMC, the recycling pathway central 
to methionine metabolism. The absence of either constitutes significant metabolic 
disruptions, preventing the normal rate of channelling of metabolites through the cycle. 
This is clearly demonstrated here through direct comparisons of each mutant containing 
the empty plasmid vector to the corresponding WT. Introducing lasIPa and rhlIPa into 
these systems exacerbates the metabolic disruptions further and is illustrated by the 
substantial reductions in the cumulative AHL production profiles, which are significantly 
more drastic in the MG1655 pfs mutant than the luxS mutant. This may seem strange 
given that there is an increase in availability of SAM in both mutants. However, both also 
lead to elevated SAH concentrations, which are much higher upon removal of Pfs, its 
sole recycling route. In terms of other metabolites, there are similar trends for HCY and 
MET in both mutants. The absence of LuxS also leads to the build up of SRH; this 
makes sense as it can no longer be removed. The pfs mutant, on the other hand, is able to 
degrade SRH, so the trends observed are similar to the WT, although the basal level is 
lower to begin with so expression of the synthase genes leads to less dramatic changes. 
Removal of Pfs is associated with further complications; not only does it lead to 
accumulation of the toxic SAH by-product, but additionally MTA. As mentioned 
previously, the build up of the latter results from the recombinant production of AHLs 
and the inability to recycle the metabolite produced from WKHFHOO·VRWKHUSURFHVVHV%RWK
SAH and MTA are potent inhibitors of SAM-dependent reactions including 
methyltransferase and polyamine biosynthesis activities. Furthermore, both have been 
shown to directly inhibit the LuxI synthase family (Parsek et al. 1999). Moreover, given 
the toxicity of SAH and MTA, there may be further consequences; for example, there 
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may be transcriptional or post-translational effects on the cell response that could shut 
down another metabolic pathway, leading to reduced secondary substrates and therefore 
reduced provisions for AHL synthesis. A precedent for this would be the information 
given in the paragraph below. 
In Gram-positive bacterium, Listeria monocytogenes, extracellular accumulation of SRH has 
been shown to modulate biofilm formation, with both SAH and SRH found in culture 
supernatants via a mechanism which remains unknown (Challan Belval et al. 2006). It has 
been suggested that the export of these metabolites may provide an appropriate system to 
eliminate SAH when the detoxification pathway is overwhelmed or down regulated 
(Challan Belval et al. 2006). This might also provide a feasible explanation for the reduced 
AHLs detected with the associated mutants. As mentioned in Section 3.11, a similar 
removal mechanism has been suggested for SAH via increasing extracellular AI-2 
concentrations during exponential growth until stationary phase when AI-2 is brought 
back into the cell to overcome catabolite repression (Surette & Bassler 1998; Surette & 
Bassler 1999; Winzer et al., 2002; Hardie et al., 2003). A study investigating the effect of a 
luxS mutation on biofilm formation in another Gram-negative bacterium, Shewanella 
oneidensis, has demonstrated the upregulation of three metabolic enzymes, cysteine 
synthase, malate dehydrogenase and transketolase using a secretome analysis (Bodor et al. 
2011). The authors hypothesise that these changes are either due to the need to 
compensate for the lack of HCY or the channelling of the accumulating SRH into carbon 
metabolism. It might be interesting to investigate whether the equivalent or functionally 
related proteins are affected in the MG1655 luxS mutant used for this study and more 
importantly whether there are any further changes in response to the functioning of the 
lasIPa and rhlIPa genes via a similar secretome analysis or simpler SDS-PAGE or western 
blotting methods. 
To date, there have been several studies which have investigated the consequences of 
luxS and pfs mutations in other bacteria. In Neisseria meningitides, both mutants have been 
shown to suffer growth defects in a sulphur limited medium (a commercial Dulbecco 
modified Eagle medium: c-DMEM); the fitness of the pfs mutant in rich medium, like 
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here, was additionally compromised (Heurlier et al. 2009). In terms of AMC metabolite 
profiling, the pfs mutant experienced no significant differences with levels of SAM and 
MET, whilst SRH was absent, SAH increased and HCY was found to be reduced under 
some conditions (c-DMEM). The luxS mutant was associated with increased SRH and 
HCY levels (Heurlier et al. 2009). In contrast, HCY was significantly lower in an E. coli 
luxS mutant when compared to the equivalent WT. Similarly, however, the accumulation 
of SRH also characterized a metabolite analysis of Helicobacter pylori and E. coli luxS 
mutants (Doherty et al. 2010, Halliday et al. 2010). Overall, it appears that the findings 
reported in this study complement the major metabolic disturbances caused by the two 
AMC mutations in the profiled bacterial strains; there is even further opposition for the 
findings reported with regards to HCY in N. meningitides (Heurlier et al. 2009). 
Another important consideration relates to how the AHL profile connects to the 
metabolite levels observed. SAM is directly exploited for AHL biosynthesis (Moré et al. 
1996, Jiang et al. 1998). In the luxS and pfs mutants, there is an increase in intracellular 
SAM levels, whilst overall AHL production decreases when compared to the WT. In 
contrast, levels of SAM decrease and AHL production increases with the expression of 
rhlIPa in the sdiA mutant. In a general sense, a feasible explanation can be offered to both 
of the trends observed in the different mutants. In the former, the accumulation of toxic 
by-products that can directly inhibit the synthase enzymes leads to an exhaustive reaction; 
as a result, despite the increased availability of the substrate, the amount of enzyme 
capable of a performing a feasible reaction is limited and is therefore not able to produce 
as much product as is possible in the WT situation. In contrast, the expression of rhlIPa in 
the sdiA mutant; given the reaction, increased substrate availabily allows increased 
product formation, reducing substrate levels as a result. In terms of the specific 
alterations in AMC metabolites, Figure 5.6 illustrates a model for the expected trends in 
each of the AMC mutants. 
The difference in QSSM expression profiles causes by lasIPa and rhlIPa in the sdiA mutant 
are difficult to interpret given the lack of information concerning the role of this 
regulator in E. coli. The absence of the SdiA protein appears to remove regulatory links 
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on other aspects of the cells which somehow affect the lasIPa and rhlIPa gene, their 
proteins expressed and/or the resulting AHLs differently. 
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Figure 5.6: Schematic representation of the expected AMC metabolite profiles 
caused by lasIPa and rhlIPa expression in the MG1655 pfs and luxS mutants. In a pfs 
mutantWKHHQ]\PH·VVXEVWUDWH6$+DFFXPXODWHV, as does SAM, whilst levels of SAH and 
HCY decrease. The expression of the synthases in this mutant directly reduces levels of 
SAM, and consequently MET, HCY and SRH, whilst intracellular SAH builds up even 
further. In contrast, the luxS PXWDQW·V inability to recycle SRH means it accumulates, and 
so does the substrate of the upstream reaction, SAH. Simultaneously, intracellular HCY 
and MET levels decrease due to the continuation of downstream reactions. In these 
circumstances, recombinant AHL synthesis draws SAM from the AMC causing SAH and 
SRH to accumulate and HCY and MET to further decrease. 
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 Chapter 6  
Analysis of the metabolic 
implications of the AHL 
synthase genes in the native 
P. aeruginosa background 
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6.1 Introduction 
The metabolic costs of communication through signal production investigated in the 
context of E. coli have suggested that the AHL synthase genes constitute major substrate 
drainage systems in P. aeruginosa. The heterologous host was exploited to avoid 
complications imposed by various regulatory components and interlinks between the 
various systems that could cause difficulties with interpretation of the level of 
dependency on the associated metabolic systems. In order to provide a more complete 
overview, the metabolic profiling of the P. aeruginosa PA01 AHL synthase mutants was 
undertaken. 
6.2 Production of QSSMs is significantly reduced in the 
PA01'lasI, PA01'rhlI and PA01'lasI'rhlI mutants and can 
be restored upon complementation 
LasI expression in the context of E. coli revealed the production of an interesting array of 
AHLs; it was therefore of interest to determine how comparable this was to the native 
host. P. aeruginosa PA01 produces a variety of AHLs, the majority of which are synthsised 
at very low concentrations. The major AHLs of the profile are C4-HSL and OC12-HSL. 
The mutation of lasI alone does not prevent rhlI activity as the production of the majority 
of shorter chain AHLs was found to still occur under these circumstances and shown to 
be only slightly reduced compared to the WT. In contrast, the majority of longer chains 
AHLs are absent or concentrations are significantly reduced. In comparison with 
PA01[pME6032], PA01'rhlI[pME6032] was associated with a higher prevalence of 
longer chain AHLs. In contrast, the dual lasI/rhlI mutations abolished AHL production 
completely or to very low AHL concentrations. However, complementation of the single 
gene mutants is sufficient to re-establish AHL synthesis back to approximate WT 
concentrations with both of the synthase mutants. 
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Studying within the context of P. aeruginosa PHDQV LW·V SRVVLEOH WR GHWHUPLQH WKH
consequences of these AHL disturbances on AQ production since there are multiple 
regulatory links between the two types of QS systems. The inactivation of either of the 
lasI or rhlI genes and/or both together was sufficient to completely knock out production 
of the entire repertoire of AQ that are observed with PA01 and PA01[pME6032] (Figure 
6.1b). LC-MS/MS demonstrated the absence of the entire AQ series with the three 
mutants tested. These phenotypes were restored upon complementation of the single 
gene mutants with the corresponding pME-lasIPa and pME-rhlIPa constructs. 
6.3 AMC metabolites 
In Chapter 3, the P. aeruginosa AHL synthases were shown to drain levels of several 
intracellular metabolites including those of the AMC in E. coli. The subsequent and 
logical next step was therefore to determine the metabolic repercussions of removing the 
activity of these enzymes from P. aeruginosa. The AMC metabolite profiles (SAM, SAH, 
HYC and MET) were again determined from late exponential phase cultures (125 ml LB 
in 500 ml-Erlenmeyer flasks at 37qC) of the PA01 WT, mutant and complemented 
strains. Mutating the AHL synthase genes independently and/or together amplified the 
concentrations of each of the metabolites compared to the WT with empty vector with 
the exception of SAH (Figure 6.2). The most significant and maximal level of change 
coordinated with the dual lasI/rhlI mutant (SAM: +128.5%, SAH: ²29.1%, HCY: 109.6% 
and MET: 139.7%) with percentage reductions of each metabolite reported comparable 
to PA01[pME6032], but this was only marginally greater than the levels observed with 
the single gene mutants. Of the four metabolites constituting the P. aeruginosa AMC, MET 
increased the most.  
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Figure 6.1: P. aeruginosa AHL synthase mutants significantly disrupt AHL 
profiles and also disrupt levels of AQ and PQS, but to a lesser extent. Compounds 
were extracted from late exponential phase supernatants of six P. aeruginosa strains 
PA01[pME6032] (1), PA01'lasI[pME6032] (2), PA01'rhlI[pME6032] (3), 
PA01'lasI'rhlI[pME6032] (4), PA01'lasI[pME-lasIPa] (5) and PA01'rhlI[pME-rhlIPa] (6) 
grown in LB with IPTG induction. Supernatants were extracted with acidified ethyl 
acetate and profiled by LC-MS/MS analysis. The actual concentration of AHLs is shown.  
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Figure 6.2: Increased levels of AMC-linked metabolic profile of P. aeruginosa 
PA01-AHL synthase mutants. Intracellular accumulation of SAM, SAH, HCY and 
MET were determined by LC-MS analysis in six P. aeruginosa strains PA01[pME6032] (1), 
PA01'lasI[pME6032] (2), PA01'rhlI[pME6032] (3), PA01'lasI'rhlI[pME6032] (4), 
PA01'lasI[pME-lasIPa] (5) and PA01'rhlI[pME-rhlIPa] (6) grown in LB with IPTG 
induction. Peak area corresponding to each compound was divided by the peak area of 
the appropriate internal standard for normalisation. 
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On the other hand, compared to the other metabolites and the levels of the 
PA01[pME6032] strain, SAH demonstrated opposing levels of change. Similarly, 
however, the maximum percentage change, which in this case was the decrease of SAH 
(29.1%) was observed with PA01'lasI'rhlI[pME6032], followed closely by the lasI 
(20.5%) and rhlI (13.8%) mutants. Complementation of the single gene mutants with the 
corresponding vector construct brought metabolite levels approximately back to those 
measured in the WT/empty vector control. 
6.4 Intracellular MTA levels decrease with removal of the 
AHL synthase genes and increase back with 
complementation 
Since expression of lasI and rhlI increased intracellular MTA concentrations in E. coli 
(Chapter 3), it was of interest to determine the consequences of their mutation in P. 
aeruginosa. Unlike E. coli, the AMC of P. aeruginosa constitutes a single step SAH 
detoxification reaction to HCY carried out by the SAH hydrolase enzyme and lacks the 
alternative Pfs enzyme which also catalyses the conversion of MTA to MTR. The levels 
of MTA observed in P. aeruginosa are therefore not affected by the activity of this latter 
enzyme and any differences that may be observed will be due to the inactivation of the 
corresponding AHL synthases. For control purposes, the detection of comparable levels 
of MTA in PA01 and PA01[pME6032] confirmed that the presence of the chosen 
expression vector did not affect intracellular levels of this metabolite (Figure 6.3). 
Interrupting the expression of the las system by mutating lasI drastically reduces MTA 
levels in the cell (93.9%). The rhlI mutant similarly demonstrates lower levels, but the 
reduction (41.1%) is significantly less than that seen with PA01[pME-lasIPa]. In addition, 
levels of MTA detected with the double AHL synthase mutant, 
PA01'lasI'rhlI[pME6032] are significantly less than the WT carrying the empty vector 
(92.5%) and mimic the level observed with the lasI mutant alone.  
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Figure 6.3: LC-MS/MS analysis of late exponential phase cultures revealed MTA 
levels decrease upon removal of the AHL synthases from the native P. aeruginosa 
background. Intracellular accumulation of MTA as determined by LC-MS analysis in 
seven P. aeruginosa strains PA01 (1), PA01[pME6032] (2), PA01'lasI[pME6032] (3), 
PA01'rhlI[pME6032] (4), PA01'lasI'rhlI[pME6032] (5), PA01'lasI[pME-lasIPa] (6) and 
PA01'rhlI[pME-rhlIPa] (7) grown in LB with (2, 3, 4, 5, 6, 7) and without (1) IPTG 
induction. Peak area corresponding to MTA was divided by the peak area of the 
appropriate internal standard for normalisation. 
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Furthermore, complementation of the P. aeruginosa lasI and rhlI single gene mutants with 
the individual AHL synthase constructs pME-lasIPa and pME-rhlIPa (Chapter 3) causes 
intracellular MTA to be restored approximately back to WT levels. 
6.5 Growth defects of P. aeruginosa AHL synthase mutants 
Given the fitness implications of heterologous expression of lasI and rhlI mentioned in 
Chapter 3, it seemed appropriate to investigate whether the mutation of these genes in 
the native host would additionally impact upon the growth of the organism. The growth 
profiles were determined by growing the PA01 WT, mutant and complemented strains in 
nutrient rich LB media and measuring OD600 values every 2 h over 12 h. The 
PA01'rhlI[pME6032] grows similarly to PA01[pME6032] with an approximate 1 h delay 
in doubling time that is most apparent during the exponential phase of growth. In 
contrast, the growth profiles of the lasI and lasI/rhlI mutants illustrate most deviation 
from the WT/empty vector strain; both mutants take 6-7 h before exponential growth is 
initiated leading to a more detrimental 3 h lag in comparison to PA01[pME6032]. 
Complementation of the lasI mutant with pME-lasIPa almost completely restores the 
growth defect, whilst complementation of the rhlI mutant with pME-rhlIPa re-establishes 
the defective growth profile and improves fitness even better than the WT. 
Under more challenging conditions, when nutritional resources in the environment are 
limited, the compromised growth of the various mutants is highlighted further. In 
comparison to growth in LB media, it takes approximately 3 h longer for the WT control 
to attain stationary phase status, totalling 10 h from set up of the experiment. In contrast, 
the lasI and rhlI mutants appear to experience fitness difficulties; the length of the lag 
phase is prolonged to approximately 6 h for both, but the rhlI mutant demonstrates 
exponential growth at a higher OD600 YDOXHOHDGLQJWRDQKRXU·VGLIIHUHQFHEHWZHHQWKH
two strains. 
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Figure 6.4: Removal of the AHL synthase genes from P. aeruginosa PA01 results 
in a growth defect that is more apparent when lasI is taken out of the system. Six 
strains PA01[pME6032], PA01'lasI[pME6032], PA01'rhlI[pME6032], 
PA01'lasI'rhlI[pME6032], PA01'lasI[pME-lasIPa] and PA01'rhlI[pME-rhlIPa] were 
inoculated into 125 ml LB (A) or CDM (B), IPTG induced and grown shaking at 37qC in 
500 ml-Erlenmeyer flasks. 1 ml samples were taken at regular intervals and measured with 
a spectrophotometer. The cell density (OD600) is plotted against time. 
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In comparison to the other strains tested, PA01 possessing the dual lasI/rhlI mutations 
suffers the greatest fitness difficulties; the OD600 fluctuates below 0.050 for 10 h, taking 
approximately 12 h for exponential growth to be initiated. Furthermore, the rate of 
exponential growth is significantly slower, with OD600 values doubling every 2 h in 
comparison to 1 h with the WT and other mutants. 
6.6 Discussion 
The previous chapters have focused on the metabolic complications of the P. aeruginosa 
AHL synthase genes in the context of E. coli. A parallel investigation into the implications 
of removing these genes from the native host has revealed the reciprocal accumulation of 
specific intracellular metabolites. However, the reasons behind the compromised fitness 
of corresponding mutants remain unclear. The inactivation of the rhl system by mutating 
rhlI led to increased production of AHLs with longer acyl side chains and correlates with 
the heterologous production of AHLs mentioned in Chapter 3. In these environmental 
circumstances, the supply of metabolic substrates and energy resource is no longer shared 
between two AHL synthase enzymes; instead LasI has a plentiful supply of SAM and 
increases synthesis of its repertoire of products. This includes the generation of AHLs 
not normally observed under WT conditions because the absence of RhlI alters the 
availability of substrates for LasI. As mentioned previously, the active site of LasI is likely 
to be less obstructive than that of RhlI and can accommodate a wider range of acyl-ACPs 
(Gould et al. 2006). In contrast, the mutation of lasI is associated with considerably 
reduced RhlI activity; AHL production is limited to C4-HSL production and to 
significantly lower levels than in the WT. In these circumstances, the absence of the LasI 
means that OC12-HSL cannot be synthesised. As a result, the activated transcriptional 
regulator protein-AHL complex (LasR²OC12-HSL) is not formed leading to the absence 
of the positive regulation of the rhlR gene; in turn this reduces the amount of RhlI²C4-
HSL in the cell and overall this negatively impacts upon the positive regulatory feedback 
loop existing within the rhl system. Furthermore, the absence of both of the AHL 
synthase genes of P. aeruginosa not only completely abolishes production of AHLs, but 
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additionally the entire repertoire of AQs; the latter makes sense considering the loss of 
the upper hierarchy of the entire QS circuit. 
The quantification of relevant intracellular metabolites revealed increased levels in all 
cases and with all mutations of the P. aeruginosa AHL synthase genes. The exception was 
SAH, levels of which remained reasonably reduced amongst all the mutant strains tested. 
Since mutation of an AHL synthase disrupts the QS system reducing the production of 
AHLs there is an accumulation of the HSL substrate (SAM).  It is possible that this 
triggers an intracellular response leading to a reduction in the flux through the AMC and 
a channelling of metabolites through alternative pathways. Such a response may be 
mediated through changes in enzyme kinetics or expression of genes encoding the 
enzymes required for the pathway. The disruption to QS negatively impacts upon AHL 
production and leads to reduced synthesis of the associated MTA by-product. The lowest 
levels of MTA are observed with the lasI and lasI/rhlI mutants given that they cause 
production of their associated AHLs to be abolished to the greatest extent. 
The compromised fitness levels of the P. aeruginosa AHL synthase mutants illustrate the 
dependency and consequences of QS. Despite the increase in availability of intracellular 
metabolic resources and overall saving on the expense of not producing the associated 
signal molecules, the mutants all demonstrate independent growth defects that are most 
detrimental upon mutation of the lasI gene in the native host. In these circumstances, 
fitness determines growth ability by measuring the rate of multiplication. It therefore 
remains uncertain as to whether the growth defect stems directly or indirectly from the 
interruption to the QS hierarchical system. Reduced fitness could be a combinatorial and 
subsequent consequence of the varying effects on virulence factor production or 
attributed directly to the QS regulation of specific genes which are essential for growth. 
Overall the metabolic repercussions associated with the P. aeruginosa AHL synthase 
mutants support what has been observed with their heterologous expression in the E. coli 
background in the previous chapters. 
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Chapter 7 
General discussion 
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The principal objective of this study was to investigate the metabolic consequences of the 
P. aeruginosa AHL synthase genes. In order to fulfill their independent, yet integral 
biological roles amongst the complex, hierarchical QS cascade, they heavily depend on 
sourcing the appropriate substrates from the AMC and fatty acid biosynthesis pathway. 
However, the metabolic sources and specific substrates for QSSMs do not only serve the 
synthases making signaling molecules for cell-cell communication, but have numerous 
roles which are important to other processes necessary for the maintenance of cellular 
homeostasis*LYHQWKDW46LVIXQGDPHQWDOWRWKHRUJDQLVP·Vexpression of a multitude 
of virulence traits and ultimate pathogenicity, investigation into the preliminary 
biosynthetic mechanisms could offer more feasible routes in the development of novel 
WKHUDSHXWLFVWUDWHJLHVIRUFRPEDWLQJWKLVSHUVLVWHQW´VXSHUEXJµ 
Through expression of lasIPa and rhlIPa in the chosen heterologous host, a strain of E. coli 
(MG1655), it was possible to determine the metabolic impact caused by the biosynthetic 
activity of each gene. As hypothesised, within this background, both proteins led to 
significant reductions in the intracellular pool of metabolites of the AMC. Interestingly, 
lasIPa was associated with metabolite disturbances of a greater severity compared to rhlIPa; 
this was observed in conjunction with an unexpected phenotype for LasI, which 
generated a larger repertoire of AHLs than detected in the natural P. aeruginosa host. 
Although this had been reported previously, some of the AHLs observed here were 
novel to this study (C12-HSL and C14-HSL). As mentioned in section 3.11, this is likely to 
be due to the difference in availability of acyl-ACP precursors and the need to maintain 
the most kinetically favourable reaction mechanism. Future work in this area could 
investigate the pool of fatty acid precursors posing as feasible substrates for the synthases 
in E. coli alongside their relative abundance in this host. Further manipulation of the 
substrate pool to investigate whether the resulting AHL repertoire is altered could also 
reveal new information on the range of potential substrates, which has the possibility to 
assist improved design of inhibitory compounds. 
Both synthases drew significantly from the metabolic pathway investigated as levels of all 
metabolites of the AMC were found to be significantly reduced when the synthases were 
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active. Intracellular SAM levels experienced the most drastic alterations. As emphasised 
throughout, SAM is fundamentally important to the cell, with diverse biological roles in 
polyamine biosynthesis, bacterial chemotaxis and methylation. In addition, more recently, 
the significance of SAM to QS has been illustrated through its contribution to the 
synthesis of a relatively newly discovered class of signals in Vibrio cholera, referred to as 
cholerae autoinducer-1 (CAI-1) (Miller et al. 2002; Higgins et al. 2007; Winans 2011). SAM 
is the source of an amine group to the synthase of CAI-1 (CqsA, cholerae quorum-sensing 
autoinducer), reacting with decanoyl-CoA to yield a variation of CAI-1 referred to as 3-
aminotridec-2-en-4-one or Ea-CAI-1 (Wei et al. 2011; Winans 2011). This is intriguing 
given that SAM provides the HSL moiety for synthesis of AHLs and the related AMC 
metabolite SRH, the substrate for AI-2 (Moré et al. 1996, Jiang et al. 1998, Schauder et al. 
2001). 
The metabolic profiling performed here in the E. coli background has enabled the 
metabolic consequences of AHL synthesis to be determined in a system lacking 
complications due to hierarchical QS control. However, one of the uncertainties with the 
chosen strategy concerns the unknown mechaniVP IRU H[SRUW RI WKH ´IRUHLJQµ VLJQDOV
since there is no known equivalent to the P. aeruginosa MexGHI system in E. coli. Under 
these circumstances, the observance of AHLs in culture supernatants could be due to 
their potentially toxic nature leading to cell death, lysis, and the release of intracellular 
contents into the surrounding environment. This could be clarified by performing 
viability assays such as live/dead staining and/or a colony forming units (CFU) count, 
both of which should be compared to the WT strain. 
More specifically, the chosen expression system could potentially be criticised for 
variability, given the difference in synthase production as determined by protein levels 
assessed via different methods (SDS-PAGE and Western blotting). However, both were 
expressed from constructs created using the same strategy and with the same expression 
conditions. Nevertheless, one alternative approach would involve integrating the genes of 
interest into a non-HVVHQWLDO UHJLRQ RI WKH KRVW·V JHQRPH WKHUHE\ Hnsuring comparable 
expression levels and subsequent conclusions. 
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Another important consideration is the difference between the steps required to detoxify 
SAH that exist in the AMC of E. coli and P. aeruginosa. The conversion of SAH to HCY in 
E. coli requires two enzymatic steps which are replaced by a single one in P. aeruginosa. 
Therefore, the production and profiling of the additional AMC metabolite (SRH) and 
reaction by-products (AI-2) has been monitored. Changes in these molecules may have 
had effects on bacterial physiology which would have been restricted to the experiments 
performed in E. coli. Despite these differences, the data presented here clearly shows that 
the overarching influence that AHL synthesis has on the AMC is mirrored in the two 
bacterial species. 
It is interesting to speculate why there is an absence of LuxS from P. aeruginosa with SAH 
hydrolase performing an analogous role. With the exception of %LÀGREDFWHULXPORQJXP and 
Escherichia blattae, which posses both variants of the AMC, organisms possess either LuxS 
or SAH hydrolase. As mentioned previously, the exchange of enzymes cannot simply be 
explained by the need to have LuxS to generate AI-2 to act solely as a QSSM because 
many organisms including Campylobacter jejuni, Helicobacter pylori and Neisseria meningitidis, 
primarily rely on the metabolic function of LuxS (Holmes et al. 2009; Doherty et al. 2010; 
Heurlier et al. 2009). Indeed, the absence of AI-2 from some bacteria casts doubt on its 
use as a universal language for interspecies communication. If AI-2 is the universal 
QSSM, why do some bacteria produce the signal and others not? The success of a 
bacterial population is governed by its ability to progress in an infection and as with all 
environments, populations are constantly trying to outcompete each other; it makes no 
sense to communicate in an identical manner between all of them! 
Further evidence for the metabolic costs of QSSM production in the associated host has 
come from the use of MG1655 mutants, in which genes have been removed that encode 
enzymes of the AMC or sdiA, another gene thought to be involved in QS (Chapter 5). 
Those mutants (pfs and luxS) harboring disruptions of the AMC limited the cumulative 
AHL concentrations observed compared to those reported in the WT strain. As, 
expected, this was due to the inability to complete the recycling process and the 
consequential impact on the levels of linked metabolites. An equivalent study within P. 
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aeruginosa would involve using mutants where the SAH hydrolyse enzyme has been 
inactivated. Preliminary findings indicate that an ahcY mutation has little impact on the 
resulting QSSM profile (Heurlier et al. unpublished). However, the associated growth 
defect has led to difficulties with characterizing aspects of virulence factor production 
and further investigations are necessary for a definitive conclusion (Heurlier et al. 
unpublished). On the other hand, the expression of lasIPa and rhlIPa had opposing effects 
in the sdiA mutant. Currently, not enough is known about the role of sdiA in E. coli to 
provide a feasible explanation for the observations described here. Light could be shed 
on the underlying molecular mechanisms by performing global metabolite profiling 
(including flux analysis), transcriptomic and post-translational proteomics. Such 
investigations would identify changes occurring within the cells in the different 
conditions, thereby highlighting likely players in the modulations. 
By constructing single synthase gene complementations, it was possible to gain the first 
unequivocal evidence for an impact on metabolism in the native P. aeruginosa background. 
Further insight might be possible by creating a double lasIPa/rhlIPa expression vector that 
would enable future metabolic studies and complementation of those findings reported in 
Chapter 3. In addition, a double lasIPa/rhlIPa expression vector could be used to restore 
the P. aeruginosa dual mutant strain used in Chapter 6, which would again have provided 
further supporting evidence for the metabolic complications caused by both AHL based 
systems together. 
Studies incorporating a metabolomic approach often integrated with proteomic and 
transcriptomic analyses have become popular over the past few years due to the move 
towards an integrated, systems approach to understand biological phenomena. What 
these have lacked is focus on quantifying the metabolome which is often directly or 
indirectly affected by many of the processes under investigation. This study has heavily 
exploited LC-MS/MS based separation/detection methods for profiling metabolites 
specific to the AMC alongside the AHL biosynthesis by-product, MTA. A parallel study 
for characterizing the consequences of PQS biosynthesis offers an interesting area with 
potential for future research. As it would be hypothesized that this QS system would also 
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cause a drain on the metabolic pool and would generate new hypotheses concerning the 
integration of the parallel PQS and AHL QS circuits within P. aeruginosa. Such studies 
would allow reflection on the metabolic influence of AHL production upon PQS 
biosynthesis and therefore enable complete profiling of a wider repertoire of compounds 
affected by the synthesis of all the QSSMs observed in P. aeruginosa. Interestingly, recent 
investigation into this area has revealed a growth phase-differential regulation of 
anthranilate metabolism; this involves an antagonistic interplay of LasR, RhlR, and QscR 
that is mediated by two intermediate regulators, AntR, involved in anthranilate 
degradation, and PqsR, and their cofactors, anthranilate and PQS (Choi et al. 2011). 
Further insight might come from the development of a novel LC-MS/MS analytical 
method for simultaneous detection of several associated compounds involved in this 
synthetic pathway, including catechol, kynurenine and tryptophan; this was in fact 
initiated during the early phases of this study. The preliminary phases of method 
development were successful in being able to simultaneously detect most of the 
compounds. Further work is required to overcome some of the challenges encountered 
and progress it into a fully functional detection method. This primarily involves testing 
various extraction methods to determine which is most suitable for the array of 
compounds under selection to optimize their detection in biological samples.  
As with all biomedical research, final thoughts lead to potential therapeutic applications. 
The ultimate question is whether there are any targets for novel anti-pseudomonas 
agents? To date, anti-QS strategies have been clustered into three main categories 
according to their mode of attack: blockage of QSSM biosynthesis, inactivation of 
QSSMs and interference with the signal receptor (Rasmussen & Givskov 2006). 
However, there are multiple enzymes contributing to the various aspects of metabolism 
which offer alternative targets for bacterial anti-infective drug design via interference with 
the associated AHL-based QS system. Table 8.1 lists a selection of targets coupled with 
feasible inhibitors which have been developed to date. Although, not all can be applied to 
P. aeruginosa, they highlight the plethora of examples relevant to the metabolic systems 
mentioned within this study. Many approaches use transition state analogue inhibitors 
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WKDW PLPLF WKH HQ]\PH·V KLJK-affinity for the intermediate, which is stronger than the 
equivalent substrate or product analogues, and lacks the accompanying chemical reaction. 
Several are interesting in that they elicit target inhibition without a direct bactericidal 
effect. This means that as well as EORFNLQJWKHWDUJHWHQ]\PH·VDFWLYHVLWHWKHLQKLELWRUV
lead to the accumulation of specific metabolites which affect other aspects of the cell. 
For example, ·-methylthioadenosine/S-adenosylhomocysteine nucleosidases (MTANs) 
have a multitude of functions, and as well as those mentioned previously, they are 
LQYROYHGLQSURFHVVLQJ·GHR[\DGHQRVLQH·-dADO) produced by SAM radical enzymes. 
In these circumstances, inactivation of MTANs prevents degUDGDWLRQ RI ·-dADO 
leading to alterations in vitamin synthesis with knock-on effects on central carbon 
metabolism. The similarity in enzyme transition states between the bacterial nucleoside 
and mammalian phosphorylase is worth mentioning. However, there are distinct 
VWUXFWXUDO GLIIHUHQFHV UHODWLQJ WR WKH VL]H RI WKH ·-alkylthio binding pocket and the 
distribution of electrostatic regions, which enable specificity for targeted drug design (Lee 
et al. 2004). 
The site-directed mutagenesis strategy adopted in this study offers vast potential for 
future investigation and therapeutics. It is hypothesised that the targeted approach to 
mutagenesis will enable an in depth understanding of the specificity of AHL synthases 
and the underlying catalytic mechanism for AHL synthesis. Despite indications of the 
importance of particular synthase residues, it was impossible to anticipate the outcome of 
these investigations. An interesting finding came from the substitution of a phenylalanine 
residue from LasI (F27L) with the initial round of mutagenesis, creating a functional 
protein with partial activity, which led to the construction of further mutants. Overall, 
this has direct implication on the possibilities for future work; the residues chosen here 
could be mutated differently or alternative critical residues subjected to mutagenesis to 
allow a greater interrogation of substrate binding and prediction of interactions with 
current drugs. Ultimately, this could lead to the improved design of inhibitors undergoing 
current development and the design of new inhibitors which directly affect LasI and RhlI 
signal producing ability. 
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Throughout the course of this study, little has been published on the interrelationship 
between QS and metabolism. Our understanding of regulatory aspects within the QS 
hierarchical cascade, however, has been extended. In terms of the additional P. aeruginosa 
LuxR homologues mentioned in Table 1.3, a crystal structure for the QscR signal 
receptor has been determined and as anticipated, it is consistent with an allosteric 
mechanism of signal transmission in the regulation of DNA binding and thus virulence 
gene expression (Lintz et al. 2011). In addition, Croda-García et al. (2011) have shown 
that the virulence factor regulator, Vfr (Table 1.3), directly regulates the transcription of 
rhlR by binding to several Vfr-binding sites present in the rhlR promoter region. On 
another note, given the history of research into QS, it is astonishing that until recently, 
the mechanism for determining the signal threshold has remained unknown. 
Interestingly, however, Seet and Zhanga (2011) have identified and characterised a novel 
anti-activator, QslA, which influences the threshold concentration of QS signal needed 
for QS activation and has been shown to directly regulate LasR. 
The metabolic approach to studying P. aeruginosa QS offers an alternative strategy to the 
exhaustive characterisation of the organisP·VYLUXOHQFHIDFWRUSURGXFWLRQ. As a 
comparison, it can give a multitude of information, often simultaneously that is similar to 
other modern day techniques such as microarray analysis. Integrated together, however, 
this can offer more promising routes to the development of novel therapeutics to 
combating P. aeruginosa in the current climate where its infection rates are increasing 
exponentially.
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Enzyme Target 
 
Function Inhibitory Mode of Action References 
·-methylthioadenosine/ 
S-adenosylhomocysteine 
nucleosidase (MTAN) 
Dual function; catalyses the bioconversion of 
substrate SAH into SRH and adenine. Also 
the conversion of MTA to MTR. 
Immucillin-based transition state analogue 
inhibitors of E. coli and V. cholera MTAN; 
slow-onset and tight-binding properties 
allowing persistence over several generations. 
Disrupt AI-2 production and biofilm 
formation, rather than antimicrobial activity 
Schramm et al. (2008); 
Gutierrez et al. (2009) 
·-methylthioadenosine/ 
S-adenosylhomocysteine 
nucleosidase (MTAN) 
Dual function; catalyses the bioconversion of 
substrate SAH into SRH and adenine. Also 
the conversion of MTA to MTR. 
High potency purine and deaza purine-based 
inhibitors. 
High potency indazole-based inhibitors. 
Antimicrobial activities reported for Neisseria 
meningitides, Streptococcus pneumonia and 
Streptococcus pyogenes in both studies. 
Tedder et al. (2004) 
 
Li et al. (2003) 
·-methylthioinosine 
phosphorylase (MTIP) 
Processes MTI as part of MTA catabolism; 
MTA is hypothesised to be converted to 
MTI via a MTA deaminase, and MTI is then 
FRQYHUWHGWR·-methylthioribose D-D-1-
phosphate (MTR-1-P) and hypoxanthine. 
Transition state analogue inhibitors based on 
immucillins (developed for N-ribosyl 
transferases) which block MTIP activity; 
induce slow-onset inhibition and do not 
LQWHUIHUHZLWKKXPDQ·-methylthioadenosine 
phosphorylase (MTAP). 
Guan et al. (2011) 
S-adenosylhomocysteine 
(SAH) hydrolase 
Reversibly hydrolyses SAH to HCY and 
adenosine as part of the AMC. 
Structural analogues based on ilimaquinone, 
which functions as a nucleoside analogue, 
hybridised to adenosine. 
Byung Gyu et al. (2009) 
S-adenosylhomocysteine 
(SAH) hydrolase  
Reversibly hydrolyses SAH to HCY and 
adenosine as part of the AMC. 
Metal coordination compounds: cis and trans 
isomers of platinum diammine dichloride 
(DDP); tested with Acinetobacter calcoaceticus 
Impagnateiello et al. (1996) 
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enzyme 
S-adenosylmethionine 
(SAM) synthetase 
Involved in the only known biosynthetic to 
SAM from L-methionine and ATP substrates 
Most potent known inhibitor is 
diimidotriphosphate (O3PNH-PO2-NH-PO3; 
PNPNP), which Is a non-hydrolyzable slow, 
tight binding intermediate analogue 
Markham &  Reczkowski 
(2003); Reczkowski & 
Markham (1999) 
Table 8.1: Metabolic enzyme targets for inhibition of QS. Targets indicated in bold have applications in P. aeruginosa.
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Appendix 
 
MOPS minimal media (MMM) 
Chemical Stock Concentration Volume added / ml 
MOPS mixture 10x 100 
K2HPO4 0.132 M 10 
Glucose* 0.1% 10 
dH20  880 
TOTAL 1000 
1. Mix ingredients above and adjust the pH to 7.2 with approximately 300 Pl  
10 M NaOH. 
2. Autoclave or filter sterilise. Can be stored at 4 qC for up to 1 month. 
3. Add carbon source before use*. 
10x MOPS mixture 
1. In a 1 L beaker with a stir bar, add the following to ~300 ml dH2O: 
Chemical Weight / g 
MOPS 83.72 
Tricine 7.17 
2.  Add 10 M KOH to a final pH of 7.4 (10 to 20 ml). 
3. Bring total volume to approximately 440 ml. 
4. Add 10ml 0.01 M FeSO4.7H2O to the MOPS/Tricine mixture. 
5. Add the following solutions to the MOPS/tricine/FeSO4 mixture in the order 
shown: 
Chemical Stock Concentration / M Volume added / ml 
NH4Cl 1.9 50 
K2SO4 0.276 10 
CaCl2.2H2O 0.02 0.25 
MgCl2 2.5 2.1 
NaCl 5 100 
Micronutrient stock - 0.2 
dH20  387 
TOTAL 1000 
6. Filter sterilise. Can be aliquoted and stored at -20 qC. 
Micronutrient stock 
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Chemical Formula Weight / g 
Ammonium molybdate  (NH4)6Mo7O24.4H2O 0.009 
Boric acid  H3BO3 0.062 
Cobalt chloride  CoCl2 0.018 
Cupric sulphate CuSO4 0.006 
Manganese chloride  MnCl2 0.040 
Zinc sulphate ZnSO4 0.007 
Mix everything together in 50 ml dH20. Store at RT. 
Table 9.1: Preparation of MOPS minimal media (MMM).  
1x Sample loading buffer  
Tris-HCl pH 6.8 50mM 
DTT 100 mM 
SDS 2% (w/v) 
Bromophenol blue 0.1% (w/v) 
Glycerol 10% (v/v) 
Destaining solution  
Isopropanol 10% (v/v) 
Electrophoresis running buffer pH 
8.8 
 
Tris-HCl 25 mM 
Glycine 190 mM 
SDS 0.1% (w/v) 
Resolving buffer  
Tris-HCl pH 8.8 1.5 M 
SDS 0.4% (w/v) 
Resolving gel (12%)  
Acrylamide 2.5 ml 
Resolving buffer 1.25 ml 
10 % APS (w/v) 25 Pl 
TEMED 2.5 Pl 
dH2O 1.22 ml 
Staining solution  
Acetic acid 10% (v/v) 
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MeOH 25% (v/v) 
Coomassie brilliant blue R250 0.2% (v/v) 
Stacking buffer  
Tris-HCl pH 6.8 0.5M 
SDS 0.4% (w/v) 
Stacking gel (3%)  
Acrylamide 200 Pl 
Stacking buffer 1 ml 
10% APS (w/v) 25 Pl 
TEMED 2.5 Pl 
dH2O 723 Pl  
Table 9.2: Standard recipes for SDS-PAGE electrophoresis.  
Blotting buffer was stored at 4 qC, ponceau S at RT and blocking and washing solutions 
freshly prepared for each experiment. 
 
